Substituted cyclopropyloxyphenyluracils and salts thereof, and use thereof as herbicidal active substances

Abstract

The present invention relates to cyclopropyloxyphenyluracils of general formula (I), (I) and the salts thereof, wherein the radicals in general formula (I), (I) correspond to the definitions given in the description, and to the use thereof as herbicides, in particular for controlling weeds and / or weed grasses in crops of useful plants, and / or as plant growth regulators for influencing the growth of crops of useful plants.

Description

[0001] Bayer AG Substituted cyclopropyloxyphenyluracils and their salts and their use as herbicidal active ingredients Description The invention relates to the technical field of crop protection agents, in particular to herbicides for the selective control of weeds and grass weeds in crops. Specifically, this invention relates to cyclopropyloxyphenyluracils with 4-difluoroalkyl substitution on the uracil and their salts, processes for their preparation, and their use as herbicides, in particular for controlling weeds and / or grass weeds in crops and / or as plant growth regulators for influencing the growth of crops.Previously known plant protection products for the selective control of weeds in crops or active substances for controlling undesirable plant growth sometimes have disadvantages in their use, either because they (a) have no or insufficient herbicidal activity against certain weeds, (b) have an insufficiently narrow spectrum of weeds that can be controlled with one active substance, (c) have insufficient selectivity in crops, and / or (d) have a toxicologically unfavorable profile. Furthermore, some active substances that can be used as plant growth regulators in some crops lead to undesirably reduced crop yields in others or are incompatible with the crop or only compatible within a narrow application rate range.Some of the known active ingredients cannot be produced economically on an industrial scale due to difficult-to-access precursors and reagents, or they have insufficient chemical stability. For other active ingredients, the effect depends too heavily on environmental conditions, such as weather and soil conditions. The herbicidal effect of these known compounds, especially at low application rates, and their tolerance to crops remain in need of improvement. It is known from various publications that certain substituted N-linked aryluracils can be used as herbicidal active ingredients (cf. EP408382, EP473551, EP648749, US4943309, US5084084, US5127935, WO91 / 00278, WO95 / 29168, WO95 / 30661, WO96 / 35679, WO97 / 01541, WO98 / 25909, WO2001 / 39597). However, the known aryluracils have several gaps in their activity, particularly against monocotyledonous weeds.A number of herbicidal active ingredient combinations based on N-linked aryluracils have also been disclosed (cf. DE4437197, EP714602, WO96 / 07323, WO96 / 08151, JP11189506). However, the properties of these active ingredient combinations are not entirely satisfactory. It is also known that certain N-aryluracils with optionally further substituted lactic acid groups can also be used as herbicidal active ingredients (cf. JP2000 / 302764, JP2001 / 172265, US6403534, EP408382A1). It is also known that N-aryluracils with specific, optionally further substituted, thiolactic acid groups also exhibit herbicidal effects (cf. WO2010 / 038953, KR2011110420, WO2020 / 013500). Selected substituted tetrahydrofuryl esters of N-aryluracils with optionally further substituted thiolactic acid groups are described in JP09188676.Also known are substituted N-benzoic acid uracils that carry chlorine substituents in the benzoic acid moiety (cf. WO91 / 000278, DE19741411, WO95 / 32952, US6207830, WO88 / 10254, EP831091). Furthermore, highly substituted 3-amino-1-(3-carboxy-4-cyanophenyl)uracils with various carboxylate side chains have been described (cf. WO98 / 25909). Highly substituted N-benzoic acid uracils with an aminosulfonylaminocarbonylalkoxy side chain are also known (cf. WO2004 / 009561). It is also known that certain substituted N-benzoic acid thiobarbiturates can be used as herbicidal active ingredients (cf. WO2021 / 259224). It is also known that certain difluoroalkyl-substituted uracils can be used as herbicidal active ingredients (cf. WO8810254; WO2023285222).Surprisingly, it has now been found that certain cyclopropyloxyphenyluracils with 4-difluoroalkyl substitution on the uracil, or salts thereof, are highly suitable as herbicides and can be used particularly advantageously as active ingredients for controlling monocotyledonous and dicotyledonous weeds in crops. The present invention thus relates to substituted cyclopropyloxyphenyluracils of the general formula (I) or salts thereof. where R 1 represents hydrogen, halogen, (C1-C8)-alkoxy, R 2 represents halogen, cyano, nitro, C(O)NH2, C(S)NH2, (C1-C8)-haloalkyl, (C2-C8)-alkynyl, R 3 and R 4 independently of one another represent hydrogen, halogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C1-C8)-alkoxy, where R 3 and R 4 do not simultaneously represent (C1-C8)-alkoxy, R 5 represents hydrogen, halogen, R 6represents (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C2-C8)-alkenyl, aryl-(C1-C8)-alkyl, (C3-C8)-cycloalkyl-(C1-C8)-alkyl, R 7 represents hydrogen, fluorine, chlorine, methyl, G represents unbranched or branched (C1-C8)-alkylene, X represents methyl, amino, Q represents a radical of the following formulas Q -A Q-B steht, R 8 for hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, aryl, aryl-(C1-C8)-alkyl, heteroaryl, (C2-C8)-alkynyl, (C2-C8)-alkenyl, C(O)R 13 , C(O)OR 13 , (C1-C8)-alkoxy-(C1-C8)-alkyl, R 9 represents hydrogen or (C1-C8)-alkyl, R 10 for hydrogen, halogen, cyano, NO2, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C3-C8)-cycloalkyl, (C3-C8)-cycloalkyl-(C1-C8)-alkyl, (C3-C8)-halocycloalkyl, (C3-C8)-halocycloalkyl-(C1-C8)- alkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, aryl, aryl-(C1-C8)-alkyl, heteroaryl, heteroaryl-(C1-C8)-alkyl, heterocyclyl, heterocyclyl-(C1-C8)-alkyl, R 11 R 12 N-(C1-C8)-alkyl, R13 O-(C1-C8)- alkyl, Cyano-(C1-C8)-alkyl, (C1-C8)-Alkylcarbonyloxy-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl- carbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl, Heteroarylcarbonyloxy-(C1-C8)- alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S- (C1-C8)-alkyl, R 14 (O)S-(C1-C8)-alkyl, R 14 O2S-(C1-C8)-alkyl, Tris-[(C1-C8)-Alkyl]silyl-(C1-C8)- alkyl, Bis-[(C1-C8)-Alkyl](aryl)silyl(C1-C8)-alkyl, [(C1-C8)-Alkyl]-bis-(aryl)silyl-(C1-C8)-alkyl, Tris-[(C1-C8)-Alkyl]silyl, Bis-hydroxyboryl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkoxy]boryl-(C1-C8)- alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2-Dioxaborolan-2-yl-(C1-C8)- alkyl, Nitro-(C1-C8)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C8)-alkyl, R 11 R 12 N(O)C-(C1-C8)-alkyl, Bis-(C1-C8)-alkoxy-(C1-C8)-alkyl steht, oder R8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12 are the same or different and independently of one another represent hydrogen, (C1-C8)-alkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C1-C8)-cyanoalkyl, (C1-C10)-haloalkyl, (C2-C8)-haloalkenyl, (C3-C8)-haloalkynyl, (C3-C10)-cycloalkyl, (C3-C10)-halocycloalkyl, (C4-C10)-cycloalkenyl, (C4-C10)-halocycloalkenyl, (C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-haloalkoxy-(C1-C8)-alkyl, (C1-C8)-alkylthio-(C1-C8)-alkyl, (C1-C8)-haloalkylthio-(C1-C8)-alkyl, (C1-C8)-alkoxy-(C1-C8)-haloalkyl, aryl, aryl-(C1-C8)-alkyl, heteroaryl, heteroaryl-(C1-C8)-alkyl, (C3-C8)-cycloalkyl- (C1-C8)-alkyl, (C4-C10)-cycloalkenyl-(C1-C8)-alkyl, COR 13 , SO2R 14, heterocyclyl, (C1-C8)-alkoxycarbonyl, bis-[(C1-C8)-alkyl]aminocarbonyl-(C1-C8)-alkyl, (C1-C8)-alkyl-amino-carbonyl-(C1-C8)-alkyl, aryl-(C1-C8)-alkyl-aminocarbonyl-(C1-C8)-alkyl, Aryl-(C1-C8)-alkoxycarbonyl, heteroaryl-(C1-C8)-alkoxycarbonyl, (C2-C8)-alkenyloxycarbonyl, (C2-C8)-alkynyloxycarbonyl, heterocyclyl-(C1-C8)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13 for hydrogen, (C1-C8)-alkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C1-C8)-cyanoalkyl, (C1-C10)-haloalkyl, (C2-C8)-haloalkenyl, (C3-C8)-haloalkynyl, (C3-C10)-cycloalkyl, (C3-C10)-Halocycloalkyl, (C4-C 10 )-cycloalkenyl, (C4-C 10)-Halocycloalkenyl, (C1-C8)-Alkoxy-(C1-C8)- alkyl, (C1-C8)-Haloalkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)-haloalkyl, (C1-C8)-Alkoxy- (C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, Aryl, Aryl- (C1-C8)-alkyl, Aryl-(C1-C8)-alkoxy-(C1-C8)-alkyl, Heteroaryl, Heteroaryl-(C1-C8)-alkyl, (C3-C8)- Cycloalkyl-(C1-C8)-alkyl, (C4-C 10 )-Cycloalkenyl-(C1-C8)-alkyl, Bis-[(C1-C8)- alkyl]aminocarbonyl-(C1-C8)-alkyl, (C1-C8)-Alkyl-aminocarbonyl-(C1-C8)-alkyl, Aryl-(C1-C8)- alkyl-aminocarbonyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]amino-(C2-C6)-alkyl, (C1-C8)-Alkyl- amino-(C2-C6)-alkyl, Aryl-(C1-C8)-alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C8)-alkyl, R 14 (O)S- (C1-C8)-alkyl, R 14O2S-(C1-C8)-alkyl, Hydroxycarbonyl-(C1-C8)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C8)-alkyl, Tris-[(C1-C8)-Alkyl]silyl-(C1-C8)-alkyl, Bis-[(C1-C8)- Alkyl](aryl)silyl(C1-C8)-alkyl, [(C1-C8)-Alkyl]-bis-(aryl)silyl-(C1-C8)-alkyl, (C1-C8)- Alkylcarbonyloxy-(C1-C8)-alkyl, (C3-C8)-Cycloalkylcarbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl, Heteroarylcarbonyloxy-(C1-C8)-alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, Aryloxy-(C1-C8)-alkyl, Heteroaryloxy-(C1-C8)-alkyl, (C1-C8)-Alkoxycarbonyl steht, R 14für Wasserstoff, (C1-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C1-C8)-Cyanoalkyl, (C1-C10)- Haloalkyl, (C2-C8)-Haloalkenyl, (C3-C8)-Haloalkinyl, (C3-C10)-Cycloalkyl, (C3-C10)- Halocycloalkyl, (C4-C10)-Cycloalkenyl, (C4-C10)-Halocycloalkenyl, (C1-C8)-Alkoxy-(C1-C8)- alkyl, (C1-C8)-Alkoxy-(C1-C8)-haloalkyl, Aryl, Aryl-(C1-C8)-alkyl, Heteroaryl, Heteroaryl- (C1-C8)-alkyl, Heterocyclyl-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl-(C1-C8)-alkyl, (C4-C10)- Cycloalkenyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]amino, (C1-C8)-Alkyl-amino, Aryl-(C1-C8)- amino, Aryl-(C1-C6)-alkyl-amino, Aryl-[(C1-C8)-alkyl]amino; (C3-C8)-Cycloalkyl-amino, (C3- C8)-Cycloalkyl-[(C1-C8)-alkyl]amino; N-Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, N- Morpholinyl steht und R 15 und R 16 unabhängig voneinander für (C1-C8)-Alkyl, (C3-C8)-Cycloalkyl, Aryl, Heteroaryl, Heterocyclyl stehen, oder R 15 und R 16with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle. The compounds of general formula (I) can form salts by addition of a suitable inorganic or organic acid, such as mineral acids such as HCl, HBr, H2SO4, H3PO4 or HNO3, or organic acids, e.g. carboxylic acids such as formic acid, acetic acid, propionic acid, oxalic acid, lactic acid or salicylic acid or sulfonic acids such as p-toluenesulfonic acid, to a basic group such as amino, alkylamino, dialkylamino, piperidino, morpholino or pyridino. These salts then contain the conjugate base of the acid as an anion. Suitable substituents which are present in deprotonated form, such as sulfonic acids, certain sulfonamides or carboxylic acids, can form internal salts with protonatable groups, such as amino groups.Salt formation can also occur through the action of a base on compounds of general formula (I). Suitable bases are, for example, organic amines, such as trialkylamines, morpholine, piperidine and pyridine, as well as ammonium, alkali or alkaline earth metal hydroxides, carbonates and bicarbonates, in particular sodium and potassium hydroxide, sodium and potassium carbonate and sodium and potassium bicarbonate. These salts are compounds in which the acidic hydrogen is replaced by a cation suitable for agriculture, for example metal salts, in particular alkali metal salts or alkaline earth metal salts, in particular sodium and potassium salts, or also ammonium salts, salts with organic amines or quaternary ammonium salts, for example with cations of the formula [NR. a R b R c R d ] + , where R a to R deach independently of one another represents an organic radical, in particular alkyl, aryl, aralkyl or alkylaryl. Alkylsulfonium and alkylsulfoxonium salts, such as (C1-C4)-trialkylsulfonium and (C1-C4)-trialkylsulfoxonium salts, are also suitable. The compounds of formula (I) and their salts used according to the invention are referred to below as "compounds of the general formula (I)". Preferred subject matter of the invention are compounds of the general formula (I) wherein R 1 represents hydrogen, fluorine, chlorine, bromine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, trifluoromethyl, ethynyl, propyn-1-yl, R 3 and R 4 independently of one another represent hydrogen, halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6)-alkoxy, where R 3 and R 4 do not simultaneously represent (C1-C6)-alkoxy, R 5 represents hydrogen, fluorine, chlorine, R 6für (C1-C6)-Alkyl, (C3-C6)-Cycloalkyl, (C2-C6)-Alkenyl, Aryl-(C1-C6)-alkyl, (C3-C6)- Cycloalkyl-(C1- C6)-alkyl steht, R 7 für Wasserstoff, Methyl steht, G für unverzweigtes oder verzweigtes (C1-C6)-Alkylen steht, X für Methyl, Amino steht, Q für einen Rest der nachfolgenden Formeln Q -A Q-B steht, R 8 für Wasserstoff, (C1-C6)-Alkyl, (C1-C6)-Haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, (C2-C6)-Alkinyl, (C2-C6)-Alkenyl, C(O)R 13 , C(O)OR 13 , (C1-C6)-Alkoxy-(C1-C6)-alkyl steht, R 9 für Wasserstoff oder (C1-C6)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C7)-Alkyl, (C1-C7)-Haloalkyl, (C3-C7)-Cycloalkyl, (C3-C7)-Cycloalkyl-(C1-C7)-alkyl, (C3-C7)-Halocycloalkyl, (C3-C7)-Halocycloalkyl-(C1-C7)- alkyl, (C2-C7)-Alkenyl, (C2-C7)-Alkinyl, Aryl, Aryl-(C1-C7)-alkyl, Heteroaryl, Heteroaryl- (C1-C7)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C7)-alkyl, R 11 R 12 N-(C1-C7)-alkyl, R 13O-(C1-C7)- alkyl, Cyano-(C1-C7)-alkyl, (C1-C7)-Alkylcarbonyloxy-(C1-C7)-alkyl, (C3-C7)- Cycloalkylcarbonyloxy-(C1-C7)-alkyl, Arylcarbonyloxy-(C1-C7)-alkyl, Heteroarylcarbonyloxy- (C1-C7)-alkyl, Heterocyclylcarbonyloxy-(C1-C7)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S-(C1-C7)-alkyl, R 14 (O)S-(C1-C7)-alkyl, R 14 O2S-(C1-C7)-alkyl, Tris-[(C1-C7)-Alkyl]silyl- (C1-C7)-alkyl, Bis-[(C1-C7)-Alkyl](aryl)silyl(C1-C7)-alkyl, [(C1-C7)-Alkyl]-bis-(aryl)silyl- (C1-C7)-alkyl, Tris-[(C1-C7)-Alkyl]silyl, Bis-hydroxyboryl-(C1-C7)-alkyl, Bis-[(C1-C7)- alkoxy]boryl-(C1-C7)-alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2- Dioxaborolan-2-yl-(C1-C7)-alkyl, Nitro-(C1-C7)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C7)-alkyl, R 11 R 12 N(O)C-(C1-C7)-alkyl, Bis-(C1-C7)-alkoxy-(C1-C7)-alkyl steht, oder R 8and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12 are the same or different and independently represent hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C1-C6)-cyanoalkyl, (C1-C6)-haloalkyl, (C2-C6)-haloalkenyl, (C3-C6)-haloalkynyl, (C3-C6)-cycloalkyl, (C3-C6)-halocycloalkyl, (C4-C6)-cycloalkenyl, (C4-C6)-halocycloalkenyl, (C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-haloalkoxy-(C1-C6)-alkyl, (C1-C6)-alkylthio-(C1-C6)-alkyl, (C1-C6)-haloalkylthio-(C1-C6)-alkyl, (C1-C6)-alkoxy-(C1-C6)-haloalkyl, aryl, aryl-(C1-C6)-alkyl, heteroaryl, heteroaryl-(C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, (C4-C6)-cycloalkenyl-(C1-C6)-alkyl, C(O)R 13 , SO2R 14, heterocyclyl, (C1-C6)-alkoxycarbonyl, bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxycarbonyl, heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-alkenyloxycarbonyl, (C2-C6)-alkynyloxycarbonyl, heterocyclyl-(C1-C6)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)- Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)- Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, (C1-C6)-Alkoxy-(C1-C6)- alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)- Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, Aryl, Aryl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxy-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl- (C1-C6)-alkyl, (C4-C6)-Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)- alkyl, (C1-C6)-Alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C7)-alkyl-aminocarbonyl-(C1-C6)- alkyl, Bis-[(C1-C6)-alkyl]amino-(C2-C6)-alkyl, (C1-C6)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1-C6)- alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C6)-alkyl, R 14(O)S-(C1-C6)-alkyl, R 14 O2S-(C1-C6)-alkyl, Hydroxycarbonyl-(C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)-alkyl, Tris-[(C1-C6)- Alkyl]silyl-(C1-C6)-alkyl, Bis-[(C1-C6)-Alkyl](aryl)silyl(C1-C6)-alkyl, [(C1-C6)-Alkyl]-bis- (aryl)silyl-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)-alkyl, (C3-C6)- Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy- (C1-C6)-alkyl, Heterocyclylcarbonyloxy-(C1-C6)-alkyl, Aryloxy-(C1-C6)-alkyl, Heteroaryloxy- (C1-C6)-alkyl, (C1-C6)-Alkoxycarbonyl steht, R 14für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)- Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)- Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)- alkyl, Heterocyclyl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C4-C6)-Cycloalkenyl- (C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino, (C1-C6)-Alkyl-amino, Aryl-(C1-C6)-amino, Aryl-(C1- C6)-alkyl-amino, Aryl-[(C1-C6)-alkyl]amino; (C3-C6)-Cycloalkyl-amino, (C3-C6)-Cycloalkyl- [(C1-C6)-alkyl]amino; N-Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, N-Morpholinyl steht, und R 15 und R 16 unabhängig voneinander für (C1-C6)-Alkyl, (C3-C6)-Cycloalkyl, Aryl, Heteroaryl, Heterocyclyl stehen, oder R 15 und R 16with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle. Particularly preferred subject matter of the invention are compounds of the general formula (I), wherein R 1 represents hydrogen, fluorine, chlorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, trifluoromethyl, R 3 and R 4 independently represent hydrogen, halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, R 5 represents hydrogen, fluorine, R 6 represents methyl, ethyl, prop-1-yl, R 7 stands for hydrogen, G stands for unbranched or branched (C1-C5)-alkylene, X stands for methyl, amino, Q stands for a radical of the following formulas Q -A Q-B stands, R 8 for hydrogen, (C1-C5)-alkyl, (C1-C5)-haloalkyl, aryl, aryl-(C1-C5)-alkyl, heteroaryl, (C2-C5)-alkynyl, (C2-C5)-alkenyl, C(O)R 13 , C(O)OR 13, (C1-C5)-Alkoxy-(C1-C5)-alkyl steht, R 9 für Wasserstoff oder (C1-C5)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C6)-Alkyl, (C1-C6)-Haloalkyl, (C3-C6)-Cycloalkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C3-C6)-Halocycloalkyl, (C3-C6)-Halocycloalkyl-(C1-C6)- alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl- (C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)-alkyl, R 11 R 12 N-(C1-C6)-alkyl, R 13 O-(C1-C6)- alkyl, Cyano-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)-alkyl, (C3-C6)- Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy- (C1-C6)-alkyl, Heterocyclylcarbonyloxy-(C1-C6)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S-(C1-C6)-alkyl, R 14 (O)S-(C1-C6)-alkyl, R 14O2S-(C1-C6)-alkyl, tris-[(C1-C6)-alkyl]silyl-(C1-C6)-alkyl, bis-[(C1-C6)-alkyl](aryl)silyl(C1-C6)-alkyl, [(C1-C6)-alkyl]-bis-(aryl)silyl-(C1-C6)-alkyl, Tris-[(C1-C6)-alkyl]silyl, bis-hydroxyboryl-(C1-C6)-alkyl, bis-[(C1-C6)-alkoxy]boryl-(C1-C6)-alkyl, tetramethyl-1,3,2-dioxaborolan-2-yl, tetramethyl-1,3,2- Dioxaborolan-2-yl-(C1-C6)-alkyl, nitro-(C1-C6)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C6)-alkyl, R 11 R 12 N(O)C-(C1-C6)-alkyl, bis-(C1-C6)-alkoxy-(C1-C6)-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12gleich oder verschieden sind und unabhängig voneinander für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)-Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C 10 )-Cycloalkyl, (C3-C6)-Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkylthio-(C1-C6)-alkyl, (C1-C6)-Haloalkylthio-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl- (C1-C6)-alkyl, (C4-C 10 )-Cycloalkenyl-(C1-C6)-alkyl, C(O)R 13 , SO2R 14, heterocyclyl, (C1-C6)-alkoxycarbonyl, bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxycarbonyl, heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-alkenyloxycarbonyl, (C2-C6)-alkynyloxycarbonyl, heterocyclyl-(C1-C6)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C10)- Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)- Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, (C1-C6)-Alkoxy-(C1-C6)- alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)- Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, Aryl, Aryl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxy-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl- (C1-C6)-alkyl, (C4-C6)-Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)- alkyl, (C1-C6)-Alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)- alkyl, Bis-[(C1-C6)-alkyl]amino-(C2-C6)-alkyl, (C1-C6)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1-C6)- alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C6)-alkyl, R 14(O)S-(C1-C6)-alkyl, R 14 O2S-(C1-C6)-alkyl, Hydroxycarbonyl-(C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)-alkyl, Tris-[(C1-C6)- Alkyl]silyl-(C1-C6)-alkyl, Bis-[(C1-C6)-Alkyl](aryl)silyl(C1-C6)-alkyl, [(C1-C6)-Alkyl]-bis- (aryl)silyl-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)-alkyl, (C3-C6)- Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy- (C1-C6)-alkyl, Heterocyclylcarbonyloxy-(C1-C6)-alkyl, Aryloxy-(C1-C6)-alkyl, Heteroaryloxy- (C1-C6)-alkyl, (C1-C6)-Alkoxycarbonyl steht, R 14für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)- Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C10)-Cycloalkyl, (C3-C6)- Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)-Alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-haloalkyl, Aryl, Aryl-(C1-C6)-alkyl, Heteroaryl, Heteroaryl-(C1-C6)- alkyl, Heterocyclyl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C4-C6)-Cycloalkenyl- (C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino, (C1-C6)-Alkyl-amino, Aryl-(C1-C6)-amino, Aryl-(C1- C6)-alkyl-amino, Aryl-[(C1-C6)-alkyl]amino; (C3-C6)-Cycloalkyl-amino, (C3-C6)-Cycloalkyl- [(C1-C6)-alkyl]amino; N-Azetidinyl, N-Pyrrolidinyl, N-Piperidinyl, N-Morpholinyl steht und R 15 und R 16 unabhängig voneinander für (C1-C6)-Alkyl, (C3-C6)-Cycloalkyl, Aryl, Heteroaryl, Heterocyclyl stehen, oder R 15 und R 16with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 6-membered carbocycle. Compounds of the general formula (I) are particularly preferred in the invention, wherein R 1 represents hydrogen, fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, R 3 and R 4 independently represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, trifluoromethyl, R 5 stands for hydrogen, R 6 stands for methyl, ethyl, R 7stands for hydrogen, G stands for methylene, (methyl)methylene, (ethyl)methylene, (prop-1-yl)methylene, (prop-2-yl)methylene, (but-1-yl)methylene, (but-2-yl)methylene, (pent-1-yl)methylene, (pent-2-yl)methylene, (pent-3-yl)methylene, (dimethyl)methylene, (diethyl)methylene, ethylene, n-propylene, (1-methyl)ethyl-1-ene, (2-methyl)ethyl-1-ene, n-butylene, 1-methylpropyl-1-ene, 2-methylpropyl-1-ene, 3-methylpropyl-1-ene, 1,1-dimethylethyl-1-ene, 2,2-dimethylethyl-1-ene, 1-ethylethyl-1-ene, 2-ethylethyl-1-ene, n-pentylene, 1-methylbutyl-1-ene, 2-methylbutyl-1-ene, 3-methylbutyl-1-ene, 4-methylbutyl-1-ene, 1,1-dimethylpropyl-1-ene, 2,2-dimethylpropyl-1-ene, 3,3-dimethylpropyl-1-ene, 1-ethylpropyl-1-ene, n-hexylene, X represents methyl or amino and Q represents one of the following specifically named groups Q-1 to Q-500:

[0002] o ..„.",....,,.S 1, ...„0„.......,,, ,Si, r ,.O. s 4 / Nor 'N., -1,, z 0

[0003] ( )) ... o r ) N ) )

[0004] o / O NVNZ o ..„.".,,,.. ,, / V

[0005] Particularly preferred subject matter of the invention are compounds of the general formula (I), wherein R 1 represents hydrogen, fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, R 3 and R 4 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, R 5 stands for hydrogen, R 6 stands for methyl, ethyl, R 7represents hydrogen, G represents methylene, (methyl)methylene, (ethyl)methylene, (prop-1-yl)methylene, (prop-2-yl)methylene, (but-1-yl)methylene, (pent-1-yl)methylene, (dimethyl)methylene, (diethyl)methylene, ethylene, n-propylene, (1-methyl)ethyl-1-ene, (2-methyl)ethyl-1-ene, n-butylene, 1-methylpropyl-1-ene, 2-methylpropyl-1-ene, 3-methylpropyl-1-ene, 1,1-dimethylethyl-1-ene, 2,2-dimethylethyl-1-ene, 1-ethylethyl-1-ene, 2-ethylethyl-1-ene, n-pentylene, X represents methyl or amino, preferably methyl, and Q represents one of the above-mentioned groups Q-1 to Q-500. In particular, preferred subject matter of the invention are compounds of the general formula (I), wherein R 1 represents hydrogen, fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, R 3 and R 4 independently represent hydrogen, R 5 stands for hydrogen, R 6 stands for methyl, ethyl, R 7represents hydrogen, G represents methylene, (methyl)methylene, (ethyl)methylene, (dimethyl)methylene, ethylene, n-propylene, (1-methyl)ethyl-1-ene, (2-methyl)ethyl-1-ene, n-butylene, X represents methyl or amino, preferably methyl, and Q represents one of the above-mentioned specifically mentioned groups Q-1 to Q-500. Particularly preferred subject matter of the invention are compounds of the general formula (I), wherein R 1 represents hydrogen, fluorine, R 2 stands for chlorine, bromine, cyano, nitro, R 3 and R 4 stand for hydrogen, R 5 stands for hydrogen, R 6 stands for methyl, ethyl, R 7 represents hydrogen, G represents methylene, X represents methyl and Q represents one of the above-mentioned groups Q-1 to Q-500. A particularly preferred subject of the invention are compounds of the general formula (I), wherein R 1 represents fluorine, R 2 stands for chlorine, R3 and R 4 stand for hydrogen, R 5 stands for hydrogen, R 6 stands for methyl, R 7represents hydrogen, G represents methylene, X represents methyl, and Q represents one of the groups Q-371, Q-442, Q-471, or Q-481 specifically mentioned above. The radical definitions listed above, either general or in preferred ranges, apply both to the end products of the formula (I) and, correspondingly, to the starting materials or intermediates required for their preparation. These radical definitions can be combined with one another as desired, i.e., even within the stated preferred ranges. With regard to the compounds according to the invention, the designations used above and below are explained. These are familiar to the person skilled in the art and have, in particular, the meanings explained below: Unless defined otherwise, the general rule for the designation of chemical groups is that the connection to the skeleton or the rest of the molecule occurs via the last-mentioned structural element of the chemical group in question, i.e.for example in the case of (C2-C8)-alkenyloxy via the oxygen atom, and in the case of heterocyclyl-(C1-C8)-alkyl or R. 13 O(O)C-(C1-C8)-alkyl via the C atom of the alkyl group. In a compound chemical group such as heterocyclyl-(C1-C8)-alkyl or R 13 O(O)C-(C1-C8)-alkyl, the term “alkyl” therefore also refers to an alkylene group. For the functional groups C(=O)R 13 , C(=O)OR 13 , C(=O)NR 11 R 12 , NR 11 R 12 , OR 13 , S(O)mR 14The bond to the skeleton or the remainder of the molecule occurs via the first-mentioned structural element of the respective chemical group. According to the invention, "alkylsulfonyl" - alone or as part of a chemical group - stands for straight-chain or branched alkylsulfonyl, preferably with 1 to 8, or with 1 to 6 carbon atoms, e.g.(aber nicht beschränkt auf) (C1-C6)-Alkylsulfonyl wie Methylsulfonyl, Ethyl- sulfonyl, Propylsulfonyl, 1-Methylethylsulfonyl, Butylsulfonyl, 1-Methylpropylsulfonyl, 2-Methyl- propylsulfonyl, 1,1-Dimethylethylsulfonyl, Pentylsulfonyl, 1-Methylbutylsulfonyl, 2-Methylbutyl- sulfonyl, 3-Methylbutylsulfonyl, 1,1-Dimethylpropylsulfonyl, 1,2-Dimethylpropylsulfonyl, 2,2-Di- methylpropylsulfonyl, 1-Ethylpropylsulfonyl, Hexylsulfonyl, 1-Methylpentylsulfonyl, 2-Methyl- pentylsulfonyl, 3-Methylpentylsulfonyl, 4-Methylpentylsulfonyl, 1,1-Dimethylbutylsulfonyl, 1,2-Di- methylbutylsulfonyl, 1,3-Dimethylbutylsulfonyl, 2,2-Dimethylbutylsulfonyl, 2,3-Dimethylbutylsulfonyl, 3,3-Dimethylbutylsulfonyl, 1-Ethylbutylsulfonyl, 2-Ethylbutylsulfonyl, 1,1,2-Trimethylpropylsulfonyl, 1,2,2-Trimethylpropylsulfonyl, 1-Ethyl-1-methylpropylsulfonyl und 1-Ethyl-2-methylpropylsulfonyl.According to the invention, "heteroarylsulfonyl" represents optionally substituted pyridylsulfonyl, pyrimidinylsulfonyl, pyrazinylsulfonyl, or optionally substituted polycyclic heteroarylsulfonyl, here in particular optionally substituted quinolinylsulfonyl, for example substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl, haloalkyl, haloalkoxy, amino, alkylamino, alkylcarbonylamino, dialkylamino, or alkoxy groups. According to the invention, "alkylthio"—alone or as part of a chemical group—represents straight-chain or branched S-alkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as (C1-C10), (C1-C6), or (C1-C4)-alkylthio, e.g.(aber nicht beschränkt auf) (C1-C6)- Alkylthio wie Methylthio, Ethylthio, Propylthio, 1-Methylethylthio, Butylthio, 1-Methylpropylthio, 2-Methylpropylthio, 1,1-Dimethylethylthio, Pentylthio, 1-Methylbutylthio, 2-Methylbutylthio, 3-Methylbutylthio, 1,1-Dimethylpropylthio, 1,2-Dimethylpropylthio, 2,2-Dimethylpropylthio, 1-Ethylpropylthio, Hexylthio, 1-Methylpentylthio, 2-Methylpentylthio, 3-Methylpentylthio, 4-Methyl- pentylthio, 1,1-Dimethylbutylthio, 1,2-Dimethylbutylthio, 1,3-Dimethylbutylthio, 2,2-Dimethylbutyl- thio, 2,3-Dimethylbutylthio, 3,3-Dimethylbutylthio, 1-Ethylbutylthio, 2-Ethylbutylthio, 1,1,2-Tri- methylpropylthio, 1,2,2-Trimethylpropylthio, 1-Ethyl-1-methylpropylthio und 1-Ethyl-2-methyl- propylthio.According to the invention, "alkenylthio" means an alkenyl radical bonded via a sulfur atom, alkynylthio means an alkynyl radical bonded via a sulfur atom, cycloalkylthio means a cycloalkyl radical bonded via a sulfur atom, and cycloalkenylthio means a cycloalkenyl radical bonded via a sulfur atom. "Alkylsulfinyl (alkyl-S(=O)-)", unless defined otherwise elsewhere, according to the invention stands for alkyl radicals bonded to the skeleton via -S(=O)-, such as (C1-C 10)-, (C1-C6)- oder (C1-C4)- Alkylsulfinyl, z. B. (aber nicht beschränkt auf) (C1-C6)-Alkylsulfinyl wie Methylsulfinyl, Ethylsulfinyl, Propylsulfinyl, 1-Methylethylsulfinyl, Butylsulfinyl, 1-Methylpropylsulfinyl, 2-Methylpropylsulfinyl, 1,1-Dimethylethylsulfinyl, Pentylsulfinyl, 1-Methylbutylsulfinyl, 2-Methylbutylsulfinyl, 3-Methyl- butylsulfinyl, 1,1-Dimethylpropylsulfinyl, 1,2-Dimethylpropylsulfinyl, 2,2-Dimethylpropylsulfinyl, 1-Ethylpropylsulfinyl, Hexylsulfinyl, 1-Methylpentylsulfinyl, 2-Methylpentylsulfinyl, 3-Methyl- pentylsulfinyl, 4-Methylpentylsulfinyl, 1,1-Dimethylbutylsulfinyl, 1,2-Dimethylbutylsulfinyl, 1,3-Dimethylbutylsulfinyl, 2,2-Dimethylbutylsulfinyl, 2,3-Dimethylbutylsulfinyl, 3,3-Dimethylbutylsulfinyl, 1-Ethylbutylsulfinyl, 2-Ethylbutylsulfinyl, 1,1,2-Trimethylpropylsulfinyl, 1,2,2-Trimethylpropylsulfinyl, 1-Ethyl-1-methylpropylsulfinyl und 1-Ethyl-2-methylpropylsulfinyl. Analog sind „Alkenylsulfinyl“ und „Alkinylsulfinyl“, erfindungsgemäß definiert als Alkenyl- bzw.Alkynyl radicals that are bonded to the skeleton via -S(=O)-, such as (C2-C10)-, (C2-C6)- or (C2-C4)-alkenylsulfinyl or (C3-C10)-, (C3-C6)- or (C3-C4)-alkynylsulfinyl. Analogously, “alkenylsulfonyl” and “alkynylsulfonyl” are defined according to the invention as alkenyl or alkynyl radicals that are bonded to the skeleton via -S(=O)2-, such as (C2-C10)-, (C2-C6)- or (C2-C4)-alkenylsulfonyl or (C3-C10)-, (C3-C6)- or (C3-C4)-alkynylsulfonyl. “Alkoxy” means an alkyl radical bonded via an oxygen atom, e.g.(but not limited to) (C1-C6) alkoxy such as methoxy, ethoxy, propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-Trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy. Alkenyloxy means an alkenyl radical bonded via an oxygen atom. Alkynyloxy means an alkynyl radical bonded via an oxygen atom, such as (C2-C10)-, (C2-C6)-, or (C2-C4)-alkenoxy or (C3-C10)-, (C3-C6)-, or (C3-C4)-alkynoxy.“Cycloalkyloxy” means a cycloalkyl radical bonded via an oxygen atom, and cycloalkenyloxy means a cycloalkenyl radical bonded via an oxygen atom. “Alkylcarbonyl” (alkyl-C(=O)-), unless defined otherwise elsewhere, represents, according to the invention, alkyl radicals bonded to the skeleton via -C(=O)-, such as (C1-C10)-, (C1-C6)-, or (C1-C4)-alkylcarbonyl. The number of C atoms refers to the alkyl radical in the alkylcarbonyl group. Analogously, “alkenylcarbonyl” and “alkynylcarbonyl,” unless defined otherwise elsewhere, represent, according to the invention, alkenyl and alkynyl radicals, respectively, bonded to the skeleton via -C(=O)-, such as (C2-C. 10 )-, (C2-C6)- or (C2-C4)-alkenylcarbonyl or (C2-C 10), (C2-C6) or (C2-C4) alkynylcarbonyl. The number of C atoms refers to the alkenyl or alkynyl radical in the alkenyl or alkynylcarbonyl group. “Alkoxycarbonyl (alkyl-OC(=O)-)”, unless defined otherwise elsewhere: Alkyl radicals that are bonded to the skeleton via -OC(=O)-, such as (C1-C 10)-, (C1-C6)- or (C1-C4)-alkoxycarbonyl. The number of C atoms refers to the alkyl radical in the alkoxycarbonyl group. Analogously, unless defined otherwise elsewhere, “alkenyloxycarbonyl” and “alkynyloxycarbonyl” represent, according to the invention, alkenyl or alkynyl radicals that are bonded to the skeleton via -OC(=O)-, such as (C2-C10)-, (C2-C6)- or (C2-C4)-alkenyloxycarbonyl or (C3-C10)-, (C3-C6)- or (C3-C4)-alkynyloxycarbonyl. The number of C atoms refers to the alkenyl or alkynyl radical in the alkene or alkynyloxycarbonyl group. According to the invention, the term "alkylcarbonyloxy" (alkyl-C(=O)-O-) stands, unless defined otherwise elsewhere, for alkyl radicals that are bonded to the skeleton via a carbonyloxy group (-C(=O)-O-), such as (C1-C10)-, (C1-C6)-, or (C1-C4)-alkylcarbonyloxy. The number of C atoms refers to the alkyl radical in the alkylcarbonyloxy group.Analogously, "alkenylcarbonyloxy" and "alkynylcarbonyloxy" are defined according to the invention as alkenyl or alkynyl radicals that are bonded to the skeleton via (-C(=O)-O-) with the oxygen, such as (C2-C10)-, (C2-C6)-, or (C2-C4)-alkenylcarbonyloxy or (C2-C10)-, (C2-C6)-, or (C2-C4)-alkynylcarbonyloxy. The number of C atoms refers to the alkenyl or alkynyl radical in the alkenyl or alkynylcarbonyloxy group. In abbreviated forms such as C(O)R. 13 , C(O)OR 13 , OC(O)NR 11 R 12 , or C(O)NR 11 R 12 The abbreviation O in parentheses stands for an oxygen atom bonded to the adjacent carbon atom via a double bond. In abbreviations such as OC(S)OR 13 , OC(S)SR 14 , OC(S)NR 11 R 12, the abbreviation S in parentheses stands for a sulfur atom bonded to the adjacent carbon atom via a double bond. The term “aryl” means an optionally substituted mono-, bi- or polycyclic aromatic system having preferably 6 to 14, in particular 6 to 10 ring C atoms, for example phenyl, naphthyl, anthryl, phenanthrenyl, and the like, preferably phenyl. The term “optionally substituted aryl” also includes multicyclic systems such as tetrahydronaphthyl, indenyl, indanyl, fluorenyl, biphenylyl, where the bonding site is on the aromatic system. From a systematic point of view, “aryl” is generally also included in the term “optionally substituted phenyl”. Preferred aryl substituents here are, for example, hydrogen, halogen, alkyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, halocycloalkyl, alkenyl, alkynyl, aryl, arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heterocyclyl, heterocyclylalkyl, alkoxyalkyl,Alkylthio, Haloalkylthio, Haloalkyl, Alkoxy, Haloalkoxy, Cycloalkoxy, Cycloalkylalkoxy, Aryloxy, Heteroraryloxy, Alkoxyalkoxy, Alkinylalkoxy, Alkenyloxy, Bis-alkylaminoalkoxy, Tris- [alkyl]silyl, Bis-[alkyl]arylsilyl, Bis-[alkyl]alkylsilyl, Tris-[alkyl]silylalkinyl, Arylalkinyl, Heteroarylalkinyl, Alkylalkinyl, Cycloalkylalkinyl, Haloalkylalkinyl, Heterocyclyl-N-alkoxy, Nitro, Cyano, Amino, Alkylamino, Bis-alkylamino, Alkylcarbonylamino, Cycloalkylcarbonylamino, Arylcarbonylamino, Alkoxycarbonylamino, Alkoxycarbonylalkylamino, Arylalkoxycarbonyl- alkylamino, Hydroxycarbonyl, Alkoxycarbonyl, Aminocarbonyl, Alkylaminocarbonyl, Cycloalkylaminocarbonyl, Bis-Alkylaminocarbonyl, Heteroarylalkoxy, Arylalkoxy. Ein heterocyclischer Rest (Heterocyclyl) enthält mindestens einen heterocyclischen Ring (=carbocyclischer Ring, in dem mindestens ein C-Atom durch ein Heteroatom ersetzt ist, vorzugsweise durch ein Heteroatom aus der Gruppe N, O, S, P) der gesättigt, ungesättigt,is partially saturated or heteroaromatic and may be unsubstituted or substituted, with the bonding site being located on a ring atom. If the heterocyclyl radical or the heterocyclic ring is optionally substituted, it may be fused with other carbocyclic or heterocyclic rings. In the case of optionally substituted heterocyclyl, polycyclic systems are also included, such as, for example, 8-aza-bicyclo[3.2.1]octanyl, 8-aza-bicyclo[2.2.2]octanyl or 1-aza-bicyclo[2.2.1]heptyl. In the case of optionally substituted heterocyclyl, spirocyclic systems are also included, such as, for example, 1-oxa-5-aza-spiro[2.3]hexyl. Unless otherwise defined, the heterocyclic ring preferably contains 3 to 9 ring atoms, in particular 3 to 6 ring atoms, and one or more, preferably 1 to 4, in particular 1, 2 or 3 heteroatoms in the heterocyclic ring, preferably from the group N, O, and S,however, two oxygen atoms should not be directly adjacent, such as, for example, with a heteroatom from the group N, O and S 1- or 2- or 3-pyrrolidinyl, 3,4-dihydro-2H-pyrrol-2- or 3-yl, 2,3-dihydro-1H-pyrrol-1- or 2- or 3- or 4- or 5-yl; 2,5-dihydro-1H-pyrrol-1- or 2- or 3-yl, 1- or 2- or 3- or 4-piperidinyl; 2,3,4,5-tetrahydropyridin-2- or 3- or 4- or 5-yl or 6-yl; 1,2,3,6-tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,4-Tetrahydropyridin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4-Dihydropyridin-1- or 2- or 3- or 4-yl; 2,3-Dihydropyridin-2- or 3- or 4- or 5- or 6-yl; 2,5-Dihydropyridin-2- or 3- or 4- or 5- or 6-yl, 1- or 2- or 3- or 4-azepanyl; 2,3,4,5-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1H-azepin-1- or 2- or 3- or 4-yl; 3,4,5,6-Tetrahydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydro-1H-azepin-1- or 2- or 3- or 4-yl; 2,5-Dihydro-1H-azepin-1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-Dihydro-1H-azepin-1- or -2- or 3- or 4-yl; 2,3-Dihydro-1H-azepin-1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 3,4-Dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 3,6-Dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 5,6-Dihydro-2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydro-3H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 1H-azepin-1- or -2- or 3- or 4- or 5- or 6- or 7-yl; 2H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 3H-azepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4H-azepine-2- or 3- or 4- or 5- or 6- or 7-yl, 2- or 3-oxolanyl (= 2- or 3-tetrahydrofuranyl); 2,3-dihydrofuran-2- or 3- or 4- or 5-yl; 2,5-dihydrofuran-2- or 3-yl,2- or 3- or 4-oxanyl (= 2- or 3- or 4-tetrahydropyranyl); 3,4-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-pyran-2- or 3- or 4- or 5- or 6-yl; 2H-pyran-2- or 3- or 4- or 5- or 6-yl; 4H-pyran-2- or 3- or 4-yl, 2- or 3- or 4-oxepanyl; 2,3,4,5-tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydrooxepin-2- or 3- or 4-yl; 2,3-Dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-Dihydrooxepin-2- or 3- or 4-yl; 2,5-Dihydrooxepin-2- or 3- or 4- or 5- or 6- or 7-yl; Oxepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2- or 3-Tetrahydrothiophenyl; 2,3-Dihydrothiophen-2- or 3- or 4- or 5-yl; 2,5-Dihydrothiophen-2- or 3-yl; tetrahydro-2H-thiopyran-2- or 3- or 4-yl; 3,4-Dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 2H-thiopyran-2- or 3- or 4- or 5- or 6-yl; 4H-thiopyran-2- or 3- or 4-yl. Preferred 3-membered and 4-membered heterocycles are, for example, 1- or 2-aziridinyl, oxiranyl, thiiranyl, 1- or 2- or 3-azetidinyl, 2- or 3-oxetanyl, 2- or 3-thietanyl, and 1,3-dioxetan-2-yl. Further examples of “heterocyclyl” are a partially or fully hydrogenated heterocyclic radical having two heteroatoms from the group consisting of N, O, and S, such as, for example, 1- or 2- or 3- or 4-pyrazolidinyl; 4,5-Dihydro-3H-pyrazol- 3- or 4- or 5-yl; 4,5-Dihydro-1H-pyrazol-1- or 3- or 4- or 5-yl; 2,3-Dihydro-1H-pyrazol-1- or 2- or 3- or 4- or 5-yl; 1- or 2- or 3- or 4- imidazolidinyl; 2,3-Dihydro-1H-imidazol-1- or 2- or 3- or 4-yl; 2,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl; 4,5-Dihydro-1H-imidazol-1- or 2- or 4- or 5-yl; Hexahydropyridazin-1- or 2- or 3- or 4-yl; 1,2,3,4-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2,3,6-Tetrahydropyridazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,4,5,6-Tetrahydropyridazin-1- or 3- or 4- or 5- or 6-yl; 3,4,5,6-Tetrahydropyridazin-3- or 4- or 5-yl; 4,5-Dihydropyridazin-3- or 4-yl; 3,4-Dihydropyridazin-3- or 4- or 5- or 6-yl; 3,6-Dihydropyridazin-3- or 4-yl; 1,6-Dihydropyriazin-1- or 3- or 4- or 5- or 6-yl; Hexahydropyrimidin-1- or 2- or 3- or 4-yl; 1,4,5,6-Tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2,5,6-Tetrahydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2,3,4-Tetrahydropyrimidin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,6-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1,2-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 2,5-Dihydropyrimidin-2- or 4- or 5-yl; 4,5-Dihydropyrimidin- 4- or 5- or 6-yl; 1,4-Dihydropyrimidin-1- or 2- or 4- or 5- or 6-yl; 1- or 2- or 3-Piperazinyl; 1,2,3,6-Tetrahydropyrazin-1- or 2- or 3- or 5- or 6-yl; 1,2,3,4-Tetrahydropyrazin-1- or 2- or 3- or 4- or 5- or 6-yl; 1,2-Dihydropyrazin-1- or 2- or 3- or 5- or 6-yl; 1,4-Dihydropyrazin-1- or 2- or 3-yl; 2,3-Dihydropyrazin-2- or 3- or 5- or 6-yl; 2,5-Dihydropyrazin-2- or 3-yl; 1,3-Dioxolan-2- or 4- or 5-yl; 1,3-Dioxol-2- or 4-yl; 1,3-Dioxan-2- or 4- or 5-yl; 4H-1,3-dioxin-2- or 4- or 5- or 6-yl; 1,4-dioxan-2- or 3- or 5- or 6-yl; 2,3-dihydro-1,4-dioxin-2- or 3- or 5- or 6-yl; 1,4-dioxin-2- or 3-yl; 1,2-dithiolan-3- or 4-yl; 3H-1,2-dithiol-3- or 4- or 5-yl; 1,3-dithiolan-2- or 4-yl; 1,3-dithiol-2- or 4-yl; 1,2-dithian-3- or 4-yl; 3,4-dihydro-1,2-dithiin-3- or 4- or 5- or 6-yl; 3,6-Dihydro-1,2-dithiin-3- or 4-yl; 1,2-dithiin-3- or 4-yl; 1,3-dithian-2- or 4- or 5-yl; 4H-1,3-dithiin-2- or 4- or 5- or 6-yl; isoxazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydroisoxazol-2- or 3- or 4- or 5-yl; 2,5-Dihydroisoxazol-2- or 3- or 4- or 5-yl; 4,5-Dihydroisoxazol-3- or 4- or 5-yl; 1,3-Oxazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydro-1,3-oxazol-2- or 3- or 4- or 5-yl; 2,5-Dihydro-1,3-oxazol-2- or 4- or 5-yl; 4,5-Dihydro-1,3-oxazol-2- or 4- or 5-yl; 1,2-Oxazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-4H-1,2-oxazin-3- or 4- or 5- or 6-yl; 2H-1,2-oxazin-2- or 3- or 4- or 5- or 6-yl; 6H-1,2-oxazin-3- or 4- or 5- or 6-yl; 4H-1,2-oxazin-3- or 4- or 5- or 6-yl; 1,3-Oxazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,3-oxazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,3-oxazin- 2- or 4- or 5- or 6-yl; 5,6-dihydro-4H-1,3-oxazin-2- or 4- or 5- or 6-yl; 2H-1,3-oxazin-2- or 4- or 5- or 6-yl; 6H-1,3-oxazin-2- or 4- or 5- or 6-yl; 4H-1,3-oxazin-2- or 4- or 5- or 6-yl; morpholin-2- or 3- or 4-yl; 3,4-dihydro-2H-1,4-oxazin-2- or 3- or 4- or 5- or 6-yl; 3,6-dihydro-2H-1,4-oxazin-2- or 3- or 5- or 6-yl; 2H-1,4-oxazin-2- or 3- or 5- or 6-yl; 4H-1,4-oxazin-2- or 3-yl; 1,2-oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-Dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,7-dihydro-1,2-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 1,2-oxazepin-3- or 4- or 5- or 6- or 7-yl; 1,3-Oxazepan-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,5-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,3-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,5-Dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 2,7-Dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 4,5-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 4,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 6,7-dihydro-1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 1,3-oxazepin-2- or 4- or 5- or 6- or 7-yl; 1,4-oxazepan-2- or 3- or 5- or 6- or 7-yl; 2,3,4,5-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,4,7-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3,6,7-Tetrahydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 2,5,6,7-Tetrahydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 4,5,6,7-Tetrahydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 2,3-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 2,5-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 2,7-Dihydro-1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 4,5-Dihydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 4,7-Dihydro-1,4-oxazepin-2- or 3- or 4- or 5- or 6- or 7-yl; 6,7-Dihydro- 1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; 1,4-oxazepin-2- or 3- or 5- or 6- or 7-yl; Isothiazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydroisothiazol-2- or 3- or 4- or 5-yl; 2,5-Dihydroisothiazol-2- or 3- or 4- or 5-yl; 4,5-Dihydroisothiazol-3- or 4- or 5-yl; 1,3-Thiazolidin-2- or 3- or 4- or 5-yl; 2,3-Dihydro-1,3-thiazol-2- or 3- or 4- or 5-yl; 2,5-Dihydro-1,3-thiazol-2- or 4- or 5-yl; 4,5-Dihydro-1,3-thiazol-2- or 4- or 5-yl; 1,3-Thiazinan-2- or 3- or 4- or 5- or 6-yl; 3,4-Dihydro-2H-1,3-thiazin-2- or 3- or 4- or 5- or 6-yl; 3,6-Dihydro-2H-1,3-thiazin-2- or 3- or 4- or 5- or 6-yl; 5,6-Dihydro-2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 5,6-Dihydro-4H-1,3-thiazin-2- or 4- or 5- or 6-yl; 2H-1,3-thiazin-2- or 4- or 5- or 6-yl; 6H-1,3-thiazin-2- or 4- or 5- or 6-yl; 4H-1,3-Thiazin-2- or 4- or 5- or 6-yl. Further examples of “heterocyclyl” are a partially or fully hydrogenated heterocyclic radical with 3 heteroatoms from the group N, O and S, such as, for example, 1,4,2-dioxazolidin-2- or 3- or 5-yl; 1,4,2-dioxazol-3- or 5-yl; 1,4,2-dioxazinan-2- or -3- or 5- or 6-yl; 5,6-dihydro-1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazin-3- or 5- or 6-yl; 1,4,2-dioxazepan-2- or 3- or 5- or 6- or 7-yl; 6,7-Dihydro-5H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl; 2,3-Dihydro-7H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 2,3-Dihydro-5H-1,4,2-dioxazepin-2- or 3- or 5- or 6- or 7-yl; 5H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl; 7H-1,4,2-dioxazepin-3- or 5- or 6- or 7-yl. Structural examples of optionally further substituted heterocycles are also listed below: ) \ ) \ ) \ \ ) ) ( )

[0006] J 9 ., / IP iel .. / ,Z / \ < / 7' / 13 Die oben aufgeführten Heterocyclen sind bevorzugt beispielsweise durch Wasserstoff, Halogen, Alkyl, Haloalkyl, Hydroxy, Alkoxy, Cycloalkoxy, Aryloxy, Alkoxyalkyl, Alkoxyalkoxy, Cycloalkyl, Halocycloalkyl, Aryl, Arylalkyl, Heteroaryl, Heterocyclyl, Alkenyl, Alkylcarbonyl, Cycloalkylcarbonyl, Arylcarbonyl, Heteroarylcarbonyl, Alkoxycarbonyl, Hydroxycarbonyl, Cycloalkoxycarbonyl, Cycloalkylalkoxycarbonyl, Alkoxycarbonylalkyl, Arylalkoxycarbonyl, Arylalkoxycarbonylalkyl, Alkinyl, Alkinylalkyl, Alkylalkinyl, Tris-alkylsilylalkinyl, Nitro, Amino, Cyano, Haloalkoxy, Haloalkylthio, Alkylthio, Hydrothio, Hydroxyalkyl, Oxo, Heteroarylalkoxy, Arylalkoxy, Heterocyclyl- alkoxy, Heterocyclylalkylthio, Heterocyclyloxy, Heterocyclylthio, Heteroaryloxy, Bis-alkylamino, Alkylamino, Cycloalkylamino, Hydroxycarbonylalkylamino, Alkoxycarbonylalkylamino, Arylalkoxycarbonylalkylamino, Alkoxycarbonylalkyl(alkyl)amino, Aminocarbonyl, Alkylaminocarbonyl, Bis-alkylaminocarbonyl, Cycloalkylaminocarbonyl,Hydroxycarbonylalkylaminocarbonyl, alkoxycarbonylalkylaminocarbonyl, arylalkoxycarbonylalkylaminocarbonyl. If a basic structure is substituted "by one or more residues" from a list of residues (= group) or a generically defined group of residues, this includes simultaneous substitution by several identical and / or structurally different residues. If it is a partially or fully saturated nitrogen heterocycle, it can be linked to the rest of the molecule via both carbon and nitrogen. Possible substituents for a substituted heterocyclic residue are the substituents listed below.Additionally, oxo and thioxo are also included. The oxo group as a substituent on a ring C atom then means, for example, a carbonyl group in the heterocyclic ring. This preferably also includes lactones and lactams. The oxo group can also occur on the hetero ring atoms, which can exist in different oxidation states, e.g., N and S, and then forms, for example, the divalent groups N(O), S(O) (also abbreviated to SO) and S(O)2 (also abbreviated to SO2) in the heterocyclic ring. In the case of -N(O)- and -S(O)- groups, both enantiomers are included. According to the invention, the term "heteroaryl" stands for heteroaromatic compounds, i.e., fully unsaturated aromatic heterocyclic compounds, preferably 5- to 7-membered rings with 1 to 4, preferably 1 or 2 identical or different heteroatoms, preferably O,S oder N. Erfindungsgemäße Heteroaryle sind beispielsweise 1H-Pyrrol-1-yl; 1H-Pyrrol-2-yl; 1H-Pyrrol- 3-yl; Furan-2-yl; Furan-3-yl; Thien-2-yl; Thien-3-yl, 1H-Imidazol-1-yl; 1H-Imidazol-2-yl; 1H-Imidazol- 4-yl; 1H-Imidazol-5-yl; 1H-Pyrazol-1-yl; 1H-Pyrazol-3-yl; 1H-Pyrazol-4-yl; 1H-Pyrazol-5-yl, 1H-1,2,3- Triazol-1-yl, 1H-1,2,3-Triazol-4-yl, 1H-1,2,3-Triazol-5-yl, 2H-1,2,3-Triazol-2-yl, 2H-1,2,3-Triazol-4-yl, 1H-1,2,4-Triazol-1-yl, 1H-1,2,4-Triazol-3-yl, 4H-1,2,4-Triazol-4-yl, 1,2,4-Oxadiazol-3-yl, 1,2,4-Oxa- diazol-5-yl, 1,3,4-Oxadiazol-2-yl, 1,2,3-Oxadiazol-4-yl, 1,2,3-Oxadiazol-5-yl, 1,2,5-Oxadiazol-3-yl, Azepinyl, Pyridin-2-yl, Pyridin-3-yl, Pyridin-4-yl, Pyrazin-2-yl, Pyrazin-3-yl, Pyrimidin-2-yl, Pyrimidin-4-yl, Pyrimidin-5-yl, Pyridazin-3-yl, Pyridazin-4-yl, 1,3,5-Triazin-2-yl, 1,2,4-Triazin-3-yl, 1,2,4-Triazin-5-yl, 1,2,4-Triazin-6-yl, 1,2,3-Triazin-4-yl, 1,2,3-Triazin-5-yl, 1,2,4-, 1,3,2-, 1,3,6- und 1,2,6-Oxazinyl, Isoxazol-3-yl, Isoxazol-4-yl, Isoxazol-5-yl, 1,3-Oxazol-2-yl,1,3-oxazol-4-yl, 1,3-oxazol-5-yl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, 1,3-thiazol-2-yl, 1,3-thiazol-4-yl, 1,3-thiazol-5-yl, oxepinyl, thiepinyl, 1,2,4-triazolonyl and 1,2,4-diazepinyl, 2H-1,2,3,4-tetrazol-5-yl, 1H-1,2,3,4-tetrazol-5-yl, 1,2,3,4-oxatriazol-5-yl, 1,2,3,4-thiatriazol-5-yl, 1,2,3,5-oxatriazol-4-yl, 1,2,3,5-Thiatriazol-4-yl. The heteroaryl groups according to the invention can further be substituted by one or more identical or different radicals. If two adjacent carbon atoms are part of another aromatic ring, these are fused heteroaromatic systems, such as benzofused or multiply fused heteroaromatics. Preferred examples are quinolines (e.g., quinolin-2-yl, quinolin-3-yl, quinolin-4-yl, quinolin-5-yl, quinolin-6-yl, quinolin-7-yl, quinolin-8-yl); isoquinolines (e.g., isoquinolin-1-yl, isoquinolin-3-yl, isoquinolin-4-yl, isoquinolin-5-yl, isoquinolin-6-yl, isoquinolin-7-yl,Isochinolin-8-yl); Chinoxalin; Chinazolin; Cinnolin; 1,5-Naphthyridin; 1,6-Naphthyridin; 1,7-Naphthyridin; 1,8-Naphthyridin; 2,6-Naphthyridin; 2,7- Naphthyridin; Phthalazin; Pyridopyrazine; Pyridopyrimidine; Pyridopyridazine; Pteridine; Pyrimido- pyrimidine. Beispiele für Heteroaryl sind auch 5- oder 6-gliedrige benzokondensierte Ringe aus der Gruppe 1H-Indol-1-yl, 1H-Indol-2-yl, 1H-Indol-3-yl, 1H-Indol-4-yl, 1H-Indol-5-yl, 1H-Indol-6-yl, 1H- Indol-7-yl, 1-Benzofuran-2-yl, 1-Benzofuran-3-yl, 1-Benzofuran-4-yl, 1-Benzofuran-5-yl, 1-Benzo- furan-6-yl, 1-Benzofuran-7-yl, 1-Benzothiophen-2-yl, 1-Benzothiophen-3-yl, 1-Benzothiophen-4-yl, 1- Benzothiophen-5-yl, 1-Benzothiophen-6-yl, 1-Benzothiophen-7-yl, 1H-Indazol-1-yl, 1H-Indazol-3-yl, 1H-Indazol-4-yl, 1H-Indazol-5-yl, 1H-Indazol-6-yl, 1H-Indazol-7-yl, 2H-Indazol-2-yl, 2H-Indazol-3-yl, 2H-Indazol-4-yl, 2H-Indazol-5-yl, 2H-Indazol-6-yl, 2H-Indazol-7-yl, 2H-Isoindol-2-yl, 2H-Isoindol-1- yl, 2H-Isoindol-3-yl, 2H-Isoindol-4-yl,2H-isoindol-5-yl, 2H-isoindol-6-yl; 2H-Isoindol-7-yl, 1H-Benzimidazol-1-yl, 1H-Benzimidazol-2-yl, 1H-Benzimidazol-4-yl, 1H-Benzimidazol-5-yl, 1H-Benzimidazol-6-yl, 1H-Benzimidazol-7-yl, 1,3-Benzoxazol-2-yl, 1,3-Benzoxazol-4-yl, 1,3-Benzoxazol-5-yl, 1,3-Benzoxazol-6-yl, 1,3-Benzoxazol-7-yl, 1,3-Benzthiazol-2-yl, 1,3-Benzthiazol-4-yl, 1,3-Benzthiazol-5-yl, 1,3-Benzthiazol-6-yl, 1,3-Benzthiazol-7-yl, 1,2-benzisoxazol-3-yl, 1,2-Benzisoxazol-4-yl, 1,2-Benzisoxazol-5-yl, 1,2-Benzisoxazol-6-yl, 1,2-Benzisoxazol-7-yl, 1,2-Benzisothiazol-3-yl, 1,2-Benzisothiazol-4-yl, 1,2-Benzisothiazol-5-yl, 1,2-Benzisothiazol-6-yl, 1,2-Benzisothiazol-7-yl. The term "halogen" means, for example, fluorine, chlorine, bromine, or iodine. If the term is used for a radical, then "halogen" means, for example, a fluorine, chlorine, bromine, or iodine atom. According to the invention, "alkyl" means a straight-chain or branched, open-chain, saturated hydrocarbon radical.which is optionally mono- or polysubstituted and in the latter case is referred to as “substituted alkyl”. Preferred substituents are halogen atoms, alkoxy, haloalkoxy, cyano, alkylthio, haloalkylthio, amino or nitro groups, particular preference being given to methoxy, methyl, fluoroalkyl, cyano, nitro, fluorine, chlorine, bromine or iodine. The prefix “bis” also includes the combination of different alkyl radicals, e.g. methyl(ethyl) or ethyl(methyl). “Haloalkyl”, “-alkenyl” and “-alkynyl” mean alkyl, alkenyl or alkynyl which is partially or fully substituted by identical or different halogen atoms, e.g. monohaloalkyl (= monohaloalkyl) such as, for example, CH2CH2Cl, CH2CH2Br, CHClCH3, CH2Cl, CH2F; perhaloalkyl such as, for example, B. CCl3, CClF2, CFCl2, CF2CClF2, CF2CClFCF3; Polyhaloalkyl such as CH2CHFCl, CF2CClFH, CF2CBrFH, CH2CF3; The term perhaloalkyl also includes the term perfluoroalkyl. "Partially fluorinated alkyl" means a straight-chain or branched,saturated hydrocarbon which is mono- or polysubstituted by fluorine, where the corresponding fluorine atoms can be located as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain, such as CHFCH3, CH2CH2F, CH2CH2CF3, CHF2, CH2F, CHFCF2CF3. “Partially fluorinated haloalkyl” means a straight-chain or branched, saturated hydrocarbon which is substituted by various halogen atoms having at least one fluorine atom, where all other optionally present halogen atoms are selected from the group consisting of fluorine, chlorine or bromine,Iodine. The corresponding halogen atoms can be located as substituents on one or more different carbon atoms of the straight-chain or branched hydrocarbon chain. Partially fluorinated haloalkyl also includes the complete substitution of the straight-chain or branched chain by halogen with the participation of at least one fluorine atom. "Haloalkoxy" is, for example, OCF3, OCHF2, OCH2F, OCF2CF3, OCH2CF3, and OCH2CH2Cl; the same applies to haloalkenyl and other halogen-substituted radicals. The term "(C1-C4)-alkyl" used here as an example is a shorthand notation for straight-chain or branched alkyl with one to four carbon atoms, corresponding to the range specified for carbon atoms, i.e., includes the radicals methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methylpropyl, or tert-butyl. General alkyl radicals with a larger specified range of C atoms, e.g. "(C1-C6)-alkyl",Accordingly, they also include straight-chain or branched alkyl radicals with a larger number of carbon atoms, ie, according to the example, also alkyl radicals with 5 and 6 carbon atoms. Unless specifically stated, lower carbon skeletons, e.g., with 1 to 6 carbon atoms, or with 2 to 6 carbon atoms in the case of unsaturated groups, are preferred for hydrocarbon radicals such as alkyl, alkenyl, and alkynyl radicals, even in compound radicals. Alkyl radicals, including compound radicals such as alkoxy, haloalkyl, etc., mean, for example, methyl, ethyl, n- or i-propyl, n-, i-, t- or 2-butyl, pentyls, hexyls, such as n-hexyl, i-hexyl and 1,3-dimethylbutyl, heptyls, such as n-heptyl, 1-methylhexyl and 1,4-dimethylpentyl; alkenyl and alkynyl radicals have the meaning of the possible unsaturated radicals corresponding to the alkyl radicals,containing at least one double bond or triple bond. Preferred are radicals with one double bond or triple bond. The term "alkenyl" includes, in particular, straight-chain or branched open-chain hydrocarbon radicals with more than one double bond, such as 1,3-butadienyl and 1,4-pentadienyl, but also allenyl or cumulenyl radicals with one or more cumulated double bonds, such as, for example, allenyl (1,2-propadienyl), 1,2-butadienyl, and 1,2,3-pentatrienyl. Alkenyl means, for example, vinyl, which may optionally be substituted by further alkyl radicals, e.g. (but not limited to) (C2-C6)-alkenyl such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl,1-Methyl-3-butenyl, 2-Methyl-3- butenyl, 3-Methyl-3-butenyl, 1,1-Dimethyl-2-propenyl, 1,2-Dimethyl-1-propenyl, 1,2-Dimethyl-2- propenyl, 1-Ethyl-1-propenyl, 1-Ethyl-2-propenyl, 1-Hexenyl, 2-Hexenyl, 3-Hexenyl, 4-Hexenyl, 5- Hexenyl, 1-Methyl-1-pentenyl, 2-Methyl-1-pentenyl, 3-Methyl-1-pentenyl, 4-Methyl-1-pentenyl, 1- Methyl-2-pentenyl, 2-Methyl-2-pentenyl, 3-Methyl-2-pentenyl, 4-Methyl-2-pentenyl, 1-Methyl-3- pentenyl, 2-Methyl-3-pentenyl, 3-Methyl-3-pentenyl, 4-Methyl-3-pentenyl, 1-Methyl-4-pentenyl, 2- Methyl-4-pentenyl, 3-Methyl-4-pentenyl, 4-Methyl-4-pentenyl, 1,1-Dimethyl-2-butenyl, 1,1-Dimethyl- 3-butenyl, 1,2-Dimethyl-1-butenyl, 1,2-Dimethyl-2-butenyl, 1,2-Dimethyl-3-butenyl, 1,3-Dimethyl-1- butenyl, 1,3-Dimethyl-2-butenyl, 1,3-Dimethyl-3-butenyl, 2,2-Dimethyl-3-butenyl, 2,3-Dimethyl-1- butenyl, 2,3-Dimethyl-2-butenyl, 2,3-Dimethyl-3-butenyl, 3,3-Dimethyl-1-butenyl, 3,3-Dimethyl-2- butenyl, 1-Ethyl-1-butenyl, 1-Ethyl-2-butenyl, 1-Ethyl-3-butenyl, 2-Ethyl-1-butenyl,2-Ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, and 1-ethyl-2-methyl-2-propenyl. The term "alkynyl" particularly includes straight-chain or branched open-chain hydrocarbon radicals with more than one triple bond or with one or more triple bonds and one or more double bonds, such as 1,3-butatrienyl or 3-penten-1-yn-1-yl. (C2-C6)-alkynyl means, for example, ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-Methyl-3-pentynyl, 1-Methyl-4-pentynyl, 2-Methyl-3-pentynyl, 2-Methyl-4-pentynyl, 3-Methyl-1-pentynyl, 3-Methyl-4-pentynyl, 4-Methyl-1-pentynyl, 4-Methyl-2-pentynyl,1,1-Dimethyl-2-butynyl, 1,1-Dimethyl-3-butynyl, 1,2-Dimethyl-3-butynyl, 2,2-Dimethyl-3-butynyl, 3,3-Dimethyl-1-butynyl, 1-Ethyl-2-butynyl, 1-Ethyl-3-butynyl, 2-Ethyl-3-butynyl and 1-Ethyl-1-methyl-2-propynyl. The term "cycloalkyl" means a carbocyclic, saturated ring system with preferably 3-8 ring carbon atoms, e.g., cyclopropyl, cyclobutyl, cyclopentyl, or cyclohexyl, which is optionally further substituted, preferably by hydrogen, alkyl, alkoxy, oxo, cyano, nitro, alkylthio, haloalkylthio, halogen, alkenyl, alkynyl, haloalkyl, amino, alkylamino, bisalkylamino, alkoxycarbonyl, hydroxycarbonyl, arylalkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, cycloalkylaminocarbonyl. In the case of optionally substituted cycloalkyl, cyclic systems with substituents are included, including substituents with a double bond on the cycloalkyl radical, e.g., an alkylidene group such as methylidene.are included. In the case of optionally substituted cycloalkyl, polycyclic aliphatic systems are also included, such as bicyclo[1.1.0]butan-1-yl, bicyclo[1.1.0]butan-2-yl, bicyclo[2.1.0]pentan-1-yl, bicyclo[1.1.1]pentan-1-yl, bicyclo[2.1.0]pentan-2-yl, bicyclo[2.1.0]pentan-5-yl, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]hept-2-yl, bicyclo[2.2.2]octan-2-yl, bicyclo[3.2.1]octan-2-yl, bicyclo[3.2.2]nonan-2-yl, adamantan-1-yl and adamantan-2-yl, but also systems such as. B. 1,1'-Bi(cyclopropyl)-1-yl, 1,1'-Bi(cyclopropyl)-2-yl. The term "(C3-C7)-cycloalkyl" is a shorthand for cycloalkyl with three to seven carbon atoms, corresponding to the range for C atoms. In the case of substituted cycloalkyl, spirocyclic aliphatic systems are also included, such as spiro[2.2]pent-1-yl, spiro[2.3]hex-1-yl, spiro[2.3]hex-4-yl, 3-spiro[2.3]hex-5-yl, spiro[3.3]hept-1-yl, spiro[3.3]hept-2-yl. "Cycloalkenyl" means a carbocyclic,Non-aromatic, partially unsaturated ring system with preferably 4-8 C atoms, e.g. 1-cyclobutenyl, 2-cyclobutenyl, 1-cyclopentenyl, 2-cyclopentenyl, 3-cyclopentenyl, or 1-cyclohexenyl, 2-cyclohexenyl, 3-cyclohexenyl, 1,3-cyclohexadienyl or 1,4-cyclohexadienyl, which also includes substituents with a double bond on the cycloalkenyl radical, e.g. an alkylidene group such as methylidene. In the case of optionally substituted cycloalkenyl, the explanations for substituted cycloalkyl apply accordingly. The term "alkylidene", e.g. B. also in the form (C1-C10)-alkylidene, means the residue of a straight-chain or branched open-chain hydrocarbon residue bonded via a double bond. Naturally, only positions on the parent structure where two H atoms can be replaced by the double bond are possible as bonding sites for alkylidene; residues are, for example, =CH2, =CH-CH3, =C(CH3)-CH3,=C(CH3)-C2H5 or =C(C2H5)-C2H5. Cycloalkylidene means a carbocyclic radical bonded via a double bond. "Cycloalkylalkyloxy" means a cycloalkylalkyl radical bonded via an oxygen atom, and "arylalkyloxy" means an arylalkyl radical bonded via an oxygen atom. "Alkoxyalkyl" means an alkoxy radical bonded via an alkyl group, and "alkoxyalkoxy" means an alkoxyalkyl radical bonded via an oxygen atom, e.g. (but not limited to) methoxymethoxy, methoxyethoxy, ethoxyethoxy,Methoxy-n-propyloxy. “Alkylthioalkyl” means an alkylthio group attached to an alkyl group, and “alkylthioalkylthio” means an alkylthioalkyl group attached to an oxygen atom. “Arylalkoxyalkyl” means an alkyl-group attached to an aryloxy group, and “heteroaryloxyalkyl” means a heteroaryloxy group attached to an alkyl group. “Haloalkoxyalkyl” means a attached haloalkoxy group, and “haloalkylthioalkyl” means a haloalkylthio group attached to an alkyl group. “Arylalkyl” means an alkyl-group attached to an aryl group, “heteroarylalkyl” means a heteroaryl group attached to an alkyl group, and “heterocyclylalkyl” means a heterocyclyl group attached to an alkyl group. “Cycloalkylalkyl” means a cycloalkyl group attached to an alkyl group, e.g. E.g. (but not limited to) cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, 1-cyclopropyleth-1-yl, 2-cyclopropyleth-1-yl,1-Cyclopropylprop-1-yl, 3-Cyclopropylprop-1-yl. "Arylalkenyl" refers to an aryl radical bonded via an alkenyl group, "heteroarylalkenyl" refers to a heteroaryl radical bonded via an alkenyl group, and "heterocyclylalkenyl" refers to a heterocyclyl radical bonded via an alkenyl group. "Arylalkynyl" refers to an aryl radical bonded via an alkynyl group, "heteroarylalkynyl" refers to a heteroaryl radical bonded via an alkynyl group, and "heterocyclylalkynyl" refers to a heterocyclyl radical bonded via an alkynyl group. According to the invention, "haloalkylthio" - alone or as part of a chemical group - stands for straight-chain or branched S-haloalkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as (C1-C8)-, (C1-C6)- or (C1-C4)-haloalkylthio, e.g. (but not limited to) trifluoromethylthio, pentafluoroethylthio, difluoromethyl, 2,2-difluoroeth-1-ylthio, 2,2,2-difluoroeth-1-ylthio, 3,3,3-prop-1-ylthio. “Halocycloalkyl” and “halocycloalkenyl” mean radicals substituted by identical or different halogen atoms, such as F, Cl and Br, or by haloalkyl, such as B. Trifluoromethyl or difluoromethyl partially or fully substituted cycloalkyl or cycloalkenyl, e.g. 1-fluorocycloprop-1-yl, 2-fluorocycloprop-1-yl, 2,2-difluorocycloprop-1-yl, 1-fluorocyclobut-1-yl, 1-trifluoromethylcycloprop-1-yl, 2-trifluoromethylcycloprop-1-yl, 1-chlorocycloprop-1-yl, 2-chlorocycloprop-1-yl, 2,2-dichlorocycloprop-1-yl, 3,3-difluorocyclobutyl. According to the invention, "trialkylsilyl" - alone or as part of a chemical group - represents straight-chain or branched Si-alkyl, preferably having 1 to 8, or having 1 to 6 carbon atoms, such as tri-[(C1-C8)-, (C1-C6)- or (C1-C4)-alkyl]silyl, e.g. (but not limited to) trimethylsilyl, triethylsilyl, tri-(n-propyl)silyl, tri-(iso-propyl)silyl, tri-(n-butyl)silyl, tri-(1-methyl-prop-1-yl)silyl, tri-(2-methylprop-1-yl)silyl,Tri(1,1-Dimethyleth-1-yl)silyl, Tri(2,2-Dimethyleth-1-yl)silyl. "Trialkylsilylalkynyl" stands for a trialkylsilyl radical bonded via an alkynyl group. If the compounds can form tautomers by hydrogen shift, which structurally would not be formally covered by formula (I), these tautomers are nevertheless encompassed by the definition of the compounds of formula (I) according to the invention, unless a specific tautomer is considered. For example, many carbonyl compounds can exist in both the keto form and the enol form, both forms being encompassed by the definition of the compound of formula (I). The compounds of general formula (I) can exist as stereoisomers depending on the nature and linkage of the substituents. The possible stereoisomers defined by their specific spatial form, such as enantiomers, diastereomers,Z and E isomers are all encompassed by formula (I). If, for example, one or more alkenyl groups are present, diastereomers (Z and E isomers) can occur. If, for example, one or more asymmetric carbon atoms are present, enantiomers and diastereomers can occur. Stereoisomers can be obtained from the mixtures obtained during production using conventional separation methods. The chromatographic separation can be carried out both on an analytical scale to determine the enantiomeric excess or diastereomeric excess, and on a preparative scale to produce test samples for biological testing. Stereoisomers can also be selectively produced by using stereoselective reactions using optically active starting materials and / or auxiliaries. The invention thus also relates to all stereoisomers encompassed by general formula (I) but not specified with their specific stereoform.and mixtures thereof. If the compounds are obtained as solids, purification can also be carried out by recrystallization or digestion. If individual compounds (I) cannot be satisfactorily obtained by the methods described below, they can be prepared by derivatization of other compounds (I). Suitable methods for the isolation, purification and stereoisomer separation of compounds of the formula (I) are methods that are generally known to the person skilled in the art from analogous cases, e.g. by physical processes such as crystallization, chromatography processes, especially column chromatography and HPLC (high-pressure liquid chromatography), distillation, optionally under reduced pressure, extraction and other processes. Any remaining mixtures can generally be separated by chromatographic separation, e.g. on chiral solid phases.be separated. For preparative quantities or on an industrial scale, processes such as crystallization are suitable, e.g. of diastereomeric salts, which can be obtained from the diastereomer mixtures with optically active acids and, if acidic groups are present, with optically active bases. Synthesis of substituted cyclopropyloxyphenyluracils of the general formula (I): The substituted cyclopropyloxyphenyluracils of the general formula (I) according to the invention can be prepared starting from known processes. The synthetic routes used and investigated start from commercially available or easily prepared synthetic building blocks. The groups G, Q, X, R, 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 and R 16In the following schemes, the terms of general formula (I) have the meanings defined above, unless they are given as examples but not as limitations. The synthesis of the cyclopropanoxyphenyluracils of general formulas Ia, Ib, and Ic proceeds as described below in Scheme 1. Scheme 1 The synthesis of 2-(dimethylamino)-4-(haloalkyl)-6H-1,3-oxazin-6-ones of type (III) is carried out in a two-step synthesis sequence (as described in WO2000 / 049002 A1) starting from the corresponding aminoacrylic acid esters, e.g. ethyl (2Z)-3-amino-4,4-difluoropent-2-enoate by reaction with dimethylcarbamoyl chloride in N,N-dimethylformamide (DMF) using a suitable base (e.g. sodium hydride or potassium tert-butoxide) and subsequent cyclization of the crotonate (II) to the oxazin-6-one (III) using phosphorus pentachloride and phosphorus oxychloride.The synthesis of ethyl (2Z)-3-amino-4,4-difluoropent-2-enoate, presented here as an example but not as a limitation, as starting material, takes place in a two-step synthesis sequence by converting the commercially available ethyl 2,2-difluoropropionate into the corresponding β-ketoester by means of Claisen condensation and subsequent conversion into the (2Z)-3-amino-4,4-difluoropent-2-enoate in the presence of ammonium acetate in ethanol. Starting from the thus obtained oxazin-6-one (III) and the literature-known (for preparation see, for example, JP60158147, EP61741 A2, WO2002020531 A2) or commercially available 3-aminophenols (IV), the synthesis of phenyluracil (V) takes place by a condensation reaction using acetic acid as the solvent at a suitable temperature. By subsequent N-alkylation, shown here as an example but not restrictively as N-methylation., is converted into N-alkyl-N'-methoxyphenyluracil (V), whereby under the reaction conditions the O-methylation of the phenol group also occurs simultaneously. The alkylation is carried out using a suitable base (e.g. sodium hydride, potassium tert-butoxide, or potassium carbonate) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform, N,N-dimethylacetamide, or N,N-dimethylformamide). The subsequent selective ether cleavage of the methoxy ether group of N-alkyl-N'-methoxyphenyluracil (V) is achieved using phosphorus tribromide in dichloromethane as the solvent at a suitable temperature and yields the N-alkyl-N'-phenoluracils (VI). Starting from the phenol building block (VI) accessible in this way (cf. also EP255047 A1; WO2003099009 A1; WO9854155 A1), the open-chain alkyloxyphenyluracil (VIII) is obtained by reaction with a corresponding 2,4-dibromobutanoic acid methyl ester (VII) using a suitable base (e.g.Potassium carbonate, cesium carbonate, or sodium carbonate) in a suitable polar aprotic solvent. Subsequent cyclization of the alkyloxyphenyluracil (VIII) using a suitable base (e.g., potassium tert-butoxide, potassium carbonate, cesium carbonate, or sodium carbonate) in a suitable polar aprotic solvent at elevated temperature yields the cyclopropaneoxyphenyluracil (IX). Ester hydrolysis of the alkyl ester side chain of the cyclopropaneoxyphenyluracil (IX) is carried out using a suitable acid, such as, for example, hydrochloric acid or acetic acid, and allows the synthesis of the cyclopropyloxyphenyluracil carboxylic acid (X). The cyclopropyloxyphenyluracil carboxylic acid (X) thus obtained is subsequently reacted with a suitable, optionally further substituted 2-haloalkylcarboxylic acid allyl ester, represented here by way of example but not limitation as α-bromoacetate allyl ester, using a suitable base (e.g.,potassium carbonate, cesium carbonate or sodium carbonate) in a suitable polar aprotic solvent into the cyclopropyloxyphenyluracil carboxylic acid allyl ester (Ia). Alternatively, the preparation of the cyclopropyloxyphenyluracil carboxylic acid allyl ester (Ia) can be carried out by reacting the cyclopropyloxyphenyluracil carboxylic acid (X) with a suitable optionally further substituted 2-hydroxyalkylcarboxylic acid allyl ester, represented here by way of example but not limitation as α-hydroxyacetic acid allyl ester, using suitable coupling reagents (e.g. HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide) and suitable bases (e.g. diisopropylethylamine, triethylamine) in a suitable polar aprotic solvents (e.g. dichloromethane, chloroform).Selective ester cleavage of the terminal allyl ester group of cyclopropyloxyphenyluracil (Ia) is achieved using phenylsilane in the presence of a suitable Pd catalyst, e.g., tetrakis(triphenylphosphine)palladium(0) in dichloromethane, yielding cyclopropyloxyphenyluracil (Ib) in the form of the carboxylic acid. This cyclopropyloxyphenyluracilcarboxylic acid (Ib) can then be converted into various ester variants of cyclopropyloxyphenyluracil (Ia) by esterification with a suitable alcohol R-OH. The esterification can be carried out, as shown by way of example but not limitation in Scheme 1, using suitable coupling reagents (e.g. HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl-1,3,5,2,4,6-trioxatri-phosphorinane-2,4,6-trioxide) and suitable bases (e.g.Diisopropylethylamine, triethylamine) in a suitable polar aprotic solvent (e.g., dichloromethane, chloroform). Alternatively, esterification with a suitable alcohol R-OH to various ester variants of the cycloalkyloxyphenyluracil (Ia) can be carried out via transformation into the acid chloride using thionyl chloride, using a suitable polar aprotic solvent (e.g., dichloromethane (DCM), chloroform, N,N-dimethylacetamide (DMA), or N,N-dimethylformamide (DMF)). The synthesis of the N-aminouracils of the general formulas Id, Ie, and If proceeds as described below by way of example in Scheme 2.

[0007] Scheme 2 Starting from the phenol building block (VI) already described above (cf. also the literature references EP255047 A1; WO2003099009 A1; WO9854155 A1), the open-chain alkyloxyphenyluracil (XII) is obtained by reaction with a corresponding 2,4-dibromobutanoic acid methyl ester (VII) using a suitable base (e.g. potassium carbonate, cesium carbonate or sodium carbonate) in a suitable polar aprotic solvent. The subsequent cyclization of the alkyloxyphenyluracil (XII) using a suitable base (e.g. potassium tert-butoxide, potassium carbonate, cesium carbonate or sodium carbonate) in a suitable polar aprotic solvent at elevated temperature yields the cyclopropanoxyphenyluracil (XII). Subsequent N-amination of the uracil nitrogen using a suitable aminating reagent LG-NH2 (e.g.Conversion to N-aminouracil (XIII) occurs with the aid of hydroxylamines (e.g., O-(mesitylsulfonyl)hydroxylamine, O-(tolylsulfonyl)hydroxylamine, O-(diphenylphosphoryl)hydroxylamine, O-(2,4-dinitrophenyl)hydroxylamine). The N-amination is carried out using a suitable base (e.g., sodium hydride, potassium tert-butoxide, or potassium carbonate) in a suitable polar aprotic solvent (e.g., dichloromethane, chloroform, N,N-dimethylacetamide, or N,N-dimethylformamide). Ester hydrolysis of the alkyl ester side chain of the N-aminouracils (XIII) is carried out using a suitable acid, such as hydrochloric acid or acetic acid, and thus allows the synthesis of the cycloalkyloxyphenyluracil carboxylic acid (XIV).The cycloalkyloxyphenyluracil carboxylic acid (XIV) thus obtained is subsequently converted into the cycloalkyloxyphenyluracil carboxylic acid allyl ester (Id) by reaction with a suitable, optionally further substituted 2-haloalkylcarboxylic acid allyl ester, represented here by way of example but not limitation as α-bromoacetic acid allyl ester, using a suitable base (e.g. potassium carbonate, cesium carbonate or sodium carbonate) in a suitable polar aprotic solvent. Alternatively, the preparation of the cycloalkyloxyphenyluracil carboxylic acid allyl ester (Id) can be carried out by reacting the cycloalkyloxyphenyluracil carboxylic acid (XIV) with a suitable optionally further substituted 2-hydroxyalkylcarboxylic acid allyl ester, represented here by way of example but not limitation as α-hydroxyacetic acid allyl ester, using suitable coupling reagents (e.g.HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl- 1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide) and suitable bases (e.g. diisopropylethylamine, triethylamine) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform). Selective ester cleavage of the terminal allyl ester group of cycloalkyloxyphenyluracil (Id) is achieved using phenylsilane in the presence of a suitable Pd catalyst, e.g., tetrakis(triphenylphosphine)palladium(0) in dichloromethane, yielding the cyclopropyloxyphenyluracils (Ie) in the form of the carboxylic acid. This cycloalkyloxyphenyluracilcarboxylic acid (Ie) can then be converted into various ester variants of the N-aminocycloalkyloxyphenyluracil (If) by esterification with a suitable alcohol R-OH.The esterification can be carried out, as shown by way of example but not limitation in Scheme 2, using suitable coupling reagents (e.g., HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide) and suitable bases (e.g., diisopropylethylamine, triethylamine) in a suitable polar aprotic solvent (e.g., dichloromethane, chloroform). The synthesis of the cyclopropanoxynitrophenyluracils of the general formulas Ig, Ih, and Ii proceeds as described below in Scheme 3.

[0008] Scheme 3 Starting from nitrophenyluracil (XV) (prepared in analogy to WO2021013800 starting from 2-(dimethylamino)-4-(haloalkyl)-6H-1,3-oxazin-6-ones of type (III)), access to cyclopropanoxynitrophenyluracil (XVII) is achieved by reaction with the commercially available 1-hydroxy-1-cyclopropanecarboxylic acid methyl ester (XVI) using a suitable base (e.g. potassium tert-butoxide, potassium carbonate, cesium carbonate or sodium carbonate) in a suitable polar aprotic solvent at elevated temperature. The ester hydrolysis of the alkyl ester side chain of cyclopropanoxynitrophenyluracil (XVII) is carried out using a suitable acid such as hydrochloric acid or acetic acid and allows the synthesis of cyclopropanoxynitrophenyluracil carboxylic acid (XVIII).The cyclopropanoxynitrophenyluracil carboxylic acid (XVIII) thus obtained is subsequently converted into the cyclopropyloxynitrophenyluracil carboxylic acid allyl ester (Ig) by reaction with a suitable, optionally further substituted 2-haloalkylcarboxylic acid allyl ester, represented here by way of example but not limitation as α-bromoacetic acid allyl ester, using a suitable base (e.g. potassium carbonate, cesium carbonate or sodium carbonate) in a suitable polar aprotic solvent. Alternatively, the cyclopropyloxynitrophenyluracil carboxylic acid allyl ester (Ig) can be prepared by reacting the cyclopropanoxynitrophenyluracil carboxylic acid (XVIII) with a suitable, optionally further substituted 2-hydroxyalkylcarboxylic acid allyl ester, represented here by way of example but not limitation as α-hydroxyacetic acid allyl ester, using suitable coupling reagents (e.g.HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-azabenzotriazol-1-yl)- N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide) and suitable bases (e.g. diisopropylethylamine, triethylamine) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform). Selective ester cleavage of the terminal allyl ester group of cyclopropyloxynitrophenyluracil carboxylic acid allyl ester (Ig) is achieved using phenylsilane in the presence of a suitable Pd catalyst, e.g., tetrakis(triphenylphosphine)palladium(0) in dichloromethane, yielding cyclopropyloxynitrophenyluracil (Ih) in the form of the carboxylic acid. This cyclopropyloxyphenylnitrouracil carboxylic acid (Ih) can then be converted into various ester variants of cyclopropaneoxynitrophenyluracil (Ii) by esterification with a suitable alcohol R-OH.The esterification can be carried out, as shown by way of example but not limitation in Scheme 3, using suitable coupling reagents (e.g. HOBt = 1-hydroxybenzotriazole, EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide, HATU = O-(7-azabenzotriazol-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, T3P = 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide) and suitable bases (e.g. diisopropylethylamine, triethylamine) in a suitable polar aprotic solvent (e.g. dichloromethane, chloroform). Alternatively, esterification with a suitable alcohol R-OH to various ester variants of the cycloalkyloxyphenyluracil (Ic) can be carried out via transformation into the acid chloride using thionyl chloride, using a suitable polar aprotic solvent (e.g. dichloromethane (DCM), chloroform, N,N-dimethylacetamide (DMA) or N,N-dimethylformamide (DMF)).Selected detailed synthesis examples for the compounds of the general formula (I) according to the invention are listed below. The example numbers given correspond to the numbering in Tables I.1 to I.26 below. The 1H-NMR, 13C-NMR and 19F-NMR spectroscopic data given for the chemical examples described in the following sections (400 MHz for 1H-NMR and 150 MHz for 13C-NMR and 375 MHz for 19F-NMR, solvent CDCl3, CD3OD or d6-DMSO, internal standard: tetramethylsilane δ = 0.00 ppm) were obtained using a Bruker instrument, and the designated signals have the meanings listed below: br = broad(es); s = singlet, d = doublet, t = triplet, dd = double doublet, ddd = doublet of a double doublet, m = multiplet, p = pseudo, q = quartet, quint = quintet, sext = sextet, sept = septet, dq = double quartet, dt = double triplet.For mixtures of diastereomers, either the significant signals of both diastereomers or the characteristic signal of the major diastereomer are given. The abbreviations used for chemical groups have, for example, the following meanings: Me = CH3, Et = CH2CH3, t-Hex = C(CH3)2CH(CH3)2, t-Bu = C(CH3)3, n-Bu = unbranched butyl, n-Pr = unbranched propyl, i-Pr = branched propyl, c-Pr = cyclopropyl, c-Hex = cyclohexyl. Synthesis Examples: No. I.1-471: 2-(Allyloxy)-2-oxoethyl-1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylate. 5-Amino-2-chloro-4-fluorophenol (3000 mg, 18.57 mmol) was dissolved in 70 mL of acetic acid along with 4-(1,1-difluoroethyl)-2-(dimethylamino)-6H-1,3-oxazin-6-one (5118 mg, 25.07 mmol; prepared analogously to WO2000 / 049002) and stirred for 2 h at 110 °C. After complete conversion, the reaction mixture was concentrated, the residue was treated with water, and then thoroughly extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered, and concentrated under reduced pressure. Final purification by column chromatography yielded 3-(4-chloro-2-fluoro-5-hydroxyphenyl)-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (4163 mg, purity: 95%, 66% of theory), which was subsequently further reacted. 3-(4-chloro-2-fluoro-5-hydroxyphenyl)-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (4000 mg, 12.48 mmol) was dissolved in 57 mL of dichloromethane and subsequently treated at room temperature with triethylamine (3156 mg, 31.1%).19 mmol) and tert-butylsilyl chloride (3760 mg, 24.95 mmol) were added. The reaction solution was then stirred at room temperature for 1 h. After TLC monitoring, the mixture was quenched with water, and the aqueous phase was thoroughly extracted several times with dichloromethane. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. Final purification by column chromatography afforded 3-(5-{[tert-butyl(dimethyl)silyl]oxy}-4-chloro-2-fluorophenyl)-6-(1,1-difluoroethyl)pyrimidine-2,4(1H,3H)-dione (5190 mg, purity: 98%, 94% of theory), which was subsequently reacted further. The thus generated 3-(5-{[tert-butyl(dimethyl)silyl]oxy}-4-chloro-2-fluorophenyl)-6-(1,1-difluoroethyl)-pyrimidine-2,4(1H,3H)-dione (440 mg, 1.01 mmol) was dissolved in 10 mL of N,N-dimethylformamide, treated with potassium carbonate (699 mg, 5.06 mmol) and subsequently iodomethane (431 mg, 3.04 mmol) was added.The reaction solution was then stirred at room temperature for 2 h. After monitoring by TLC, the mixture was quenched with water, and the aqueous phase was thoroughly extracted several times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered, and carefully concentrated under reduced pressure. Subsequent purification by column chromatography afforded 3-(4-chloro-2-fluoro-5-methoxyphenyl)-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (378 mg, purity: 94%, 99% of theory) as a colorless oil, which was further reacted. The resulting 3-(4-chloro-2-fluoro-5-methoxyphenyl)-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (3240 mg, 9.29 mmol) was dissolved in 30 mL of dichloromethane and cooled to -78 °C using a dry ice bath. Subsequently, boron tribromide (1M solution in dichloromethane, 27.88 mL, 27.88 mmol) was added dropwise and stirred for 2 h at -78 °C.The reaction solution was allowed to warm to room temperature overnight and then quenched by adding water. After phase separation, the aqueous phase was extracted several times. The combined organic phases were washed four times with water, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. Purification of the crude product by column chromatography yielded 3-(4-chloro-2-fluoro-5-hydroxyphenyl)-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (3050 mg, purity: 92%, 90% of theory) as a colorless oil, which was then used in the next step. 3-(4-Chloro-2-fluoro-5-hydroxyphenyl)-6-(1,1-difluoroethyl)-1-methylpyrimidine-2,4(1H,3H)-dione (3050 mg, 9.11 mmol) was dissolved in 30 mL DMF, potassium carbonate (1637 mg, 11.8 mmol) was added, and subsequently methyl 2,4-dibromobutanoate (3079 mg, 11.8 mmol) was added portionwise.The reaction solution was then stirred for 8 hours at room temperature (monitored by TLC). The reaction solution was then poured into 1N hydrochloric acid solution. Ethyl acetate was added, and the aqueous phase was extracted several times. The combined organic phases were washed three times with water, dried over magnesium sulfate, filtered, and concentrated under reduced pressure. Purification of the crude product by column chromatography afforded methyl 4-bromo-2-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}butanoate (2974 mg, purity: 95%, 60% of theory) as a colorless oil, which was subsequently reacted further. The resulting methyl 4-bromo-2-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}butanoate (2980 mg, 5.80 mmol) was dissolved in 51 mL of tetrahydrofuran and treated portionwise with potassium tert-butoxide (97%; 705 mg, 6.09 mmol) was added. The reaction solution was then stirred for 6 h at room temperature and, after standing overnight, was then poured into 1N hydrochloric acid solution. It was treated with ethyl acetate, and the aqueous phase was extracted several times. The combined organic phases were dried over sodium sulfate, filtered off, and concentrated under reduced pressure. Purification of the crude product by column chromatography afforded methyl 1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylate (1650 mg, purity: 93%, 61% of theory) in the form of a colorless oil, which was further reacted in this manner. Subsequently, methyl 1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylate (1650 mg, 3.81 mmol) was dissolved in 12 mL of dioxane and treated with 15 mL of 36% aqueous hydrochloric acid.The reaction solution was then stirred under reflux for 6 h under TLC monitoring and, after cooling to room temperature, poured into ice water. Ethyl acetate was added, and the aqueous phase was extracted several times. The combined organic phases were dried over sodium sulfate, filtered, and concentrated under reduced pressure. Purification of the resulting crude product by column chromatography yielded 1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylic acid (1458 mg, purity: 92%, 83% of theory) as colorless crystals. The resulting 1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylic acid (1160 mg, 2.77 mmol) was dissolved in 38 mL of acetonitrile under an argon atmosphere and treated with allyl chloroacetate (571 mg, 4.16 mmol) and triethylamine (449 mg, 4.43 mmol). The mixture was stirred for 6 h at 65 °C.TLC monitoring showed complete conversion, so the reaction was stopped by adding water to the reaction mixture. The aqueous phase was then extracted several times with ethyl acetate. The combined organic phases were dried over magnesium sulfate, filtered, and concentrated under reduced pressure. Purification of the crude product by column chromatography yielded 2-(allyloxy)-2-oxoethyl-1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylate (870 mg, purity: 92%, 56% of theory) as a colorless oil. 1H NMR (CDCl3, ppm): 7.27 (d, 1H), 7.14 (d, 1H), 6.12 (s, 1H), 5.85 (m, 1H), 5.-23-5.32 (m, 2H), 4.68 (ps q, 2H), 4.59 (d, 2H), 3.57 (s, 3H), 2.06 (t, 3H), 1.71 (m, 2H), 1.47 (m, 2H). No. I.1-481: {[(1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropyl)carbonyl]oxy}acetic acid. 2-(Allyloxy)-2-oxoethyl-1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylate (800 mg, 1.55 mmol) was dissolved in approximately 40 mL of dichloromethane under an argon atmosphere. After cooling to 0 °C, phenylsilane (335 mg, 3.10 mmol) and subsequently tetrakis(triphenylphosphine)palladium(0) (89 mg, 0.08 mmol) were added. The reaction mixture was stirred at room temperature for approximately 2 h. Complete conversion was detected by thin-layer chromatography, so the reaction was subsequently quenched by adding 20 mL of water and made basic by adding sodium bicarbonate solution. After phase separation, the aqueous phase was acidified by adding 2N hydrochloric acid and subsequently extracted several times with dichloromethane. The combined organic phases were dried, and the solvent was removed in vacuo.Purification of the crude product by column chromatography gave {[(1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropyl)carbonyl]oxy}acetic acid (292 mg, purity: 95%, 37% of theory) as a colorless oil. 1H NMR (CDCl3, ppm): 7.64 (d, 1H), 7.51 (d, 1H), 6.21 (s, 1H), 4.13 (s, 2H), 3.44 (s, 3H), 2.12 (t, 3H), 1.62 (m, 2H), 1.27 (m, 2H). No. I.1-371: 2-(Cyclopropylmethoxy)-2-oxoethyl-1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropane carboxylate. To a solution of cyclopropylcarbinol (23 mg, 0.31 mmol) in 5 ml of dichloromethane was added {[(1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropyl)carbonyl]oxy}-acetic acid (115 mg, 0.24 mmol), followed by 1-hydroxy-1H-benzotriazole hydrate (48 mg, 0.31 mmol), 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (60 mg, 0.31 mmol), and 4-dimethylaminopyridine (10 mol%). The mixture was stirred at RT for 5 h. After standing overnight at RT, water was added, dichloromethane was added and the mixture was separated using a phase separator, followed by evaporation under reduced pressure.By column chromatographic purification of the crude product obtained, 2-(cyclopropylmethoxy)-2-oxoethyl-1-{2-chloro-5-[4-(1,1-difluoroethyl)-3-methyl-2,6-dioxo-3,6-dihydropyrimidin-1(2H)-yl]-4-fluorophenoxy}cyclopropanecarboxylate (84 mg, purity: 95%, 62% of theory) was obtained as a colorless oil, which crystallized after prolonged standing. 1H NMR (CDCl3, ppm): 7.27 (d, 1H), 7.16 (d, 1H), 6.11 (s, 1H), 4.68 (ps q, 2H), 3.92 (d, 2H), 3.57 (s, 3H), 2.05 (t, 3H), 1.71 (m, 2H), 1.46 (m, 2H), 1.09 (m, 1H), 0.57 (m, 2H), 0.25 (m, 2H). The following compounds are obtained analogously to the preparation examples given above and cited in the relevant sections, and taking into account the general information for the preparation of substituted cyclopropyloxyphenyluracils.If a structural element in Table 1 is defined by a structural formula containing a dashed line, this dashed line indicates that the group in question is bonded to the rest of the molecule at this position. If a structural element in Table 1 is defined by a structural formula containing an arrow, the arrow represents a bond between the respective group Q and the carbonyl group in the general formula (I). Table I.1: Preferred compounds of formula (I.1) are compounds I.1-1 to I.1-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.1-1 to I.1-500 of Table I.1 are thus defined by the meaning of the respective entries No. 1 to 500 for Q in Table 1. Table 1: Table I.2: Preferred compounds of formula (I.2) are the compounds I.2-1 to I.2-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.2-1 to I.2-500 of Table I.2 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.3: Preferred compounds of formula (I.3) are compounds I.3-1 to I.3-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.3-1 to I.3-500 of Table I.3 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.4: Preferred compounds of formula (I.4) are compounds I.4-1 to I.4-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.4-1 to I.4-500 of Table I.4 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.5: Preferred compounds of formula (I.5) are compounds I.5-1 to I.5-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.5-1 to I.5-500 of Table I.7 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.6: Preferred compounds of formula (I.6) are compounds I.6-1 to I.6-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.6-1 to I.6-500 of Table I.6 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.7: Preferred compounds of formula (I.7) are compounds I.7-1 to I.7-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.7-1 to I.7-500 of Table I.7 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.8: Preferred compounds of formula (I.8) are compounds I.8-1 to I.8-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.8-1 to I.8-500 of Table I.8 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.9: Preferred compounds of formula (I.9) are compounds I.9-1 to I.9-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.9-1 to I.9-500 of Table I.9 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.10: Preferred compounds of formula (I.10) are the compounds I.10-1 to I.10-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.10-1 to I.10-500 of Table I.10 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.11: Preferred compounds of formula (I.11) are compounds I.11-1 to I.11-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.11-1 to I.11-500 of Table I.11 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.12: Preferred compounds of formula (I.12) are compounds I.12-1 to I.12-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.12-1 to I.12-500 of Table I.12 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.13: Preferred compounds of formula (I.13) are compounds I.13-1 to I.13-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.13-1 to I.13-500 of Table I.13 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.14: Preferred compounds of formula (I.14) are compounds I.14-1 to I.14-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.14-1 to I.14-500 of Table I.14 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.15: Preferred compounds of formula (I.15) are compounds I.15-1 to I.15-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.15-1 to I.15-500 of Table I.15 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.16: Preferred compounds of formula (I.16) are compounds I.16-1 to I.16-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.16-1 to I.16-500 of Table I.16 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.17: Preferred compounds of formula (I.17) are compounds I.17-1 to I.17-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.17-1 to I.17-500 of Table I.17 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.18: Preferred compounds of formula (I.18) are compounds I.18-1 to I.18-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.18-1 to I.18-500 of Table I.7 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.19: Preferred compounds of formula (I.19) are compounds I.19-1 to I.19-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.19-1 to I.19-500 of Table I.19 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.20: Preferred compounds of formula (I.20) are the compounds I.20-1 to I.20-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.20-1 to I.20-500 of Table I.7 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.21: Preferred compounds of formula (I.21) are compounds I.21-1 to I.21-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.21-1 to I.21-500 of Table I.21 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.22: Preferred compounds of formula (I.22) are compounds I.22-1 to I.22-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.22-1 to I.22-500 of Table I.22 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.23: Preferred compounds of formula (I.23) are compounds I.23-1 to I.23-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.23-1 to I.23-500 of Table I.23 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.24: Preferred compounds of formula (I.24) are compounds I.24-1 to I.24-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.24-1 to I.24-500 of Table I.24 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.25: Preferred compounds of formula (I.25) are compounds I.25-1 to I.25-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.25-1 to I.25-500 of Table I.25 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. Table I.26: Preferred compounds of formula (I.26) are the compounds I.26-1 to I.26-500, wherein Q has the meanings given in the respective row of Table 1. The compounds I.26-1 to I.26-500 of Table I.26 are thus defined by the meaning of the respective entries No. 1 to 500 for Q of Table 1. NMR data of selected examples: The 1 H-NMR data of selected examples of compounds of general formula (I) are presented in two different ways, namely (a) classical NMR evaluation and interpretation or (b) in the form of 1H-NMR peak lists according to the methods described below a) Classical NMR interpretation No. I.1-371: 1H NMR (CDCl3, ppm): 7.27 (d, 1H), 7.15 (d, 1H), 6.12 (s, 1H), 4.68 (ps q, 2H), 4.15 (q, 2H), 3.57 (s, 3H), 2.05 (t, 3H), 1.71 (m, 2H), 1.47 (m, 2H), 1.25 (t, 3H). b) NMR peak list method The 1 H-NMR data of selected examples can also be provided in the form of 1 H-NMR peak lists are recorded. For each signal peak, first the δ value in ppm is listed, followed by the signal intensity in parentheses. The δ value – signal intensity pairs of different signal peaks are listed separated by semicolons. The peak list of an example therefore has the form: δ1 (Intensity1 ) ; δ2 (intensity2);……..; δi (intensityi );……; δn (Intensityn) The intensity of sharp signals correlates with the height of the signals in a printed example of an NMR spectrum in cm and shows the true ratios of the signal intensities. For broad signals, multiple peaks or the center of the signal and their relative intensity compared to the most intense signal in the spectrum can be shown. For calibration of the chemical shift of 1 For H-NMR spectra, we use tetramethylsilane and / or the chemical shift of the solvent, especially in the case of spectra measured in DMSO. Therefore, the tetramethylsilane peak may or may not appear in NMR peak lists. The lists of 1 H-NMR peaks are similar to the classical 1 H-NMR printouts and thus usually contain all peaks that are found in a classical NMR interpretation. In addition, they can be interpreted like classical 1H-NMR printouts show solvent signals, signals of stereoisomers of the target compounds, which are also the subject of the invention, and / or peaks of impurities. When reporting compound signals in the delta range of solvents and / or water, our lists of 1H NMR peaks show the usual solvent peaks, for example, peaks of DMSO in DMSO-D6 and the peak of water, which usually have a high average intensity. The peaks of stereoisomers of the target compounds and / or peaks of impurities usually have a lower average intensity than the peaks of the target compounds (e.g., with a purity of >90%). Such stereoisomers and / or impurities can be typical for the respective manufacturing process. Their peaks can thus help identify the reproduction of our manufacturing process based on "by-product fingerprints." An expert who calculates the peaks of the target compounds using known methods (MestreC, ACD simulation, but also empirically evaluated expected values) can isolate the peaks of the target compounds as needed, using additional intensity filters if necessary.This isolation would be similar to the peak picking involved in classical music. 1 H-NMR interpretation. Further details on 1H-NMR peak lists can be found in Research Disclosure Database Number 564025. Example No.: - The present invention furthermore relates to the use of one or more compounds of the formula (I) according to the invention and / or salts thereof, as defined above, preferably in one of the embodiments characterized as preferred or particularly preferred, in particular one or more compounds of the formulas (I.1-1) to (I.26-500) and / or salts thereof, each as defined above, as a herbicide and / or plant growth regulator, preferably in crops of useful and / or ornamental plants. The present invention furthermore relates to a method for controlling weeds and / or for regulating the growth of plants, characterized in that an effective amount of - one or more compounds of the formula (I) according to the invention and / or salts thereof, as defined above,preferably in one of the embodiments characterized as preferred or particularly preferred, in particular one or more compounds of the formulas (I.1-1) to (I.26-500) and / or salts thereof, each as defined above, or - an agent according to the invention, as defined below, is applied to the (harmful) plants, (harmful) plant seeds, the soil in or on which the (harmful) plants grow, or the cultivated area. The present invention also provides a method for controlling undesirable plants, preferably in crops of useful plants, characterized in that an effective amount of - one or more compounds of the formula (I) and / or salts thereof, as defined above, preferably in one of the embodiments characterized as preferred or particularly preferred, in particular one or more compounds of the formulas (I.1-1) to (I.26-500) and / or salts thereof, each as defined above, or - an agent according to the invention,as defined below, to undesirable plants (e.g. harmful plants such as mono- or dicotyledonous weeds or undesirable crop plants), the seed of the undesirable plants (i.e. plant seeds, e.g. grains, seeds or vegetative propagating organs such as tubers or shoot parts with buds), the soil in or on which the undesirable plants grow (e.g. the soil of cultivated land or non-cultivated land) or the cultivated area (i.e. area on which the undesirable plants will grow). The present invention furthermore also relates to methods for controlling or regulating the growth of plants, preferably of useful plants, characterized in that an effective amount of - one or more compounds of the formula (I) and / or salts thereof, as defined above, preferably in one of the embodiments characterized as preferred or particularly preferred,in particular one or more compounds of the formulas (I.1-1) to (I.26-500) and / or salts thereof, each as defined above, or - a composition according to the invention, as defined below, the plant, the seed of the plant (i.e. plant seeds, e.g. grains, seeds or vegetative propagating organs such as tubers or shoot parts with buds), the soil in or on which the plants grow (e.g. the soil of cultivated land or non-cultivated land) or the area under cultivation (i.e. area on which the plants will grow). The compounds according to the invention or the compositions according to the invention can be applied, for example, by pre-sowing (optionally also by incorporation into the soil), pre-emergence and / or post-emergence methods. Specific examples include some representatives of the mono- and dicotyledonous weed flora which can be controlled by the compounds according to the invention,without the mention being intended to imply a restriction to specific species. Preferably, in a method according to the invention for controlling weeds or for regulating plant growth, one or more compounds of formula (I) and / or salts thereof are used for controlling weeds or for regulating growth in crops of useful plants or ornamental plants, wherein the useful plants or ornamental plants are, in a preferred embodiment, transgenic plants. The compounds of formula (I) according to the invention and / or salts thereof are suitable for controlling the following genera of monocotyledonous and dicotyledonous weeds: Monocotyledonous weeds of the genera: Aegilops, Agropyron, Agrostis, Alopecurus, Apera, Avena, Brachiaria, Bromus, Cenchrus, Commelina, Cynodon, Cyperus, Dactyloctenium, Digitaria, Echinochloa, Eleocharis, Eleusine, Eragrostis, Eriochloa, Festuca, Fimbristylis, Heteranthera, Imperata, Ischaemum, Leptochloa, Lolium, Monochoria,Panicum, Paspalum, Phalaris, Phleum, Poa, Rottboellia, Sagittaria, Scirpus, Setaria, Sorghum. Dicotyledonous harmful plants of the genera: Abutilon, Amaranthus, Ambrosia, Anoda, Anthemis, Aphanes, Artemisia, Atriplex, Bellis, Bidens, Capsella, Carduus, Cassia, Centaurea, Chenopodium, Cirsium, Convolvulus, Datura, Desmodium, Emex, Erysimum, Euphorbia, Galeopsis, Galinsoga, Galium, Hibiscus, Ipomoea, Kochia, Lamium, Lepidium, Lindernia, Matricaria, Mentha, Mercurialis, Mullugo, Myosotis, Papaver, Pharbitis, Plantago, Polygonum, Portulaca, Ranunculus, Raphanus, Rorippa, Rotala, Rumex, Salsola, Senecio, Sesbania, Sida, Sinapis, Solanum, Sonchus, Sphenoclea, Stellaria, Taraxacum, Thlaspi, Trifolium, Urtica, Veronica, Viola, Xanthium. If the compounds according to the invention are applied to the soil surface before the germination of the harmful plants (grasses and / or weeds) (pre-emergence method),This means that either the emergence of weed seedlings is completely prevented, or they grow to the cotyledon stage, but then cease growth and finally die completely after three to four weeks. When the active ingredients are applied post-emergence to the green parts of the plant, growth stops after treatment, and the weeds remain in the growth stage present at the time of application or die completely after a certain time, so that weed competition that is harmful to the crop plants is eliminated very early and sustainably. Although the compounds according to the invention have excellent herbicidal activity against monocotyledonous and dicotyledonous weeds, crops of economically important crops, e.g. dicotyledonous crops of the genera Arachis, Beta, Brassica, Cucumis, Cucurbita, Helianthus, Daucus, Glycine, Gossypium, Ipomoea, Lactuca, Linum,Lycopersicon, Miscanthus, Nicotiana, Phaseolus, Pisum, Solanum, Vicia, or monocotyledonous crops of the genera Allium, Ananas, Asparagus, Avena, Hordeum, Oryza, Panicum, Saccharum, Secale, Sorghum, Triticale, Triticum, Zea,Depending on the structure of the respective compound according to the invention and the application rate, only insignificant or no damage is caused. For these reasons, the present compounds are very well suited for the selective control of undesired plant growth in plant crops, such as agricultural crops or ornamental plants. Furthermore, the compounds according to the invention (depending on their respective structure and the application rate) exhibit outstanding growth-regulating properties in crop plants. They regulate the plant's own metabolism and can thus be used to specifically influence plant constituents and to facilitate harvesting, for example by inducing desiccation and stunted growth. Furthermore, they are also suitable for the general control and inhibition of undesired vegetative growth.without killing the plants. Inhibition of vegetative growth plays a major role in many monocotyledonous and dicotyledonous crops, as it can, for example, reduce or completely prevent lodging. Due to their herbicidal and plant growth regulatory properties, the active ingredients can also be used to control weeds in crops of plants modified genetically or by conventional mutagenesis. The transgenic plants are generally characterized by particularly advantageous properties, for example, resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria or viruses. Other special properties affect, for example, the harvested product in terms of quantity, quality, storability,Composition and special ingredients. Thus, transgenic plants with increased starch content or altered starch quality, or those with a different fatty acid composition of the harvested crop, are known. With regard to transgenic crops, the use of the compounds according to the invention and / or their salts is preferred in economically important transgenic crops of crops and ornamental plants, e.g., cereals such as wheat, barley, rye, oats, millet, rice, and maize, or crops of sugar beet, cotton, soybeans, rapeseed, potatoes, tomatoes, peas, and other vegetables. The compounds according to the invention can preferably also be used as herbicides in crops.which are resistant to the phytotoxic effects of herbicides or have been genetically engineered to be resistant. Due to their herbicidal and plant growth regulatory properties, the active ingredients can also be used to control weeds in crops of known or yet-to-be-developed genetically modified plants. The transgenic plants are generally characterized by particularly advantageous properties, for example, resistance to certain pesticides, especially certain herbicides, resistance to plant diseases or pathogens of plant diseases such as certain insects or microorganisms such as fungi, bacteria, or viruses. Other special properties affect, for example, the harvested product in terms of quantity, quality, storability,Composition and special ingredients. Thus, transgenic plants with increased starch content or altered starch quality, or those with a different fatty acid composition of the harvested product, are known. Further special properties can include tolerance or resistance to abiotic stressors, e.g., heat, cold, drought, salt, and ultraviolet radiation. The compounds of the formula (I) according to the invention or their salts are preferably used in economically important transgenic crops of crops and ornamental plants, e.g., cereals such as wheat, barley, rye, oats, triticale, millet, rice, cassava, and maize, or also crops of sugar beet, cotton, soybeans, rapeseed, potatoes, tomatoes, peas, and other vegetables. The compounds of formula (I) can preferably be used as herbicides in crops.which are resistant to the phytotoxic effects of herbicides or have been genetically engineered to be resistant. Conventional methods for producing new plants that have modified properties compared to previously existing plants include, for example, classical breeding methods and the creation of mutants. Alternatively, new plants with modified properties can be created using genetic engineering techniques. Numerous molecular biological techniques that can be used to produce new transgenic plants with modified properties are known to those skilled in the art. For such genetic manipulations, nucleic acid molecules can be introduced into plasmids that allow mutagenesis or sequence modification through recombination of DNA sequences. Using standard methods, base exchanges can be performed, for example.Partial sequences can be removed or natural or synthetic sequences can be added. Adapters or linkers can be attached to the fragments to connect the DNA fragments to each other. The production of plant cells with reduced activity of a gene product can be achieved, for example, by expressing at least one corresponding antisense RNA, a sense RNA to achieve a co-suppression effect, or the expression of at least one appropriately constructed ribozyme that specifically cleaves transcripts of the aforementioned gene product. For this purpose, DNA molecules can be used that comprise the entire coding sequence of a gene product, including any flanking sequences present, as well as DNA molecules that comprise only parts of the coding sequence, whereby these parts must be long enough to produce an antisense effect in the cells. It is also possible to use DNA sequences,which exhibit a high degree of homology to the coding sequences of a gene product, but are not completely identical. When nucleic acid molecules are expressed in plants, the synthesized protein can be localized in any compartment of the plant cell. However, to achieve localization in a specific compartment, the coding region can, for example, be linked to DNA sequences that ensure localization in a specific compartment. Such sequences are known to the person skilled in the art (see, for example, Braun et al., EMBO J. 11 (1992), 3219-3227). Expression of the nucleic acid molecules can also take place in the organelles of the plant cells. The transgenic plant cells can be regenerated into whole plants using known techniques. In principle, the transgenic plants can be plants of any plant species,i.e., both monocotyledonous and dicotyledonous plants. Thus, transgenic plants are obtainable which exhibit altered properties through overexpression, suppression, or inhibition of homologous (= natural) genes or gene sequences, or through expression of heterologous (= foreign) genes or gene sequences. The compounds (I) according to the invention can preferably be used in transgenic crops which are resistant to growth promoters, such as dicamba, or to herbicides that inhibit essential plant enzymes, e.g., acetolactate synthases (ALS), EPSP synthases, glutamine synthases (GS), or hydroxyphenylpyruvate dioxygenases (HPPD), or to herbicides from the group of sulfonylureas, glyphosates, glufosinates, or benzoylisoxazoles and analogous active ingredients. When the active ingredients according to the invention are used in transgenic crops, in addition to the effects observed in other crops, effects against weeds often occur,which are specific for application in the respective transgenic crop, for example a modified or specifically expanded weed spectrum that can be controlled, modified application rates that can be used for application, preferably good combinability with the herbicides to which the transgenic crop is resistant, and influencing the growth and yield of the transgenic crop plants. The invention therefore also relates to the use of the compounds of the formula (I) according to the invention and / or salts thereof as herbicides for controlling weeds in crops of useful or ornamental plants, optionally in transgenic crop plants. Preference is given to use in cereals, preferably maize, wheat, barley, rye, oats, millet, or rice.pre- or post-emergence. Preference is also given to pre- or post-emergence use in soybeans. The use according to the invention for controlling weeds or for regulating plant growth also includes the case in which the active ingredient of formula (I) or its salt is formed from a precursor substance ("prodrug") only after application to the plant, in the plant, or in the soil. The invention also relates to the use of one or more compounds of formula (I) or their salts or an agent according to the invention (as defined below) (in a method) for controlling weeds or for regulating plant growth, characterized in that an effective amount of one or more compounds of formula (I) or their salts is applied to the plants (weeds, optionally together with the useful plants), plant seeds, the soil in or on which the plants grow,or the cultivated area. The invention also relates to a herbicidal and / or plant growth regulating agent, characterized in that the agent contains (a) one or more compounds of the formula (I) and / or salts thereof as defined above, preferably in one of the embodiments characterized as preferred or particularly preferred, in particular one or more compounds of the formulas (I.1-1) to (I.26-500) and / or salts thereof, each as defined above, and (b) one or more further substances selected from groups (i) and / or (ii): (i) one or more further agrochemically active substances, preferably selected from the group consisting of insecticides, acaricides, nematicides, further herbicides (i.e. those which do not correspond to the formula (I) defined above), fungicides, safeners, fertilizers and / or further growth regulators,(ii) one or more formulation auxiliaries customary in crop protection. The other agrochemically active substances of component (i) of an agent according to the invention are preferably selected from the group of substances listed in "The Pesticide Manual", 19th edition, The British Crop Protection Council and the Royal Society of Chemistry, 2021. A herbicidal or plant growth-regulating agent according to the invention preferably comprises one, two, three, or more formulation auxiliaries (ii) customary in crop protection, selected from the group consisting of surfactants, emulsifiers, dispersants, film formers, thickeners, inorganic salts, dusting agents, carriers that are solid at 25°C and 1013 mbar, preferably adsorbent, granulated inert materials, wetting agents, antioxidants, stabilizers, buffer substances, antifoam agents, water, organic solvents,Organic solvents miscible with water in any ratio, preferably at 25°C and 1013 mbar. The compounds (I) according to the invention can be used in the form of wettable powders, emulsifiable concentrates, sprayable solutions, dusts, or granules in the customary preparations. The invention therefore also relates to herbicidal and plant growth-regulating agents containing compounds of formula (I) and / or salts thereof. The compounds of formula (I) and / or salts thereof can be formulated in various ways, depending on the biological and / or chemical-physical parameters specified. Possible formulation options include, for example: wettable powders (WP), water-soluble powders (SP), water-soluble concentrates, emulsifiable concentrates (EC), emulsions (EW), such as oil-in-water and water-in-oil emulsions, sprayable solutions, suspension concentrates (SC), oil- or water-based dispersions,Oil-miscible solutions, capsule suspensions (CS), dusts (DP), seed dressings, granules for broadcast and soil application, granules (GR) in the form of microgranules, spray granules, coating granules, and adsorption granules, water-dispersible granules (WG), water-soluble granules (SG), ULV formulations, microcapsules, and waxes. These individual formulation types and the formulation aids such as inert materials, surfactants, solvents, and other additives are known to the person skilled in the art and are described, for example, in: Watkins, "Handbook of Insecticide Dust Diluents and Carriers," 2nd Ed., Darland Books, Caldwell, NJ; Hv. Olphen, "Introduction to Clay Colloid Chemistry"; 2nd Ed., J. Wiley & Sons, NY; C. Marsden, "Solvents Guide"; 2nd Ed., Interscience, NY, 1963; McCutcheon's "Detergents and Emulsifiers Annual", MC Publ. Corp., Ridgewood NJ; Sisley and Wood, "Encyclopedia of Surface Active Agents", Chem. Publ. Co. Inc., NY 1964; Schönfeldt, "Interface-active ethylene oxide adducts",Wiss. Verlagsgesellschaft, Stuttgart 1976; Winnacker-Küchler, "Chemische Technologie", Volume 7, C. Hanser Verlag, Munich, 4th edition, 1986. Wettable powders are preparations that are evenly dispersible in water and contain, in addition to the active ingredient and a diluent or inert substance, ionic and / or non-ionic surfactants (wetting agents, dispersants), e.g., polyoxyethylated alkylphenols, polyoxyethylated fatty alcohols, polyoxyethylated fatty amines, fatty alcohol polyglycol ether sulfates, alkanesulfonates, alkylbenzenesulfonates, sodium ligninsulfonate, sodium 2,2'-dinaphthylmethane-6,6'-disulfonate, sodium dibutylnaphthalenesulfonate, or sodium oleoylmethyltaurine. For the production of the wettable powders, the herbicidal active ingredients are, for example, milled in conventional equipment such as hammer mills,The mixture is finely ground in blower mills and air jet mills and simultaneously or subsequently mixed with the formulation auxiliaries. Emulsifiable concentrates are produced by dissolving the active ingredient in an organic solvent, e.g., butanol, cyclohexanone, dimethylformamide, xylene, or higher-boiling aromatics or hydrocarbons, or mixtures of organic solvents, with the addition of one or more ionic and / or non-ionic surfactants (emulsifiers). Examples of emulsifiers that can be used are: calcium alkylarylsulfonic acid salts such as Ca-dodecylbenzenesulfonate, or non-ionic emulsifiers such as fatty acid polyglycol esters, alkylaryl polyglycol ethers, fatty alcohol polyglycol ethers, propylene oxide-ethylene oxide condensation products, alkyl polyethers,Sorbitan esters such as sorbitan fatty acid esters or polyoxyethylene sorbitan esters such as polyoxyethylene sorbitan fatty acid esters. Dusts are obtained by grinding the active ingredient with finely divided solid substances, e.g. talc, natural clays such as kaolin, bentonite and pyrophyllite, or diatomaceous earth. Suspension concentrates can be water- or oil-based. They can be produced, for example, by wet grinding using commercially available bead mills and, if necessary, with the addition of surfactants, as already listed above for the other formulation types. Emulsions, e.g. oil-in-water emulsions (EW), can be produced, for example, using stirrers, colloid mills and / or static mixers using aqueous organic solvents and, if necessary, surfactants, as already listed above for the other formulation types. Granules can be obtained either by spraying the active ingredient onto adsorptive,They can be produced from granulated inert material or by applying active ingredient concentrates to the surface of carrier materials such as sand, kaolinite, or granulated inert material using adhesives, e.g., polyvinyl alcohol, sodium polyacrylate, or mineral oils. Suitable active ingredients can also be granulated in the manner customary for the production of fertilizer granules—if desired, mixed with fertilizers. Water-dispersible granules are generally produced using conventional processes such as spray drying, fluidized-bed granulation, disc granulation, mixing with high-speed mixers, and extrusion without solid inert material. For the production of disc, fluidized-bed, extruder, and spray granules, see, for example, the processes in "Spray-Drying Handbook," 3rd ed. 1979, G. Goodwin Ltd., London; J.E. Browning, "Agglomeration," Chemical and Engineering 1967, pages 147 ff. "Perry's Chemical Engineer's Handbook", 5th Ed., McGraw-Hill,New York 1973, pp. 8-57. For further details on the formulation of crop protection agents, see, for example, GC Klingman, "Weed Control as a Science", John Wiley and Sons, Inc., New York, 1961, pages 81-96 and JD Freyer, SA Evans, "Weed Control Handbook", 5th Ed., Blackwell Scientific Publications, Oxford, 1968, pages 101-103. The agrochemical preparations, preferably herbicidal or plant growth regulating agents of the present invention preferably contain a total amount of 0.1 to 99% by weight, preferably 0.5 to 95% by weight, more preferably 1 to 90% by weight, especially preferably 2 to 80% by weight, of active ingredients of the formula (I) and salts thereof. In wettable powders, the active ingredient concentration is, for example, about 10 to 90% by weight, the remainder to 100% by weight consisting of conventional formulation components. For emulsifiable concentrates, the active ingredient concentration can be approximately 1 to 90,preferably 5 to 80 wt.%. Dust-like formulations contain 1 to 30 wt.% active ingredient, preferably mostly 5 to 20 wt.% active ingredient, sprayable solutions contain about 0.05 to 80, preferably 2 to 50 wt.% active ingredient. In water-dispersible granules, the active ingredient content depends partly on whether the active compound is liquid or solid and which granulation aids, fillers, etc. are used. In water-dispersible granules, the active ingredient content is, for example, between 1 and 95 wt.%, preferably between 10 and 80 wt.%. In addition, the said active ingredient formulations may contain the usual adhesives, wetting agents, dispersing agents, emulsifying agents, penetrating agents, preservatives, antifreeze agents and solvents, fillers, carriers and dyes, defoamers,Evaporation inhibitors and agents that affect pH and viscosity. Examples of formulation aids are described, among others, in "Chemistry and Technology of Agrochemical Formulations," ed. DA Knowles, Kluwer Academic Publishers (1998). The compounds of formula (I) or their salts can be used as such or in the form of their preparations (formulations) in combination with other pesticidally active substances, such as insecticides, acaricides, nematicides, herbicides, fungicides, safeners, fertilizers, and / or growth regulators, e.g., as ready-to-use formulations or as tank mixes. The combination formulations can be prepared based on the above-mentioned formulations.The physical properties and stabilities of the active ingredients to be combined must be taken into account. Combination partners for the compounds of formula (I) according to the invention in mixture formulations or in tank mixes include, for example, known active ingredients based on the inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate 3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II, and protoporphyrinogen oxidase, as described, for example, in Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 19th edition, The British Crop Protection Council and the Royal Society of Chemistry.2021 and the literature cited therein. Of particular interest is the selective control of weeds in crops of useful and ornamental plants. Although the compounds (I) according to the invention already exhibit very good to sufficient selectivity in many crops, phytotoxicity can in principle occur in some crops, and especially in the case of mixtures with other herbicides that are less selective. In this regard, combinations of compounds (I) according to the invention that comprise the compounds (I) or their combinations with other herbicides or pesticides and safeners are of particular interest. The safeners, which are used in an antidote-effective concentration, reduce the phytotoxic side effects of the herbicides / pesticides used, e.g., in economically important crops such as cereals (wheat, barley, rye, maize, rice, millet), sugar beet, sugar cane, rapeseed, cotton, and soybeans.preferably cereals. The weight ratios of herbicide (mixture) to safener generally depend on the application rate of herbicide and the effectiveness of the respective safener and can vary within wide limits, for example in the range from 200:1 to 1:200, preferably 100:1 to 1:100, in particular 20:1 to 1:20. The safeners can be formulated analogously to the compounds (I) or mixtures thereof with other herbicides / pesticides and can be supplied and applied as a ready-to-use formulation or tank mix with the herbicides. For application, the herbicide or herbicide-safener formulations available in commercial form are, if appropriate, diluted in the usual way, e.g., with water for wettable powders, emulsifiable concentrates, dispersions, and water-dispersible granules. Dust-like preparations,Soil or broadcast granules as well as sprayable solutions are not usually diluted with other inert substances prior to application. External conditions such as temperature, humidity, etc. influence to a certain extent the application rate of the compounds of formula (I) and / or their salts. The application rate can vary within wide limits. For use as a herbicide for controlling weeds, the total amount of compounds of formula (I) and their salts is preferably in the range from 0.001 to 10.0 kg / ha, preferably in the range from 0.005 to 5 kg / ha, more preferably in the range from 0.01 to 1.5 kg / ha, particularly preferably in the range from 0.05 to 1 kg / ha. This applies to both pre-emergence and post-emergence applications. When using compounds of formula (I) and / or their salts as plant growth regulators, for example as stalk shorteners in crops, as mentioned above,Preferably in cereal crops such as wheat, barley, rye, triticale, millet, rice, or maize, the total application rate is preferably in the range of 0.001 to 2 kg / ha, preferably in the range of 0.005 to 1 kg / ha, in particular in the range of 10 to 500 g / ha, and most preferably in the range of 20 to 250 g / ha. This applies to both pre-emergence and post-emergence applications. Application as a stem shortener can occur at various stages of plant growth. For example, application after tillering at the beginning of longitudinal growth is preferred. Alternatively, when used as a plant growth regulator, seed treatment is also possible.which includes the various seed dressing and coating techniques. The application rate depends on the individual techniques and can be determined in preliminary trials. As combination partners for the compounds of formula (I) according to the invention in agents according to the invention (e.g. mixture formulations or in tank mix), known active ingredients which are based on an inhibition of, for example, acetolactate synthase, acetyl-CoA carboxylase, cellulose synthase, enolpyruvylshikimate-3-phosphate synthase, glutamine synthetase, p-hydroxyphenylpyruvate dioxygenase, phytoene desaturase, photosystem I, photosystem II or protoporphyrinogen oxidase can be used, as they are known, for example, from Weed Research 26 (1986) 441-445 or "The Pesticide Manual", 19th edition, The British Crop Protection Council and the Royal Soc. of Chemistry,2021 and the literature cited therein. Examples of known herbicides or plant growth regulators that can be combined with the compounds according to the invention are listed below. These active ingredients are designated either by their common name in the English version according to the International Organization for Standardization (ISO) or by their chemical name or code number. This always includes all application forms, such as acids, salts, esters, as well as all isomeric forms such as stereoisomers and optical isomers, even if these are not explicitly mentioned. Examples of such herbicidal mixture partners: Known herbicides or plant growth regulators that can be combined with compounds of the general formula (I) include:For example, the following active ingredients are to be mentioned (the compounds are designated either by the "common name" according to the International Organization for Standardization (ISO) or by the chemical name or by the code number) and always include all application forms such as acids, salts, esters and isomers such as stereoisomers and optical isomers. Examples of Icaeine and, in some cases, several application forms are mentioned: Acetochlor, Acifluorfen, Acifluorfen-methyl, Acifluorfen-sodium, Aclonifen, Alachlor, Allidochlor, Alloxydim, Alloxydim-sodium, Ametryn, Amicarbazon, Amidochlor, Amidosulfuron, 4-Amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridine-2-carboxylic acid, Aminocyclopyrachlor, Aminocyclopyrachlor-potassium, Aminocyclopyrachlor-methyl, Aminopyralid, Aminopyralid-dimethylammonium, Aminopyralid-tripromine, Amitrol, Ammonium sulfamate, Anilofos, Asulam, Asulam-potassium, Asulam-sodium, Atrazine, Azafenidine, Azimsulfuron, Beflubutamid, (S)-(-)- Beflubutamide,Beflubutamid-M, Benazolin, Benazolin-ethyl, Benazolin-dimethylammonium, Benazolin-Klaium, Benfluralin, Benfuresate, Bensulfuron, Bensulfuron-methyl, Bensulide, Bentazone, Bentazone-Sodium, Benzobicyclon, Benzofenap, Bicyclopyrone, Bifenox, Bilanafos, Bilanafos-Sodium, Bipyrazone, Bispyribac, bispyribac sodium, bixlozone, bromacil, bromacil lithium, bromacil sodium, bromobutide, bromofenoxime, bromoxynil, bromoxynil butyrate, bromoxynil potassium, bromoxynil heptanoate and bromoxynil octanoate, busoxinone, butachlor, butafenacil, butamifos, Butenachlor, Butralin, Butroxydim, Butylate, Cafenstrol, Cambendichlor, Carbetamide, Carfentrazone, Carfentrazone-Ethyl, Chloramben, Chloramben-ammonium, Chloramben-diolamine, Chloramben-methyl, Chloramben-methylammonium, Chloramben-sodium, Chlorbromuron, Chlorfenac, Chlorfenac-ammonium, Chlorfenac-sodium, Chlorfenprop, Chlorfenprop-methyl, Chlorflurenol, Chlorflurenol-methyl, Chloridazon, Chlorimuron, Chlorimuron-ethyl, Chlorophthalim, Chlorotoluron,Chlorsulfuron, Chlorthal, Chlorthal-dimethyl, Chlorthal-monomethyl, Cinidon, Cinidon-ethyl, Cinmethylin, exo-(+)- Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7-oxabicyclo[2.2.1]heptan, exo-(-)-Cinmethylin, d.h. (1R,2S,4S)-4-isopropyl-1-methyl-2-[(2-methylbenzyl)oxy]-7- oxabicyclo[2.2.1]heptan, Cinosulfuron, Clacyfos, Clethodim, Clodinafop, Clodinafop-ethyl, Clodinafop- propargyl, Clomazon, Clomeprop, Clopyralid, Clopyralid-methyl, Clopyralid-olamin, Clopyralid- Kalium, Clopyralid-tripomin, Cloransulam, Cloransulam-methyl, Cumyluron, Cyanamide, Cyanazine, Cycloat, Cyclopyranil, Cyclopyrimorat, Cyclosulfamuron, Cycloxydim, Cyhalofop, Cyhalofop-butyl, Cyprazin, 2,4-D (sowie die Ammonium, Butotyl, Butyl, Cholin, Diethylammonium, Dimethylammonium, Diolamin, Doboxyl, Dodecylammonium, Etexyl, Ethyl, 2-Ethylhexyl, Heptylammonium, Isobutyl, Isooctyl, Isopropyl, Isopropylammonium, Lithium, Meptyl, Methyl, Kalium, Tetradecylammonium, Triethylammonium,Triisopropanolammonium, Tripromin and Trolamin Salze davon), 2,4-DB, 2,4-DB-butyl, 2,4-DB-Dimethylammonium, 2,4-DB-isooctyl, 2,4-DB-Kalium und 2,4-DB-Natrium, Daimuron (Dymron), Dalapon, Dalapon-Calcium, Dalapon-Magnesium, Dalapon- Natium, Dazomet, Dazomet-Natrium, n-Decanol, 7-Deoxy-D-sedoheptulose, Desmedipham, Detosyl- pyrazolat (DTP), Dicamba und seine Salze (z.B. Dicamba-biproamin, Dicamba-N,N-Bis(3- aminopropyl)methylamin, Dicamba-butotyl, Dicamba-cholin, Dicamba-Diglycolamin, Dicamba- Dimethylammonium, Dicamba-Diethanolaminemmonium, Dicamba-Diethylammonium, Dicamba- isopropylammonium, Dicamba-methyl, Dicamba-monoethanolamin, Dicamba-olamin, Dicamba- Kalium, Dicamba-Natium, Dicamba-Triethanolamin), Dichlobenil, 2-(2,4-Dichlorbenzyl)-4,4-dimethyl- 1,2-oxazolidin-3-on, 2-(2,5-Dichlorbenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, Dichlorprop, Dichlorprop-butotyl, Dichlorprop-Dimethylammonium, Dichhlorprop-etexyl, Dichlorprop- ethylammonium, Dichlorprop-isoctyl, Dichlorprop-methyl,Dichlorprop-Kalium, Dichlorprop-Natrium, Dichlorprop-P, Dichlorprop-P-Dimethylammonium, Dichlorprop-P-etexyl, Dichlorprop-P-Kalium, Dichlorprop-Natrium, Diclofop, Diclofop-methyl, Diclofop-P, Diclofop-P-methyl, Diclosulam, Difenzoquat, Difenzoquat-metilsulfate, Diflufenican, Diflufenzopyr, Diflufenzopyr-Natrium, Dimefuron, Dimepiperate, Dimesulfazet, Dimethachlor, Dimethametryn, Dimethenamid, Dimethenamid-P, Dimetrasulfuron, Dinitramine, Dinoterb, Dinoterb-Acetate, Diphenamid, Diquat, Diquat-Dibromid, Diquat-Dichloride, Dithiopyr, Diuron, DNOC, DNOC-Ammonium, DNOC-Kalium, DNOC-Natrium, Endothal, Endothal-Diammonium, Endothal-Dikalium, Endothal-Dinatrium, Epyrifenacil (S-3100), EPTC, Esprocarb, Ethalfluralin, Ethametsulfuron, Ethametsulfuron-Methyl, Ethiozin, Ethofumesate, Ethoxyfen, Ethoxyfen-Ethyl, Ethoxysulfuron, Etobenzanid, F-5231, d.h. N-[2- Chlor-4-fluor-5-[4-(3-fluorpropyl)-4,5-dihydro-5-oxo-1H-tetrazol-1-yl]-phenyl]-ethansulfonamid, F- 7967,i.e.3-[7-Chlor-5-fluor-2-(trifluormethyl)-1H-benzimidazol-4-yl]-1-methyl-6- (trifluormethyl)pyrimidin-2,4(1H,3H)-dion, Fenoxaprop, Fenoxaprop-P, Fenoxaprop-Ethyl, Fenoxaprop-P-Ethyl, Fenoxasulfone, Fenpyrazone, Fenquinotrione, Fentrazamid, Flamprop, Flamprop- Isoproyl, Flamprop-Methyl, Flamprop-M-Isopropyl, Flamprop-M-Methyl, Flazasulfuron, Florasulam, Florpyrauxifen, Florpyrauxifen-benzyl, Fluazifop, Fluazifop-Butyl, Fluazifop-Methyl, Fluazifop-P, Fluazifop-P-Butyl, Flucarbazone, Flucarbazone-Natrium, Flucetosulfuron, Fluchloralin, Flufenacet, Flufenpyr, Flufenpyr-Ethyl, Flumetsulam, Flumiclorac, Flumiclorac-Pentyl, Flumioxazin, Fluometuron, Flurenol, Flurenol-Butyl, -Dimethylammonium und -Methyl, Fluoroglycofen, Fluoroglycofen-Ethyl, Flupropanat, Flupropanat-Natrium, Flupyrsulfuron, Flupyrsulfuron-Methyl, Flupyrsulfuron-Methyl- Natrium, Fluridon, Flurochloridon, Fluroxypyr, Fluroxypyr-Butometyl, Fluroxypyr-Meptyl, Flurtamon, Fluthiacet, Fluthiacet-Methyl, Fomesafen,Fomesafen-Natrium, Foramsulfuron, Foramsulfuron-Natrium, Fosamine, Fosamine-Ammonium, Glufosinat, Glufosinat-Ammonium, Glufosinat-Natrium, L- Glufosinat-Ammonium, L-Glufosinat-Natrium, Glufosinat-P-Natrium, Glufosinat-P-Ammonium, Glyphosat, Glyphosat-Ammonium, Glyphosat-Isopropylammonium, Glyphosat-Diammonium, Glyphosat-Dimethylammonium, Glyphosat-Kalium, Glyphosat-Natrium, Glyphosat-Sesquinatrium und Glyphosat-Trimesium, H-9201, d.h. O-(2,4-Dimethyl-6-nitrophenyl)-O-ethyl- isopropylphosphoramidothioat, Halauxifen, Halauxifen-methyl, Halosafen, Halosulfuron, Halosulfuron- Methyl, Haloxyfop, Haloxyfop-P, Haloxyfop-Ethoxyethyl, Haloxyfop-P-Ethoxyethyl, Haloxyfop- Methyl, Haloxyfop-P-Methyl, Haloxifop-Natrium, Hexazinon, HNPC-A8169, i.e. Prop-2-yn-1-yl (2S)- 2-{3-[(5-tert-butylpyridin-2-yl)oxy]phenoxy}propanoat, HW-02, d.h.1-(Dimethoxyphosphoryl)-ethyl- (2,4-dichlorphenoxy)acetat, Hydantocidin, Icafolin, Icafolin-Methyl, Imazamethabenz, Imazamethabenz-Methyl, Imazamox, Imazamox-Ammonium,Imazapic, Imazapic-Ammonium, Imazapyr, Imazapyr-Isopropylammonium, Imazaquin, Imazaquin-Ammonium, Imazaquin-Methyl, Imazethapyr, Imazethapyr-Ammonium, Imazosulfuron, Indanofan, Indaziflam, Indolauxipyr, Iodosulfuron, Iodosulfuron-Methyl, Iodosulfuron-Methyl-Natrium, Ioxynil, Ioxynil-Lithium, -Octanoat, -Kalium und Natrium, Ipfencarbazon, Iptriazopyrid, i.e. 3-[(Isopropylsulfonyl)methyl]-N-(5-methyl- 1,3,4-oxadiazol-2-yl)-5-(trifluormethyl)[1,2,4]triazolo-[4,3-a]pyridin-8-carboxamid, Isoproturon, Isouron, Isoxaben, Isoxaflutole, Karbutilat, KUH-043, d.h.3-({[5-(Difluormethyl)-1-methyl-3- (trifluormethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazol, Ketospiradox, Ketospiradox-Kalium, Lactofen, Lenacil, Linuron, MCPA, MCPA-Butotyl, -Butyl, -Dimethyl- ammonium, -Diolamin, -2-Ethylhexyl, -Ethyl, -Isobutyl, Isoctyl, -Isopropyl, -Isopropylammonium, - Methyl, Olamin, -Kalium, –Natrium und -Trolamin, MCPB, MCPB-Methyl, -Ethyl und -Natrium, Mecoprop, Mecoprop-Butotyl,Mecoprop- dimethylammonium, Mecoprop-Diolamin, Mecoprop-Etexyl, Mecoprop-Ethadyl, Mecoprop-Isoctyl, Mecoprop-Methyl, Mecoprop-Kalium, Mecoprop-Natrium, und Mecoprop-Trolamin, Mecoprop-P, Mecoprop-P-Butotyl, -Dimethylammonium, -2-Ethylhexyl und - Kalium, Mefenacet, Mefluidid, Mefluidid-Diolamin, Mefluidid-Kalium, Mesosulfuron, Mesosulfuron- Methyl, Mesosulfuron-Natrium, Mesotrion, Methabenzthiazuron, Metam, Metamifop, Metamitron, Metazachlor, Metazosulfuron, Methabenzthiazuron, Methiopyrsulfuron, Methiozolin, Methyl isothiocyanat, Metobromuron, Metolachlor, S-Metolachlor, Metosulam, Metoxuron, Metproxybicyclon, Metribuzin, Metsulfuron, Metsulfuron-Methyl, Molinat, Monolinuron, Monosulfuron, Monosulfuron- Methyl, MT-5950, d.h. N-[3-Chlor-4-(1-methylethyl)-phenyl]-2-methylpentanamid, NGGC-011, Napropamid, NC-310, i.e.4-(2,4-Dichlorbenzoyl)-1-methyl-5-benzyloxypyrazol, Neburon, Nicosulfuron, Nonansäure (Pelargonsäure), Norflurazon, Ölsäure (Fettsäuren), Orbencarb, Orthosulfamuron,Oryzalin, Oxadiargyl, Oxadiazon, Oxasulfuron, Oxaziclomefone, Oxyfluorfen, Paraquat, Paraquat-dichlorid, Paraquat-Dimethylsulfat, Pebulat, Pendimethalin, Penoxsulam, Pentachlorphenol, Pentoxazon, Pethoxamid, Petroleumöl, Phenmedipham, Phenmedipham-Ethyl, Picloram, Picloram-dimethylammonium, Picloram-Etexyl, Picloram-Isoctyl, Picloram-Methyl, Picloram-Olamin, Picloram-Kalium, Picloram-Triethylammonium, Picloram-Tripromin, Picloram- Trolamin, Picolinafen, Pinoxaden, Piperophos, Pretilachlor, Primisulfuron, Primisulfuron-Methyl, Prodiamine, Profoxydim, Prometon, Prometryn, Propachlor, Propanil, Propaquizafop, Propazine, Propham, Propisochlor, Propoxycarbazone, Propoxycarbazone-Natrium, Propyrisulfuron, Propyzamid, Prosulfocarb, Prosulfuron, Pyraclonil, Pyraflufen, Pyraflufen-Ethyl, Pyraquinat, Pyrasulfotol, Pyrazolynat (Pyrazolat), Pyrazosulfuron, Pyrazosulfuron-Ethyl, Pyrazoxyfen, Pyribambenz, Pyribambenz-Isopropyl, Pyribambenz-Propyl, Pyribenzoxim, Pyributicarb, Pyridafol, Pyridat,Pyriftalid, Pyriminobac, Pyriminobac-Methyl, Pyrimisulfan, Pyrithiobac, Pyrithiobac-Natrium, Pyroxasulfon, Pyroxsulam, Quinclorac, Quinclorac-Dimethylammonium, Quinclorac-Methyl, Quinmerac, Quinoclamin, Quizalofop, Quizalofop-Ethyl, Quizalofop-P, Quizalofop-P-Ethyl, Quizalofop-P-Tefuryl, QYM201, i.e.1-{2-Chlor-3-[(3-cyclopropyl-5-hydroxy-1-methyl-1H-pyrazol-4-yl)carbonyl]-6- (trifluormethyl)phe-nyl}piperidin-2-on, Rimisoxafen, Rimsulfuron, Saflufenacil, Sethoxydim, Siduron, Simazine, Simetryn, SL-261, Sulcotrione, Sulfentrazone, Sulfometuron, Sulfometuron-Methyl, Sulfosulfuron, , SYP-249, d.h.1-Ethoxy-3-methyl-1-oxobut-3-en-2-yl-5-[2-chlor-4- (trifluormethyl)phenoxy]-2-nitrobenzoat, SYP-300, i.e.1-[7-Fluor-3-oxo-4-(prop-2-in-1-yl)-3,4- dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioxoimidazolidin-4,5-dion, 2,3,6-TBA, TCA (Trichloressigsäure) und seine Salze, z.B. TCA-ammonium, TCA-Calcium, TCA-Ethyl, TCA- Magnesium, TCA-Natrium, Tebuthiuron, Tefuryltrione, Tembotrion, Tepraloxydim,Terbacil, Terbucarb, Terbumeton, Terbuthylazine, Terbutryn, Tetflupyrolimet, Thaxtomin, Thenylchlor, Thiazopyr, Thiencarbazone, Thiencarbazon-Methyl, Thifensulfuron, Thifensulfuron-Methyl, Thiobencarb, Tiafenacil, Tolpyralat, Topramezon, Tralkoxydim, Triafamon, Tri-allat, Triasulfuron, Triaziflam, Tribenuron, Tribenuron-Methyl, Triclopyr, Triclopyr-Butotyl, Triclopyr-Cholin, Triclopyr- Ethyl, Triclopyr-Triethylammonium, Trietazine, Trifloxysulfuron, Trifloxysulfuron-Natrium, Trifludimoxazin, Trifluralin, Triflusulfuron, Triflusulfuron-Methyl, Tritosulfuron, Harnstoffsulfat, Vernolat, XDE-848, ZJ-0862, d.h.3,4-Dichlor-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}anilin, 3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4-trifluormethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5- methyl-4,5-dihydroisoxazol-5-carbonsäuremethylester, 3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4- trifluormethyl-3,6-dihydropyrimidin-1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazol-5- carbonsäureethylester,3-(2-Chlor-4-fluor-5-(3-methyl-2,6-dioxo-4-trifluormethyl-3,6-dihydropyrimidin- 1(2H)-yl)phenyl)-5-methyl-4,5-dihydroisoxazol-5-carbonsäure, Ethyl-[(3-{2-chlor-4-fluor-5-[3-methyl- 2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}pyridin-2-yl)oxy]acetat, 3-Chlor- 2-[3-(difluormethyl)isoxazolyl-5-yl]phenyl-5-chlorpyrimidin-2-ylether, 2-(3,4-Dimethoxyphenyl)-4-[(2- hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-6-methylpyridazin-3(2H)-on, 2-({2-[(2- Methoxyethoxy)methyl]-6-methylpyridin-3-yl}carbonyl)cyclohexane-1,3-dion, (5-Hydroxy-1-methyl- 1H-pyrazol-4-yl)(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)methanon, 1-Methyl-4- [(3,3,4-trimethyl-1,1-dioxido-2,3-dihydro-1-benzothiophen-5-yl)carbonyl]-1H-pyrazol-5-yl propan-1- sulfonat, 4-{2-Chlor-3-[(3,5-dimethyl-1H-pyrazol-1-yl)methyl]-4-(methylsulfonyl)benzoyl}-1-methyl- 1H-pyrazol-5-yl-1,3-dimethyl-1H-pyrazol-4-carboxylat; Cyanomethyl-4-amino-3-chlor-5-fluor-6-(7- fluor-1H-indol-6-yl)pyridin-2-carboxylat,Prop-2-yn-1-yl 4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol- 6-yl)pyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2- carboxylat, Benzyl-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2-carboxylat, Ethyl-4- amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor- 6-(7-fluor-1-isobutyryl-1H-indol-6-yl)pyridin-2-carboxylat, Methyl 6-(1-acetyl-7-fluor-1H-indol-6-yl)- 4-amino-3-chlor-5-fluorpyridin-2-carboxylat, Methyl-4-amino-3-chlor-6-[1-(2,2-dimethylpropanoyl)-7- fluor-1H-indol-6-yl]-5-fluorpyridin-2-carboxylat, Methyl-4-amino-3-chlor-5-fluor-6-[7-fluor-1- (methoxyacetyl)-1H-indol-6-yl]pyridin-2-carboxylat, Kalium 4-amino-3-chlor-5-fluor-6-(7-fluor-1H- indol-6-yl)pyridin-2-carboxylat, Natrium-4-amino-3-chlor-5-fluor-6-(7-fluor-1H-indol-6-yl)pyridin-2- carboxylat, Butyl-4-amino-3-chlor-5-fluoro-6-(7-fluoro-1H-indol-6-yl)pyridin-2-carboxylat,4-Hydroxy-1-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 3-(5-tert-butyl-1,2-oxazol-3-yl)-4-hydroxy-1-methylimidazolidin-2-one, 3-[5-chloro-4-(trifluoromethyl)pyridin-2-yl]-4-hydroxy-1- methylimidazolidin-2-one, 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)pyridin-2-yl]imidazolidin-2-one, 6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1,5-dimethyl-3-(2- methylphenyl)quinazoline-2,4(1H,3H)-dione, 3-(2,6-Dimethylphenyl)-6-[(2-hydroxy-6-oxocyclohex-1-en-1-yl)carbonyl]-1-methylquinazolin-2,4(1H,3H)-dione, 2-[2-chloro-4-(methylsulfonyl)-3-(morpholin-4-ylmethyl)benzoyl]-3-hydroxycyclohex-2-en-1-one, 1-(2-carboxyethyl)-4-(pyrimidin-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(pyridazin-3-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 4-(Pyrimidin-2-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate),4-(Pyridazin-3-yl)-1-(2-sulfoethyl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(1,3-thiazol-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), 1-(2-carboxyethyl)-4-(1,3,4-thiadiazol-2-yl)pyridazin-1-ium salt (with suitable anions such as chloride, acetate or trifluoroacetate), methyl (2R)-2-{[(E)-({2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methylidene)amino]oxy}propanoate, methyl (2S)- 2-{[(E)({2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methylidene)amino]oxy}propanoate, methyl (2R / S)-2-{[(E)({2-chloro-4-fluoro-5-[3-methyl-2,6- dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}methylidene)amino]oxy}propanoate, (E)- 2-(trifluoromethyl)benzaldehyde-O-{2,6-bis[(4,6-dimethoxypyrimidin-2-yl)oxy]benzoyl}oxime, 2-fluoro- N-(5-methyl-1,3,4-oxadiazol-2-yl)-3-[(R)-propylsulfinyl]-4-(trifluormethyl)benzamid, (2R)-2-[(4- Amino-3,5-dichlor-6-fluor-2-pyridyl)oxy]propancarbonsäure, 2-Ethoxy-2-oxoethyl-1-{2-chlor-4-fluor- 5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenoxy}cyclopropancarboxylat, 2-Methoxy-2-oxoethyl-1-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4- (trifluormethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenoxy}cyclopropancarboxylat, {[(1-{2-Chlor-4- fluor-5-[3-methyl-2,6-dioxo-4-(trifluormethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenoxy}cyclopropyl)carbonyl]oxy}essigsäure, 2-(2-Brom-4-chlorbenzyl)-4,4-dimethyl-1,2- oxazolidin-3-on, Methyl 3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6- dihydropyrimidin-1(2H)-yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat, Ethyl 3-{2-chlor-4-fluor-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)- yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazol-6a-carboxylat,Methyl-3-{2-chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}-6-methyl-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazole-6a-carboxylate, 3-{2-Chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)-3,6-dihydropyrimidin-1(2H)-yl]phenyl}-6-methyl-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazole-6a-carboxylic acid, 3-{2-Chloro-4-fluoro-5-[3-methyl-2,6-dioxo-4-(trifluoromethyl)- 3,6-dihydropyrimidin-1(2H)-yl]phenyl}-3a,4,5,6-tetrahydro-6aH-cyclopenta[d][1,2]oxazole-6a-carboxylic acid. Examples of growth regulators and plant stimulants as mixing partners are: Abscisic acid and related analogues [e.g. (2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid, methyl-(2Z,4E)-5-[6-ethynyl-1-hydroxy-2,6-dimethyl-4-oxocyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoate, (2Z,4E)-3-ethyl-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)penta-2,4-dienoic acid, (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-dienoic acid, methyl (2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-(trifluoromethyl)penta-2,4-dienoate, (2Z,4E)-5-(2-hydroxy-1,3-dimethyl-5-oxobicyclo[4.1.0]hept-3-en-2-yl)-3-methylpenta-2,4-dienoic acid], Acibenzolar, Acibenzolar- S-methyl, S-adenosylhomocysteine, Allantoin, 2-Aminoethoxyvinylglycine (AVG), Aminooxyacetic acid and related esters [e.g (Isopropylidene)-aminooxyacetic acid 2-(methoxy)-2-oxoethyl ester, (Isopropylidene)-aminooxyacetic acid 2-(hexyloxy)-2-oxoethyl ester, (Cyclohexylidene)-aminooxyacetic acid 2-(isopropyloxy)-2-oxoethyl ester], 1-Aminocycloprop-1-ylcarboxylic acid N-Methyl-1-aminocyclopropyl-1-carboxylic acid, 1-Aminocyclopropyl-1-carboxylic acid amide, substituted 1-Aminocyclopropyl-1-carboxylic acid derivatives as described in DE3335514, EP30287, DE2906507 or US5123951, 1-Aminocyclopropyl-1-hydroxamic acid, 5-Aminolevulinic acid, Ancymidol, 6-Benzylaminopurine, Bikinin, Brassinolide,Brassinolide-ethyl, L-canalin, catechin and catechins (e.g. (2S,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol), chitooligosaccharides (CO; COs differ from LCOs in that they lack the fatty acid side chain characteristic of LCOs. COs, sometimes referred to as N-acetylchitooligosaccharides, are also composed of GlcNAc units, but have side chains that distinguish them from chitin molecules [(C8H13NO5)n, CAS No.1398-61-4] and chitosan molecules [(C5H11NO4)n, CAS No.9012-76-4]), chitin-like compounds, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, 1-[2-(4-cyano-3,5-dicyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-[2-(4-cyano-3-cyclopropylphenyl)acetamido]cyclohexanecarboxylic acid, 1-cyclopropenylmethanol, Daminozide, Dazomet, Dazomet sodium, n-Decanol, Dikegulac, Dikegulac sodium, Endothal, Endothal-di-potassium, -di-sodium, and mono(N,N-dimethylalkylammonium), ethephon,1-Ethylcyclopropene, flumetralin, flurenol, flurenol-butyl, flurenol-methyl, flurprimidol, forchlorfenuron, gibberellic acid, inabenfid, indole-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, jasmonic acid esters or other derivatives (e.g. jasmonic acid methyl ester, jasmonic acid ethyl ester), lipochitooligosaccharides (LCO, sometimes also referred to as symbiotic nodulation signals (Nod or Nod factors) or Myc factors), consist of an oligosaccharide backbone of β-l,4-linked N-acetyl-D-glucosamine residues (“GlcNAc”) with an N-linked fatty acid side chain fused to the non-reducing end. As can be seen from the literature, LCOs differ in the number of GlcNAc units in the backbone structure, in the length and saturation of the fatty acid chain as well as in the substitution of the reducing and non-reducing sugar units), linoleic acid or its derivatives, linolenic acid or its derivatives,Maleic hydrazide, mepiquat chloride, mepiquat pentaborate, 1-methylcyclopropene, 3-methylcyclopropene, methoxyvinylglycine (MVG), 3'-methylabscisic acid, 1-(4-methylphenyl)-N-(2-oxo-1-propyl-1,2,3,4-tetrahydroquinolin-6-yl)methanesulfonamide and related substituted (tetrahydroquinolin-6-yl)methanesulfonamides, (3E,3αR,8βS)-3-({[(2R)-4-methyl-5-oxo-2,5-dihydrofuran-2-yl]oxy}methylene)-3,3a,4,8b-tetrahydro-2H-indeno[1,2-b]furan-2-one and related lactones as described in EP2248421, 2-(1-naphthyl)acetamide, 1-Naphthylacetic acid, 2-Naphthyloxyacetic acid, nitrophenolate mixture, 4-oxo-4[(2-phenylethyl)amino]butyric acid, paclobutrazol, 4-phenylbutyric acid and its salts (e.g. sodium 4-phenylbutanoate, potassium 4-phenylbutanoate), phenylalanine, N-phenylphthalamic acid, prohexadione, prohexadione calcium, 1-n-propylcyclopropene, putrescine, prohydrojasmone, rhizobitoxin, salicylic acid and salicyclic acid methyl ester, sarcosine, sodium cycloprop-1-en-1-yl acetate, sodium cycloprop-2-en-1-yl acetate,Sodium 3-(cycloprop-2-en-1-yl)propanoate, sodium 3-(cycloprop-1-en-1-yl)propanoate, sidefungin, spermidine, spermine, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tryptophan, tsitodef, uniconazole, uniconazole-P, 2-fluoro-N-(3-methoxyphenyl)-9H-purin-6-amine, 2-chloro-N-(3-methoxyphenyl)-9H-purin-6-amine. Also suitable as combination partners for the compounds of formula (I) according to the invention are, for example, the following safeners: S1) Compounds of formula (S1), where the symbols and indices have the following meanings: n A is a natural number from 0 to 5, preferably 0 to 3; R A 1 is halogen, (C1-C4)alkyl, (C1-C4)alkoxy, nitro or (C1-C4)haloalkyl; WA is an unsubstituted or substituted divalent heterocyclic radical from the group of saturated or aromatic five-membered ring heterocycles with 1 to 3 hetero ring atoms from the group N and O, wherein at least one N atom and at most one O atom is contained in the ring, preferably a radical from the group (WA 1 ) to (WA 5 ), mA is 0 or 1; RA 2 is ORA 3 , SRA 3 or NRA 3 RA 4 or a saturated or unsaturated 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group O and S, which is linked via the N atom to the carbonyl group in (S1) and is unsubstituted or substituted by radicals from the group (C1-C4)-alkyl, (C1-C4)-alkoxy or optionally substituted phenyl, preferably a radical of the formula ORA 3 , NHRA 4 or N(CH3)2, in particular of the formula ORA 3 ; RA 3is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably with a total of 1 to 18 C atoms; RA 4 is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkoxy or substituted or unsubstituted phenyl; RA 5 is hydrogen, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy(C1-C8)alkyl, cyano or COORA 9 , where RA 9 is hydrogen, (C1-C8)alkyl, (C1-C8)haloalkyl, (C1-C4)alkoxy-(C1-C4)alkyl, (C1-C6)hydroxyalkyl, (C3-C12)cycloalkyl or tri-(C1-C4)alkylsilyl; R.A 6 , Attorney 7 , Attorney 8 are identical or different and are hydrogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C3-C12)-cycloalkyl or substituted or unsubstituted phenyl; R A 10 is H, (C3-C 12 )-cycloalkyl, substituted or unsubstituted phenyl or substituted or unsubstituted heteroaryl; preferably: a) compounds of the dichlorophenylpyrazolin-3-carboxylic acid type (S1a ), preferably compounds such as 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid, 1-(2,4-dichlorophenyl)-5-(ethoxycarbonyl)-5-methyl-2-pyrazole-3-carboxylic acid ethyl ester (S1-1) ("Mefenpyr-diethyl"), and related compounds as described in WO-A-91 / 07874; b) derivatives of dichlorophenylpyrazolecarboxylic acid (S1 b ), preferably compounds such as ethyl 1-(2,4-dichlorophenyl)-5-methyl-pyrazole-3-carboxylate (S1-2), ethyl 1-(2,4-dichlorophenyl)-5-isopropyl-pyrazole-3-carboxylate (S1-3), ethyl 1-(2,4-dichlorophenyl)-5-(1,1-dimethyl-ethyl)pyrazole-3-carboxylate (S1-4) and related compounds as described in EP-A-333131 and EP-A-269806; c) derivatives of 1,5-diphenylpyrazole-3-carboxylic acid (S1 c), preferably compounds such as ethyl 1-(2,4-dichlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-5), methyl 1-(2-chlorophenyl)-5-phenylpyrazole-3-carboxylate (S1-6) and related compounds as described, for example, in EP-A-268554; d) compounds of the triazolecarboxylic acid type (S1 d ), preferably compounds such as fenchlorazole (ethyl ester), ie 1-(2,4-dichlorophenyl)-5-trichloromethyl-(1H)-1,2,4-triazole-3-carboxylic acid ethyl ester (S1-7), and related compounds as described in EP-A-174562 and EP-A-346620; e) compounds of the type 5-benzyl- or 5-phenyl-2-isoxazoline-3-carboxylic acid or 5,5-diphenyl-2-isoxazoline-3-carboxylic acid (S1 e), preferably compounds such as ethyl 5-(2,4-dichlorobenzyl)-2-isoxazoline-3-carboxylate (S1-8) or ethyl 5-phenyl-2-isoxazoline-3-carboxylate (S1-9) and related compounds as described in WO-A-91 / 08202, or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-10) or ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate (S1-11) ("isoxadifen-ethyl") or -n-propyl ester (S1-12) or ethyl 5-(4-fluorophenyl)-5-phenyl-2-isoxazoline-3-carboxylate (S1-13) as described in patent application WO-A-95 / 07897.f) Compounds of the triazolyloxyacetic acid derivative type (S1f), preferably compounds such as methyl {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-14) or {[1,5-bis(4-chloro-2-fluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-15) or methyl {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-16) or {[5-(4-chloro-2-fluorophenyl)-1-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-17) or Methyl {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetate (S1-18) or {[1-(4-chloro-2-fluorophenyl)-5-(2,4-difluorophenyl)-1H-1,2,4-triazol-3-yl]oxy}acetic acid (S1-19), as described in patent application WO2021105101. S2) Quinoline derivatives of the formula (S2). where the symbols and indices have the following meanings: RB 1 is halogen, (C1-C4)alkyl, (C1-C4)alkoxy, nitro or (C1-C4)haloalkyl; n Bis a natural number from 0 to 5, preferably 0 to 3; R B 2 is OR B 3 , SR B 3 or NR B 3 R B 4 or a saturated or unsaturated 3- to 7-membered heterocycle having at least one N atom and up to 3 heteroatoms, preferably from the group O and S, which is bonded via the N atom to the carbonyl group in (S2) and is unsubstituted or substituted by radicals from the group (C1-C4)-alkyl, (C1-C4)-alkoxy or optionally substituted phenyl, preferably a radical of the formula OR B 3 , NHR B 4 or N(CH3)2, in particular of the formula OR B 3 ; R B 3 is hydrogen or an unsubstituted or substituted aliphatic hydrocarbon radical, preferably having a total of 1 to 18 C atoms; R B 4is hydrogen, (C1-C6)-alkyl, (C1-C6)-alkoxy or substituted or unsubstituted phenyl; T B is a (C1 or C2)-alkanediyl chain which is unsubstituted or substituted by one or two (C1-C4)-alkyl radicals or by [(C1-C3)-alkoxy]-carbonyl; preferably: a) compounds of the 8-quinolinoxyacetic acid type (S2 a), preferably (5-chloro-8-quinolinoxy)acetic acid (1-methylhexyl) ester ("Cloquintocet-mexyl") (S2-1), (5-chloro-8-quinolinoxy)acetic acid (1,3-dimethyl-but-1-yl) ester (S2-2), (5-chloro-8-quinolinoxy)acetic acid 4-allyloxy-butyl ester (S2-3), (5-chloro-8-quinolinoxy)acetic acid 1-allyloxy-prop-2-yl ester (S2-4), (5-chloro-8-quinolinoxy)acetic acid ethyl ester (S2-5), (5-chloro-8-quinolinoxy)acetic acid methyl ester (S2-6), (5-chloro-8-quinolinoxy)acetic acid allyl ester (S2-7), (5-chloro-8-quinolinoxy)acetic acid 2-(2-propylidene- iminoxy)-1-ethyl ester (S2-8), (5-chloro-8-quinolinoxy)acetate 2-oxo-prop-1-yl ester (S2-9) and related compounds as described in EP-A-86750, EP-A-94349 and EP-A-191736 or EP-A-0492 366, and (5-chloro-8-quinolinoxy)acetic acid (S2-10), their hydrates and salts, for example their lithium, sodium, potassium, calcium, magnesium, aluminum, iron, ammonium, quaternary ammonium, sulfonium,or phosphonium salts as described in WO-A-2002 / 34048; b) compounds of the type (5-chloro-8-quinolinoxy)malonic acid (S2, b ), preferably compounds such as (5-chloro-8-quinolinoxy)malonic acid diethyl ester, (5-chloro-8-quinolinoxy)malonic acid diallyl ester, (5-chloro-8-quinolinoxy)malonic acid methyl ethyl ester and related compounds as described in EP-A-0582198. S3) Compounds of formula (S3) where the symbols and indices have the following meanings: RC 1 is (C1-C4)alkyl, (C1-C4)haloalkyl, (C2-C4)alkenyl, (C2-C4)haloalkenyl, (C3-C7)cycloalkyl, preferably dichloromethyl; RC 2 , RC 3sind gleich oder verschieden Wasserstoff, (C1-C4)-Alkyl, (C2-C4)-Alkenyl, (C2-C4)-Alkinyl, (C1-C4), Haloalkyl, (C2-C4)-Haloalkenyl, (C1-C4)-Alkylcarbamoyl-(C1-C4)-Alkyl, (C2-C4)- Alkenylcarbamoyl-(C1-C4)-alkyl, (C1-C4)-Alkoxy-(C1-C4)-alkyl, Dioxolanyl-(C1-C4)-alkyl, Thiazolyl, Furyl, Furylalkyl, Thienyl, Piperidyl, substituiertes oder unsubstituiertes Phenyl, oder RC 2 und RC 3together form a substituted or unsubstituted heterocyclic ring, preferably an oxazolidine, thiazolidine, piperidine, morpholine, hexahydropyrimidine or benzoxazine ring; preferably: active ingredients of the dichloroacetamide type, which are frequently used as pre-emergence safeners (soil-acting safeners), such as: B. "Dichlormid" (N,N-diallyl-2,2-dichloroacetamide) (S3-1), "R-29148" (3-dichloroacetyl-2,2,5-trimethyl-1,3-oxazolidine) from Stauffer (S3-2), "R-28725" (3-dichloroacetyl-2,2,-dimethyl-1,3-oxazolidine) from Stauffer (S3-3), "Benoxacor" (4-dichloroacetyl-3,4-dihydro-3-methyl-2H-1,4-benzoxazine) (S3-4), "PPG-1292" (N-allyl-N-[(1,3-dioxolan-2-yl)-methyl]-dichloroacetamide) from PPG Industries (S3-5), "DKA-24" (N-allyl-N-[(allylaminocarbonyl)methyl]-dichloroacetamide) from Sagro-Chem (S3-6), "AD-67" or "MON 4660" (3-dichloroacetyl-1-oxa-3-aza-spiro[4,5]decane) from Nitrokemia orMonsanto (S3-7), "TI-35" (1-Dichloroacetyl-azepane) from TRI-Chemical RT (S3-8), "Diclonon" (Dicyclonone) or "BAS145138" or "LAB145138" (S3-9) ((RS)-1-Dichloroacetyl-3,3,8a-trimethylperhydropyrrolo[1,2-a]pyrimidin-6-one) from BASF, "Furilazole" or "MON 13900" ((RS)-3-Dichloroacetyl-5-(2-furyl)-2,2-dimethyloxazolidine) (S3-10); and its (R)-isomer (S3-11). S4) N-Acylsulfonamides of the formula (S4) and their salts,. where the symbols and indices have the following meanings: X D is CH or N; R D 1 is CO-NR D 5 R D 6 or NHCO-R D 7 ; R D 2 is halogen, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, nitro, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl or (C1-C4)-alkylcarbonyl; R D 3 is hydrogen, (C1-C4)alkyl, (C2-C4)alkenyl or (C2-C4)alkynyl; R D 4is halogen, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-haloalkoxy, (C3-C6)-cycloalkyl, phenyl, (C1-C4)-alkoxy, cyano, (C1-C4)-alkylthio, (C1-C4)-alkylsulfinyl, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl or (C1-C4)-alkylcarbonyl; R D 5 is hydrogen, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, (C5-C6)-cycloalkenyl, phenyl or 3- to 6-membered heterocyclyl containing vD heteroatoms from the group nitrogen, oxygen and sulfur, where the last seven radicals are replaced by v D Substituents from the group consisting of halogen, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy, (C1-C2)-alkylsulfinyl, (C1-C2)-alkylsulfonyl, (C3-C6)-cycloalkyl, (C1-C4)-alkoxycarbonyl, (C1-C4)-alkylcarbonyl and phenyl and, in the case of cyclic radicals, also (C1-C4)-alkyl and (C1-C4)-haloalkyl; R D 6 is hydrogen, (C1-C6)-alkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where the last three radicals areD radicals from the group halogen, hydroxy, (C1-C4)-alkyl, (C1-C4)-alkoxy and (C1-C4)-alkylthio, or R D 5 and R D 6 together with the nitrogen atom they carry form a pyrrolidinyl or piperidinyl residue; RD 7 is hydrogen, (C1-C4)-alkylamino, di-(C1-C4)-alkylamino, (C1-C6)-alkyl, (C3-C6)-cycloalkyl, where the last two radicals are substituted by vD substituents from the group halogen, (C1-C4)-alkoxy, (C1-C6)-haloalkoxy and (C1-C4)-alkylthio and, in the case of cyclic radicals, also (C1-C4)-alkyl and (C1-C4)-haloalkyl; nD is 0, 1 or 2; mD is 1 or 2; vD is 0, 1, 2 or 3; of these, preference is given to compounds of the N-acylsulfonamide type, e.g. of the following formula (S4) a ), which are known, for example, from WO-A-97 / 45016 where R D 7 (C1-C6)-alkyl, (C3-C6)-cycloalkyl, where the last two radicals are replaced by v DSubstituents from the group consisting of halogen, (C1-C4)-alkoxy, (C1-C6)-haloalkoxy and (C1-C4)-alkylthio and, in the case of cyclic radicals, also (C1-C4)-alkyl and (C1-C4)-haloalkyl; R D 4 Halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, CF 3; m D 1 or 2; vD is 0, 1, 2 or 3; and acylsulfamoylbenzoic acid amides, e.g. of the following formula (S4 b ), which are known for example from WO-A-99 / 16744, e.g. those in which RD 5 = Cyclopropyl and (RD 4 ) = 2-OMe is ("Cyprosulfamide", S4-1), RD 5 = Cyclopropyl and (RD 4 ) = 5-Cl-2-OMe is (S4-2), RD 5 = Ethyl and (RD 4 ) = 2-OMe is (S4-3), RD 5 = Isopropyl and (RD 4 ) = 5-Cl-2-OMe is (S4-4) and RD 5 = Isopropyl and (RD 4 ) = 2-OMe (S4-5). as well as compounds of the N-acylsulfamoylphenylurea type of the formula (S4 c ), which are known for example from EP-A-365484, where R D 8 and R D 9 independently of one another hydrogen, (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C3-C6)-alkenyl, (C3-C6)-alkynyl, R D 4 Halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, CF3m D1 or 2; for example 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3-methylurea, 1-[4-(N-2-methoxybenzoylsulfamoyl)phenyl]-3,3-dimethylurea, 1-[4-(N-4,5-dimethylbenzoylsulfamoyl)phenyl]-3-methylurea. S5) Active ingredients from the class of hydroxyaromatics and aromatic-aliphatic carboxylic acid derivatives (S5), e.g. ethyl 3,4,5-triacetoxybenzoate, 3,5-dimethoxy-4-hydroxybenzoic acid, 3,5-dihydroxybenzoic acid, 4-hydroxysalicylic acid, 4-fluorosalicyclic acid, 2-hydroxycinnamic acid, 2,4-dichlorocinnamic acid, as described in WO-A-2004 / 084631, WO-A-2005 / 015994, WO-A-2005 / 016001. S6) Active ingredients from the class of 1,2-dihydroquinoxalin-2-ones (S6), e.g. 1-methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, 1-methyl-3-(2-thienyl)-1,2-dihydroquinoxalin-2-thione, 1-(2-aminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one hydrochloride, 1-(2-methylsulfonylaminoethyl)-3-(2-thienyl)-1,2-dihydroquinoxalin-2-one, as described in WO-A-2005 / 112630.S7) Compounds of formula (S7) as described in WO-A-1998 / 38856. where the symbols and indices have the following meanings: RE 1 , RE 2 are independently halogen, (C1-C4)-alkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkyl, (C1-C4)-alkylamino, di-(C1-C4)-alkylamino, nitro; AE is COORE 3 or COSRE 4 RE 3 , RE 4 are independently hydrogen, (C1-C4)-alkyl, (C2-C6)-alkenyl, (C2-C4)-alkynyl, cyanoalkyl, (C1-C4)-haloalkyl, phenyl, nitrophenyl, benzyl, halobenzyl, pyridinylalkyl and alkylammonium, n E 1 is 0 or 1 n E 2 , n E 3 are independently 0, 1 or 2, preferably diphenylmethoxyacetic acid, ethyl diphenylmethoxyacetate, methyl diphenylmethoxyacetate (CAS Reg. No. 41858-19-9) (S7-1). S8) Compounds of formula (S8) as described in WO-A-98 / 27049 where XF is CH or N, nF is an integer from 0 to 4 when XF=N and an integer from 0 to 5 when XF=CH, RF 1 Halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, nitro, (C1-C4)-alkylthio, (C1-C4)-alkylsulfonyl, (C1-C4)-alkoxycarbonyl, optionally substituted phenyl, optionally. substituted phenoxy, RF 2 Hydrogen or (C1-C4)-alkyl RF 3 hydrogen, (C1-C8)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, or aryl, where each of the aforementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy; or salts thereof, preferably compounds wherein XF is CH, nF is an integer from 0 to 2, RF 1 Halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, R F 2 hydrogen or (C1-C4)-alkyl, R F 3Hydrogen, (C1-C8)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, or aryl, where each of the aforementioned C-containing radicals is unsubstituted or substituted by one or more, preferably up to three identical or different radicals from the group consisting of halogen and alkoxy, or salts thereof. S9) Active ingredients from the class of 3-(5-tetrazolylcarbonyl)-2-quinolones (S9), e.g. 1,2-dihydro-4-hydroxy-1-ethyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No. 219479-18-2), 1,2-dihydro-4-hydroxy-1-methyl-3-(5-tetrazolylcarbonyl)-2-quinolone (CAS Reg. No. 95855-00-8), as described in WO-A-1999 / 000020. S10) Compounds of the formulas (S10 a ) or (S10 b ) as described in WO-A-2007 / 023719 and WO-A-2007 / 023764 where RG 1 Halogen, (C1-C4)-alkyl, methoxy, nitro, cyano, CF3, OCF3 YG, ZG independently of one another are O or S, nG is an integer from 0 to 4, RG 2(C1-C16)-Alkyl, (C2-C6)-Alkenyl, (C3-C6)-Cycloalkyl, Aryl; Benzyl, Halogenbenzyl, RG 3hydrogen or (C1-C6)-alkyl. S11) Active ingredients of the oxyimino compound type (S11), which are known as seed dressings, such as B. "Oxabetrinil" ((Z)-1,3-dioxolan-2-ylmethoxyimino(phenyl)acetonitrile) (S11-1), which is known as a seed dressing safener for millet against metolachlor damage, "Fluxofenim" (1-(4-chlorophenyl)-2,2,2-trifluoro-1-ethanone-O-(1,3-dioxolan-2-ylmethyl)-oxime) (S11-2), which is known as a seed dressing safener for millet against metolachlor damage, and "Cyometrinil" or "CGA-43089" ((Z)-cyanomethoxyimino(phenyl)acetonitrile) (S11-3), which is known as a seed dressing safener for millet against metolachlor damage. S12) Active ingredients from the class of isothiochromanones (S12), such as methyl [(3-oxo-1H-2-benzothiopyran-4(3H)-ylidene)methoxy]acetate (CAS Reg. No. 205121-04-6) (S12-1) and related compounds from WO-A-1998 / 13361.S13) One or more compounds from group (S13): "Naphthalic anhydride" (1,8-naphthalenedicarboxylic anhydride) (S13-1), known as a seed dressing safener for maize against damage from thiocarbamate herbicides, "Fenclorim" (4,6-dichloro-2-phenylpyrimidine) (S13-2), known as a safener for pretilachlor in sown rice, "Flurazole" (benzyl 2-chloro-4-trifluoromethyl-1,3-thiazole-5-carboxylate) (S13-3), known as a seed dressing safener for millet against damage from alachlor and metolachlor, "CL 304415" (CAS Reg. No. 31541-57-8) (4-carboxy-3,4-dihydro-2H-1-benzopyran-4-acetic acid) (S13-4) from American Cyanamid, which is known as a safener for corn against damage from imidazolinones, "MG 191" (CAS Reg. No. 96420-72-3) (2-Dichloromethyl-2-methyl-1,3-dioxolane) (S13-5) from Nitrokemia, which is known as a safener for corn, "MG-838" (CAS Reg. No. 133993-74-5) (2-propenyl 1-oxa-4-azaspiro[4.5]decane-4-carbodithioate) (S13-6) from Nitrokemia, "Disulfoton" (O,O-diethyl S-2-ethylthioethyl phosphodithioate) (S13-7), "Dietholate" (O,O-diethyl-O-phenylphosphorothioate) (S13-8), "Mephenate" (4-chlorophenyl methylcarbamate) (S13-9). S14) Active ingredients that, in addition to herbicidal activity against weeds, also have safener effects on crops such as rice, such as"Dimepiperate" or "MY-93" (S-1-methyl-1-phenylethyl-piperidine-1-carbothioate), known as a safener for rice against damage from the herbicide molinate, "Daimuron" or "SK 23" (1-(1-methyl-1-phenylethyl)-3-p-tolylurea), known as a safener for rice against damage from the herbicide imazosulfuron, "Cumyluron" = "JC-940" (3-(2-chlorophenylmethyl)-1-(1-methyl-1-phenylethyl)urea, see JP-A-60087254), known as a safener for rice against damage from some herbicides, "Methoxyphenone" or "NK 049" (3,3'-dimethyl-4-methoxybenzophenone), known as a safener for rice against damage from some herbicides, "CSB" (1-Bromo-4-(chloromethylsulfonyl)benzene) from Kumiai (CAS Reg. No. 54091-06-4), which is known as a safener against damage from some herbicides in rice. S15) Compounds of formula (S15) or their tautomers as described in WO-A-2008 / 131861 and WO-A-2008 / 131860. where R H 1 a (C1-C6)-haloalkyl radical and RH 2 hydrogen or halogen and R H 3 , R H 4 independently of each other hydrogen, (C1-C 16 )-alkyl, (C2-C 16 )-alkenyl or (C2-C 16)-Alkynyl, where each of the last three radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted, or (C3-C6)-cycloalkyl, (C4-C6)-cycloalkenyl, (C3-C6)-cycloalkyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring, or (C4-C6)-cycloalkenyl which is condensed on one side of the ring with a 4 to 6-membered saturated or unsaturated carbocyclic ring, wherein each of the latter 4 radicals is unsubstituted or substituted by one or more radicals from the group consisting of halogen, hydroxy, cyano, (C1-C4)-alkyl,(C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy, (C1-C4)-alkylthio, (C1-C4)-alkylamino, di[(C1-C4)-alkyl]-amino, [(C1-C4)-alkoxy]-carbonyl, [(C1-C4)-haloalkoxy]-carbonyl, (C3-C6)-cycloalkyl, which is unsubstituted or substituted, phenyl, which is unsubstituted or substituted, and heterocyclyl, which is unsubstituted or substituted, is substituted, or R, H 3 (C1-C4)-alkoxy, (C2-C4)-alkenyloxy, (C2-C6)-alkynyloxy or (C2-C4)-haloalkoxy and R H 4 hydrogen or (C1-C4)-alkyl, or R H 3 and R H 4together with the directly bonded N atom forms a four- to eight-membered heterocyclic ring which, in addition to the N atom, may also contain further hetero ring atoms, preferably up to two further hetero ring atoms from the group N, O and S and which is unsubstituted or substituted by one or more radicals from the group halogen, cyano, nitro, (C1-C4)-alkyl, (C1-C4)-haloalkyl, (C1-C4)-alkoxy, (C1-C4)-haloalkoxy and (C1-C4)-alkylthio. S16) Active substances which are primarily used as herbicides but also have a safener effect on crops, e.g. (2,4-dichlorophenoxy)acetic acid (2,4-D), (4-chlorophenoxy)acetic acid, (R,S)-2-(4-chloro-o-tolyloxy)propionic acid (mecoprop), 4-(2,4-dichlorophenoxy)butyric acid (2,4-DB), (4-chloro-o-tolyloxy)acetic acid (MCPA), 4-(4-chloro-o-tolyloxy)butyric acid, 4-(4-chlorophenoxy)butyric acid, 3,6-dichloro-2-methoxybenzoic acid (dicamba), 1-(ethoxycarbonyl)ethyl 3,6-dichloro-2-methoxybenzoate (lactidichloroethyl).Preferred safeners in combination with the compounds of the formula (I) according to the invention and / or their salts, in particular with the compounds of the formulas (I.1-1) to (I.26-500) and / or their salts are: cloquintocet-mexyl, cyprosulfamide, fenchlorazole ethyl ester, isoxadifen ethyl, mefenpyr diethyl, fenclorim, cumyluron, S1-14, S1-15, S1-16, S1-17, S1-18, S1-19, S4-1 and S4-5, and particularly preferred safeners are: cloquintocet-mexyl, cyprosulfamide, isoxadifen ethyl and mefenpyr diethyl.Biological examples: The following abbreviations are used for the crops and weeds listed in the following tables: ABUTH: Abutilon theophrasti ALOMY: Alopecurus myosuroides AMARE: Amaranthus retroflexus AVEFA: Avena fatua BRSNS: Brassica napus DIGSA: Digitaria sanguinalis ECHCG: Echinochloa crus-galli GLXMA: Glycine max KCHSC: Kochia scoparia LOLRI: Lolium rigidum MATIN: Matricaria inodora ORYZA: Oryza sativa PHPBU : Pharbitis purpurea POLCO: Polygonum convolvulus SETVI: Setaria viridis VERPE: Veronica persica VIOTR: Viola tricolor TRZAS : Triticum aestivum ZEAMX: Zea mays A. Post-emergence herbicidal action Seeds of monocotyledonous and dicotyledonous weeds were sown in plastic or Wood fiber pots were placed in sandy loam soil, covered with soil, and grown in a greenhouse under controlled growth conditions. Two to three weeks after sowing, the test plants were treated at the single-leaf stage.The compounds according to the invention, formulated in the form of wettable powders (WP) or emulsion concentrates (EC), were then sprayed onto the green parts of the plants as an aqueous suspension or emulsion with the addition of 0.5% additive at a water application rate equivalent to 600 l / ha. After approximately three weeks of the test plants standing in the greenhouse under optimal growth conditions, the effect of the preparations was visually assessed in comparison to untreated controls. For example, 100% effect means plants died, 0% effect means the same as the control plants. Tables A1 to A12 below show the effects of selected compounds of general formula (I) according to Table 1 on various weeds and at an application rate corresponding to 20 g / ha and lower, obtained according to the aforementioned test procedure. Table A1a: Post-emergence effect at 1.25 g / ha against ABUTH in %. Table A1b: Post-emergence effect at 5g / ha against ABUTH in % Table A1c: Post-emergence effect at 20g / ha against ABUTH in % Table A2a: Post-emergence effect at 1.25g / ha against ALOMY in % Table A2b: Post-emergence effect at 5g / ha against ALOMY in % Table A2c: Post-emergence effect at 20g / ha against ALOMY in % Table A3a: Post-emergence effect at 5g / ha against DIGSA in % Table A3b: Post-emergence effect at 20g / ha against DIGSA in % Table A4a: Post-emergence efficacy at 1.25g / ha against ECHCG in % Table A4b: Post-emergence effect at 5g / ha against ECHCG in % Table A4c: Post-emergence effect at 20g / ha against ECHCG in % Table A5a: Post-emergence effect at 5g / ha against LOLRI in % Table A5b: Post-emergence effect at 20g / ha against LOLRI in % Table A6a: Post-emergence effect at 1.25g / ha against MATIN in % Table A6b: Post-emergence effect at 5g / ha against MATIN in % Table A6c: Post-emergence effect at 20g / ha against MATIN in % Table A7a: Post-emergence effect at 1.25g / ha against PHBPU in % Table A7b: Post-emergence effect at 5g / ha against PHBPU in % Table A7c: Post-emergence effect at 20g / ha against PHBPU in % Table A8a: Post-emergence effect at 5g / ha against POLCO in % Table A8b: Post-emergence effect at 20g / ha against POLCO in % Table A9a: Post-emergence effect at 1.25g / ha against SETVI in % Table A9b: Post-emergence effect at 5g / ha against SETVI in % Table A9c: Post-emergence effect at 20g / ha against SETVI in % Table A10a: Post-emergence effect at 1.25g / ha against VERPE in % Table A10b: Post-emergence effect at 5g / ha against VERPE in % Table A10c: Post-emergence effect at 20g / ha against VERPE in % Table A11a: Post-emergence effect at 1.25g / ha against VIOTR in % Table A11b: Post-emergence effect at 5g / ha against VIOTR in % Table A11c: Post-emergence effect at 20g / ha against VIOTR in % Table A12a: Post-emergence effect at 1.25g / ha against KCHSC in % Table A12b: Post-emergence effect at 5g / ha against KCHSC in % Table A12c: Post-emergence effect at 20g / ha against KCHSC in % B. Post-emergence effect on crops. Seeds of monocotyledonous and dicotyledonous crops were sown in sandy loam soil in plastic or wood fiber pots, covered with soil, and grown in a greenhouse under controlled growth conditions. Two to three weeks after sowing, the test plants were treated at the single-leaf stage. The compounds according to the invention, formulated as wettable powders (WP) or emulsion concentrates (EC), were then sprayed onto the green plant parts as an aqueous suspension or emulsion with the addition of 0.5% additive at a water application rate equivalent to 600 l / ha. After the test plants had been in the greenhouse for approximately three weeks under optimal growth conditions, the effect of the preparations was visually assessed in comparison to untreated controls. For example, 100% effect means plants have died, 0% effect means the same as the control plants.Tables B1 to B3 below show the effects of selected compounds of general formula (I) according to Table 1 on various crops and at application rates corresponding to 1.25 g / ha and lower, obtained according to the aforementioned test protocol. Table B1: Postemergence effect at 1.25 g / ha against ZEAMX in %. Table B2: Post-emergence effect at 1.25g / ha against TRZAS in % Table B3: Post-emergence effect at 1.25g / ha against GLXMA in % As the above-mentioned results show, compounds of the general formula (I) according to the invention, when applied post-emergence, have good herbicidal activity against harmful plants such as, for example, Abutilon theophrasti, Alopecurus myosuroides, Digitaria sanguinalis, Echinochloa crus-galli, Lolium rigidum, Matricaria inodora, Pharbitis purpurea, Polygonum convolvulus, Setaria viridis, Veronica persica, Viola tricolor and Kochia scoparia at an application rate of 0.02 kg of active ingredient or less per hectare, and good crop plant tolerance by organisms such as, for example, Zea mays, Triticum aestivum and Glycine max at an application rate of 1.25 g per hectare or less.

Claims

Claims:

1. Substituted cyclopropyloxyphenyluracils of the general formula (I) or their salts where R 1 represents hydrogen, halogen, (C1-C8)-alkoxy, R 2 represents halogen, cyano, nitro, C(O)NH2, C(S)NH2, (C1-C8)-haloalkyl, (C2-C8)-alkynyl, R 3 and R 4 independently of one another represent hydrogen, halogen, (C1-C8)-alkyl, (C1-C8)-haloalkyl, (C1-C8)-alkoxy, where R 3 and R 4 do not simultaneously represent (C1-C8)-alkoxy, R 5 represents hydrogen, halogen, R 6 represents (C1-C8)-alkyl, (C3-C8)-cycloalkyl, (C2-C8)-alkenyl, aryl-(C1-C8)-alkyl, (C3-C8)-cycloalkyl-(C1-C8)-alkyl, R 7 stands for hydrogen, fluorine, chlorine, methyl, G stands for unbranched or branched (C 1 -C 8 )-alkylene, X is methyl, amino, Q is a radical of the following formulas steht, R 8für Wasserstoff, (C1-C8)-Alkyl, (C1-C8)-Haloalkyl, Aryl, Aryl-(C1-C8)-alkyl, Heteroaryl, (C2-C8)-Alkinyl, (C2-C8)-Alkenyl, C(O)R 13 , C(O)OR 13 , (C1-C8)-Alkoxy- (C1-C8)-alkyl steht, R 9 für Wasserstoff oder (C1-C8)-Alkyl steht, R 10 für Wasserstoff, Halogen, Cyano, NO2, (C1-C8)-Alkyl, (C1-C8)-Haloalkyl, (C3-C8)- Cycloalkyl, (C3-C8)-Cycloalkyl-(C1-C8)-alkyl, (C3-C8)-Halocycloalkyl, (C3-C8)- Halocycloalkyl-(C1-C8)-alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, Aryl, Aryl-(C1-C8)- alkyl, Heteroaryl, Heteroaryl-(C1-C8)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C8)-alkyl, R 11 R 12 N-(C1-C8)-alkyl, R 13 O-(C1-C8)-alkyl, Cyano-(C1-C8)-alkyl, (C1-C8)- Alkylcarbonyloxy-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl-carbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl, Heteroarylcarbonyloxy-(C1-C8)-alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R14 S- (C 1 -C 8 )-alkyl, R 14 (O)S-(C 1 -C 8 )-alkyl, R 14 O 2 S-(C 1 -C 8 )-alkyl, Tris-[(C 1 -C 8 )-Alkyl]silyl- (C 1 -C 8 )-alkyl, Bis-[(C 1 -C 8 )-Alkyl](aryl)silyl(C 1 -C 8 )-alkyl, [(C 1 -C 8 )-Alkyl]-bis- (aryl)silyl-(C 1 -C 8 )-alkyl, Tris-[(C 1 -C 8 )-Alkyl]silyl, Bis-hydroxyboryl-(C 1 -C 8 )-alkyl, Bis- [(C 1 -C 8 )-alkoxy]boryl-(C 1 -C 8 )-alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2-Dioxaborolan-2-yl-(C 1 -C 8 )-alkyl, Nitro-(C 1 -C 8 )-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C 1 -C 8 )-alkyl, R 11 R 12 N(O)C-(C 1 -C8 )-alkyl, bis- (C 1 -C 8 )-alkoxy-(C 1 -C 8 )-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12 are the same or different and independently represent hydrogen, (C 1 -C 8 )-alkyl, (C2-C8)-alkenyl, (C2-C8)-alkynyl, (C1-C8)-cyanoalkyl, (C1-C10)-haloalkyl, (C 2 -C 8 )-haloalkenyl, (C 3 -C 8 )-haloalkynyl, (C 3 -C 10 )-cycloalkyl, (C 3 -C 10 )- Halocycloalkyl, (C 4 -C 10 )-cycloalkenyl, (C 4 -C 10 )-Halocycloalkenyl, (C 1 -C 8 )-alkoxy- (C 1 -C 8 )-alkyl, (C1 -C 8 )-Haloalkoxy-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkylthio-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Haloalkylthio-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkoxy-(C 1 -C 8 )-haloalkyl, Aryl, Aryl- (C 1 -C 8 )-alkyl, Heteroaryl, Heteroaryl-(C 1 -C 8 )-alkyl, (C 3 -C 8 )-Cycloalkyl-(C 1 -C 8 )-alkyl, (C 4 -C 10 )-Cycloalkenyl-(C 1 -C 8 )-alkyl, COR 13 , SO 2 R 14 , Heterocyclyl, (C 1 -C 8 )- Alkoxycarbonyl, Bis-[(C 1 -C 8 )-alkyl]aminocarbonyl-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkyl-amino- carbonyl-(C 1 -C 8 )-alkyl, Aryl-(C 1 -C 8 )-alkyl-aminocarbonyl-(C 1 -C 8)-alkyl, aryl-(C 1 -C 8 )-alkoxycarbonyl, heteroaryl-(C 1 -C 8 )-alkoxycarbonyl, (C 2 -C 8 )-Alkenyloxycarbonyl, (C2-C8)-alkynyloxycarbonyl, heterocyclyl-(C1-C8)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C8)-Alkyl, (C2-C8)-Alkenyl, (C2-C8)-Alkinyl, (C1-C8)-Cyanoalkyl, (C1-C10)-Haloalkyl, (C2-C8)-Haloalkenyl, (C3-C8)-Haloalkinyl, (C3-C10)-Cycloalkyl, (C3-C10)-Halocycloalkyl, (C4-C10)-Cycloalkenyl, (C4-C10)-Halocycloalkenyl, (C1-C8)- Alkoxy-(C1-C8)-alkyl, (C1-C8)-Haloalkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)- haloalkyl, (C1-C8)-Alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)- alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkyl, (C1-C8)-Alkoxy-(C1-C8)-alkoxy-(C1-C8)-alkoxy- (C1-C8)-alkoxy-(C1-C8)-alkyl, Aryl, Aryl-(C1-C8)-alkyl, Aryl-(C1-C8)-alkoxy-(C1-C8)- alkyl, Heteroaryl, Heteroaryl-(C1-C8)-alkyl, (C3-C8)-Cycloalkyl-(C1-C8)-alkyl, (C4-C10)- Cycloalkenyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]aminocarbonyl-(C1-C8)-alkyl, (C1-C8)- Alkyl-aminocarbonyl-(C1-C8)-alkyl, Aryl-(C1-C8)-alkyl-aminocarbonyl-(C1-C8)-alkyl, Bis-[(C1-C8)-alkyl]amino-(C2-C6)-alkyl, (C1-C8)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1- C8)-alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C8)-alkyl, R 14(O)S-(C1-C8)-alkyl, R 14 O2S- (C1-C8)-alkyl, Hydroxycarbonyl-(C1-C8)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C8)- alkyl, Tris-[(C1-C8)-Alkyl]silyl-(C1-C8)-alkyl, Bis-[(C1-C8)-Alkyl](aryl)silyl(C1-C8)- alkyl, [(C1-C8)-Alkyl]-bis-(aryl)silyl-(C1-C8)-alkyl, (C1-C8)-Alkylcarbonyloxy-(C1-C8)- alkyl, (C3-C8)-Cycloalkylcarbonyloxy-(C1-C8)-alkyl, Arylcarbonyloxy-(C1-C8)-alkyl, Heteroarylcarbonyloxy-(C1-C8)-alkyl, Heterocyclylcarbonyloxy-(C1-C8)-alkyl, Aryloxy- (C 1 -C 8 )-alkyl, Heteroaryloxy-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C 1 -C 8 )-Alkyl, (C 2 -C 8 )-Alkenyl, (C 2 -C 8 )-Alkinyl, (C 1 -C 8 )-Cyanoalkyl, (C 1 -C 10 )-Haloalkyl, (C 2 -C 8 )-Haloalkenyl, (C 3 -C 8 )-Haloalkinyl, (C 3 -C 10 )-Cycloalkyl, (C 3 -C10 )-Halocycloalkyl, (C 4 -C 10 )-Cycloalkenyl, (C 4 -C 10 )-Halocycloalkenyl, (C 1 -C 8 )- Alkoxy-(C 1 -C 8 )-alkyl, (C 1 -C 8 )-Alkoxy-(C 1 -C 8 )-haloalkyl, Aryl, Aryl-(C 1 -C 8 )-alkyl, Heteroaryl, Heteroaryl-(C 1 -C 8 )-alkyl, Heterocyclyl-(C 1 -C 8 )-alkyl, (C 3 -C 8 )-Cycloalkyl- (C 1 -C 8 )-alkyl, (C 4 -C 10 )-Cycloalkenyl-(C 1 -C 8 )-alkyl, Bis-[(C 1 -C 8 )-alkyl]amino, (C 1 -C 8 )- Alkyl-amino, Aryl-(C 1 -C 8 )-amino, Aryl-(C 1 -C 6 )-alkyl-amino, Aryl-[(C 1 -C 8 )- alkyl]amino; (C 3 -C 8 )-Cycloalkyl-amino, (C 3 -C 8 )-Cycloalkyl-[(C 1 -C 8)-alkyl]amino; N-azetidinyl, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl and R 15 and R 16 independently of one another represent (C1-C8)-alkyl, (C3-C8)-cycloalkyl, aryl, heteroaryl, heterocyclyl, or R 15 and R 16 with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle.

2. Compounds of the general formula (I) according to claim 1 and / or a salt thereof, characterized in that R 1 represents hydrogen, fluorine, chlorine, bromine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, trifluoromethyl, ethynyl, propyn-1-yl, R 3 and R 4 independently of one another represent hydrogen, halogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C1-C6)-alkoxy, where R 3 and R 4 do not simultaneously represent (C1-C6)-alkoxy, R 5 stands for hydrogen, fluorine, chlorine, R 6represents (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl, aryl-(C1-C6)-alkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, R 7 stands for hydrogen, methyl, G stands for unbranched or branched (C 1 -C 6 )-alkylene, X is methyl, amino, Q for a remainder of the following formulas Q -A Q-B stands, R 8 for hydrogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, aryl, aryl-(C1-C6)-alkyl, heteroaryl, (C2-C6)-alkynyl, (C2-C6)-alkenyl, C(O)R 13 , C(O)OR 13 , (C1-C6)-alkoxy-(C1-C6)-alkyl, R 9 represents hydrogen or (C1-C6)-alkyl, R 10 for hydrogen, halogen, cyano, NO2, (C1-C7)-alkyl, (C1-C7)-haloalkyl, (C3-C7)-cycloalkyl, (C3-C7)-cycloalkyl-(C1-C7)-alkyl, (C3-C7)-halocycloalkyl, (C3-C7)- Halocycloalkyl-(C1-C7)-alkyl, (C2-C7)-alkenyl, (C2-C7)-alkynyl, aryl, aryl-(C1-C7)-alkyl, heteroaryl, heteroaryl-(C1-C7)-alkyl, heterocyclyl, heterocyclyl-(C1-C7)-alkyl, R11 R 12 N-(C1-C7)-alkyl, R 13 O-(C1-C7)-alkyl, Cyano-(C1-C7)-alkyl, (C1-C7)- Alkylcarbonyloxy-(C1-C7)-alkyl, (C3-C7)-Cycloalkylcarbonyloxy-(C1-C7)-alkyl, Arylcarbonyloxy-(C1-C7)-alkyl, Heteroarylcarbonyloxy-(C1-C7)-alkyl, Heterocyclylcarbonyloxy-(C1-C7)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S- (C1-C7)-alkyl, R 14 (O)S-(C1-C7)-alkyl, R 14 O2S-(C1-C7)-alkyl, Tris-[(C1-C7)-Alkyl]silyl- (C1-C7)-alkyl, Bis-[(C1-C7)-Alkyl](aryl)silyl(C1-C7)-alkyl, [(C1-C7)-Alkyl]-bis- (aryl)silyl-(C1-C7)-alkyl, Tris-[(C1-C7)-Alkyl]silyl, Bis-hydroxyboryl-(C1-C7)-alkyl, Bis- [(C1-C7)-alkoxy]boryl-(C1-C7)-alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2-Dioxaborolan-2-yl-(C1-C7)-alkyl, Nitro-(C1-C7)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C7)-alkyl, R 11 R 12N(O)C-(C1-C7)-alkyl, bis-(C 1 -C 7 )-alkoxy-(C 1 -C 7 )-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12 are the same or different and independently represent hydrogen, (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 1 -C 6 )-cyanoalkyl, (C 1 -C 6 )-haloalkyl, (C 2 -C 6 )-haloalkenyl, (C 3 -C 6 )-haloalkynyl, (C 3 -C 6 )-cycloalkyl, (C 3 -C 6 )-halocycloalkyl, (C 4 -C 6 )-cycloalkenyl, (C 4 -C 6)-Halocycloalkenyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Haloalkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkylthio-(C 1 -C 6 )-alkyl, (C 1 -C 6 )- Haloalkylthio-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-haloalkyl, Aryl, Aryl-(C 1 -C 6 )- alkyl, Heteroaryl, Heteroaryl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkyl-(C 1 -C 6 )-alkyl, (C 4 -C 6 )- Cycloalkenyl-(C 1 -C 6 )-alkyl, C(O)R 13 , SO 2 R 14 , Heterocyclyl, (C 1 -C 6 )-Alkoxycarbonyl, Bis-[(C 1 -C 6 )-alkyl]aminocarbonyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkyl-aminocarbonyl-(C 1 -C 6)-alkyl, aryl-(C 1 -C 6 )-alkyl-aminocarbonyl-(C 1 -C 6 )-alkyl, aryl-(C 1 -C 6 )-alkoxycarbonyl, heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-alkenyloxycarbonyl, (C2-C6)-alkynyloxycarbonyl, heterocyclyl-(C1-C6)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C6)-Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)-Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)- Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- haloalkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy- (C1-C6)-alkoxy-(C1-C6)-alkyl, Aryl, Aryl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxy-(C1-C6)- alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C4-C6)- Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)- Alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C7)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino-(C2-C6)-alkyl, (C1-C6)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1- C6)-alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C6)-alkyl, R 14(O)S-(C1-C6)-alkyl, R 14 O2S- (C1-C6)-alkyl, Hydroxycarbonyl-(C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)- alkyl, Tris-[(C1-C6)-Alkyl]silyl-(C1-C6)-alkyl, Bis-[(C1-C6)-Alkyl](aryl)silyl(C1-C6)- alkyl, [(C1-C6)-Alkyl]-bis-(aryl)silyl-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)- alkyl, (C3-C6)-Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy-(C 1 -C 6 )-alkyl, Heterocyclylcarbonyloxy-(C 1 -C 6 )-alkyl, Aryloxy- (C 1 -C 6 )-alkyl, Heteroaryloxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C 1 -C 6 )-Alkyl, (C 2 -C 6 )-Alkenyl, (C 2 -C 6 )-Alkinyl, (C 1 -C 6 )-Cyanoalkyl, (C 1 -C 6 )-Haloalkyl, (C 2 -C 6 )-Haloalkenyl, (C 3 -C 6 )-Haloalkinyl, (C 3-C 6 )-Cycloalkyl, (C 3 -C 6 )-Halocycloalkyl, (C 4 -C 6 )-Cycloalkenyl, (C 4 -C 6 )-Halocycloalkenyl, (C 1 -C 6 )- Alkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-haloalkyl, Aryl, Aryl-(C 1 -C 6 )-alkyl, Heteroaryl, Heteroaryl-(C 1 -C 6 )-alkyl, Heterocyclyl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkyl- (C 1 -C 6 )-alkyl, (C 4 -C 6 )-Cycloalkenyl-(C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-alkyl]amino, (C 1 -C 6 )- Alkyl-amino, Aryl-(C 1 -C 6 )-amino, Aryl-(C 1 -C 6 )-alkyl-amino, Aryl-[(C 1 -C 6 )- alkyl]amino; (C 3 -C 6 )-Cycloalkyl-amino, (C 3 -C 6)-Cycloalkyl-[(C 1 -C 6 )-alkyl]amino; N-azetidinyl, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl, and R 15 and R 16 independently of each other for (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, aryl, heteroaryl, heterocyclyl, or R 15 and R 16 with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 7-membered carbocycle.

3. Compounds of the general formula (I) according to claim 1 or 2 and / or a salt thereof, characterized in that R 1 represents hydrogen, fluorine, chlorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, trifluoromethyl, R 3 and R 4 independently represent hydrogen, halogen, (C1-C4)-alkyl, (C1-C4)-haloalkyl, R 5 represents hydrogen, fluorine, R 6 represents methyl, ethyl, prop-1-yl, R 7stands for hydrogen, G for unbranched or branched (C 1 -C 5 )-alkylene, X is methyl, amino, Q for a remainder of the following formulas Q -A Q-B stands, R 8 for hydrogen, (C1-C5)-alkyl, (C1-C5)-haloalkyl, aryl, aryl-(C1-C5)-alkyl, heteroaryl, (C2-C5)-alkynyl, (C2-C5)-alkenyl, C(O)R 13 , C(O)OR 13 , (C1-C5)-alkoxy-(C1-C5)-alkyl, R 9 represents hydrogen or (C1-C5)-alkyl, R 10 for hydrogen, halogen, cyano, NO2, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C6)-alkyl, (C3-C6)-halocycloalkyl, (C3-C6)- Halocycloalkyl-(C1-C6)-alkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, aryl, aryl-(C1-C6)-alkyl, heteroaryl, heteroaryl-(C1-C6)-alkyl, heterocyclyl, heterocyclyl-(C1-C6)-alkyl, R 11 R 12 N-(C1-C6)-alkyl, R 13O-(C1-C6)-alkyl, Cyano-(C1-C6)-alkyl, (C1-C6)- Alkylcarbonyloxy-(C1-C6)-alkyl, (C3-C6)-Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy-(C1-C6)-alkyl, Heterocyclylcarbonyloxy-(C1-C6)-alkyl, OR 13 , NR 11 R 12 , SR 14 , S(O)R 14 , SO2R 14 , R 14 S- (C1-C6)-alkyl, R 14 (O)S-(C1-C6)-alkyl, R 14 O2S-(C1-C6)-alkyl, Tris-[(C1-C6)-Alkyl]silyl- (C1-C6)-alkyl, Bis-[(C1-C6)-Alkyl](aryl)silyl(C1-C6)-alkyl, [(C1-C6)-Alkyl]-bis- (aryl)silyl-(C1-C6)-alkyl, Tris-[(C1-C6)-Alkyl]silyl, Bis-hydroxyboryl-(C1-C6)-alkyl, Bis- [(C1-C6)-alkoxy]boryl-(C1-C6)-alkyl, Tetramethyl-1,3,2-Dioxaborolan-2-yl, Tetramethyl-1,3,2-Dioxaborolan-2-yl-(C1-C6)-alkyl, Nitro-(C1-C6)-alkyl, C(O)OR 13 , C(O)R 13 , C(O)NR 11 R 12 , R 13 O(O)C-(C1-C6)-alkyl, R 11 R 12 N(O)C-(C1-C6)-alkyl, Bis- (C 1 -C 6 )-alkoxy-(C 1 -C6 )-alkyl, or R 8 and R 10 with the carbon atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 11 and R 12 are the same or different and independently represent hydrogen, (C 1 -C 6 )-alkyl, (C 2 -C 6 )-alkenyl, (C 2 -C 6 )-alkynyl, (C 1 -C 6 )-cyanoalkyl, (C 1 -C 6 )-haloalkyl, (C 2 -C 6 )-haloalkenyl, (C 3 -C 6 )-haloalkynyl, (C 3 -C 10 )-cycloalkyl, (C 3 -C 6 )-halocycloalkyl, (C 4 -C 6 )-cycloalkenyl, (C 4 -C 6 )-Halocycloalkenyl, (C 1 -C 6 )-alkoxy-(C 1 -C 6)-alkyl, (C 1 -C 6 )-Haloalkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkylthio-(C 1 -C 6 )-alkyl, (C 1 -C 6 )- Haloalkylthio-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-haloalkyl, Aryl, Aryl-(C 1 -C 6 )- alkyl, Heteroaryl, Heteroaryl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkyl-(C 1 -C 6 )-alkyl, (C 4 -C 10 )- Cycloalkenyl-(C 1 -C 6 )-alkyl, C(O)R 13 , SO 2 R 14 , Heterocyclyl, (C 1 -C 6 )-Alkoxycarbonyl, Bis-[(C 1 -C 6 )-alkyl]aminocarbonyl-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkyl-aminocarbonyl-(C 1 -C 6 )- alkyl, Aryl-(C 1 -C 6 )-alkyl-aminocarbonyl-(C 1 -C6 )-alkyl, aryl-(C 1 -C 6 )-alkoxycarbonyl, heteroaryl-(C1-C6)-alkoxycarbonyl, (C2-C6)-alkenyloxycarbonyl, (C2-C6)-alkynyloxycarbonyl, heterocyclyl-(C1-C6)-alkyl, or R 11 and R 12 with the nitrogen atom to which they are attached, form a fully saturated or partially saturated, optionally interrupted by heteroatoms and optionally further substituted 3 to 10-membered monocyclic or bicyclic ring, R 13für Wasserstoff, (C1-C6)-Alkyl, (C2-C6)-Alkenyl, (C2-C6)-Alkinyl, (C1-C6)-Cyanoalkyl, (C1-C10)-Haloalkyl, (C2-C6)-Haloalkenyl, (C3-C6)-Haloalkinyl, (C3-C6)-Cycloalkyl, (C3-C6)-Halocycloalkyl, (C4-C6)-Cycloalkenyl, (C4-C6)-Halocycloalkenyl, (C1-C6)- Alkoxy-(C1-C6)-alkyl, (C1-C6)-Haloalkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- haloalkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)- alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkyl, (C1-C6)-Alkoxy-(C1-C6)-alkoxy-(C1-C6)-alkoxy- (C1-C6)-alkoxy-(C1-C6)-alkyl, Aryl, Aryl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkoxy-(C1-C6)- alkyl, Heteroaryl, Heteroaryl-(C1-C6)-alkyl, (C3-C6)-Cycloalkyl-(C1-C6)-alkyl, (C4-C6)- Cycloalkenyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]aminocarbonyl-(C1-C6)-alkyl, (C1-C6)- Alkyl-aminocarbonyl-(C1-C6)-alkyl, Aryl-(C1-C6)-alkyl-aminocarbonyl-(C1-C6)-alkyl, Bis-[(C1-C6)-alkyl]amino-(C2-C6)-alkyl, (C1-C6)-Alkyl-amino-(C2-C6)-alkyl, Aryl-(C1- C6)-alkyl-amino-(C2-C6)-alkyl, R 14 S-(C1-C6)-alkyl, R 14(O)S-(C1-C6)-alkyl, R 14 O2S- (C1-C6)-alkyl, Hydroxycarbonyl-(C1-C6)-alkyl, Heterocyclyl, Heterocyclyl-(C1-C6)- alkyl, Tris-[(C1-C6)-Alkyl]silyl-(C1-C6)-alkyl, Bis-[(C1-C6)-Alkyl](aryl)silyl(C1-C6)- alkyl, [(C1-C6)-Alkyl]-bis-(aryl)silyl-(C1-C6)-alkyl, (C1-C6)-Alkylcarbonyloxy-(C1-C6)- alkyl, (C3-C6)-Cycloalkylcarbonyloxy-(C1-C6)-alkyl, Arylcarbonyloxy-(C1-C6)-alkyl, Heteroarylcarbonyloxy-(C 1 -C 6 )-alkyl, Heterocyclylcarbonyloxy-(C 1 -C 6 )-alkyl, Aryloxy- (C 1 -C 6 )-alkyl, Heteroaryloxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxycarbonyl steht, R 14 für Wasserstoff, (C 1 -C 6 )-Alkyl, (C 2 -C 6 )-Alkenyl, (C 2 -C 6 )-Alkinyl, (C 1 -C 6 )-Cyanoalkyl, (C 1 -C 6 )-Haloalkyl, (C 2 -C 6 )-Haloalkenyl, (C 3 -C 6 )-Haloalkinyl, (C 3-C 10 )-Cycloalkyl, (C 3 -C 6 )-Halocycloalkyl, (C 4 -C 6 )-Cycloalkenyl, (C 4 -C 6 )-Halocycloalkenyl, (C 1 -C 6 )- Alkoxy-(C 1 -C 6 )-alkyl, (C 1 -C 6 )-Alkoxy-(C 1 -C 6 )-haloalkyl, Aryl, Aryl-(C 1 -C 6 )-alkyl, Heteroaryl, Heteroaryl-(C 1 -C 6 )-alkyl, Heterocyclyl-(C 1 -C 6 )-alkyl, (C 3 -C 6 )-Cycloalkyl- (C 1 -C 6 )-alkyl, (C 4 -C 6 )-Cycloalkenyl-(C 1 -C 6 )-alkyl, Bis-[(C 1 -C 6 )-alkyl]amino, (C 1 -C 6 )- Alkyl-amino, Aryl-(C 1 -C 6 )-amino, Aryl-(C 1 -C 6 )-alkyl-amino, Aryl-[(C 1 -C 6 )- alkyl]amino; (C 3 -C 6 )-Cycloalkyl-amino, (C 3 -C 6)-Cycloalkyl-[(C 1 -C 6 )-alkyl]amino; N-azetidinyl, N-pyrrolidinyl, N-piperidinyl, N-morpholinyl and R 15 and R 16 independently of each other for (C 1 -C 6 )-alkyl, (C 3 -C 6 )-cycloalkyl, aryl, heteroaryl, heterocyclyl, or R 15 and R 16 with the carbon atom to which they are attached, form a fully saturated monocyclic 3- to 6-membered carbocycle.

4. Compounds of the general formula (I) according to any one of claims 1 to 3 and / or a salt thereof, characterized in that R 1 represents hydrogen, fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, C(O)NH2, C(S)NH2, R 3 and R 4 independently represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, prop-1-yl, prop-2-yl, but-1-yl, but-2-yl, 2-methyl-prop-1-yl, 1,1-dimethyleth-1-yl, trifluoromethyl, R 5 stands for hydrogen, R6 stands for methyl, ethyl, R 7 stands for hydrogen, G stands for methylene, (methyl)methylene, (ethyl)methylene, (prop-1-yl)methylene, (prop-2-yl)methylene, (but-1-yl)methylene, (but-2-yl)methylene, (pent-1-yl)methylene, (pent-2-yl)methylene, (pent-3-yl)methylene, (dimethyl)methylene, (diethyl)methylene, ethylene, n- Propylene, (1-methyl)ethyl-1-ene, (2-methyl)ethyl-1-ene, n-butylene, 1-methylpropyl-1-ene, 2-methylpropyl-1-ene, 3-methylpropyl-1-ene, 1,1-dimethylethyl-1-ene, 2,2-dimethylethyl-1-ene, 1-ethylethyl-1-ene, 2-ethylethyl-1-ene, n-pentylene, 1-methylbutyl-1-ene, 2-methylbutyl-1-ene, 3-methylbutyl-1-ene, 4-methylbutyl-1-ene, 1,1-dimethylpropyl-1-ene, 2,2-dimethylpropyl-1-ene, 3,3-dimethylpropyl-1-ene, 1-ethylpropyl-1-ene, n-hexylene, X represents methyl or amino and Q represents one of the following specifically mentioned groups Q-1 to Q-500: 0 y ' o.'. / `c3 N o.-.N„,"..0.-N--- ' ' '' ' ."'"o"----"-0 . . . , -- .1 . yo s z oN7Nsz r oN / Ns z ,r•C) „."0 -... / .'-s-'`,. I 0 S (:)- -s , `-.0.---...„...---.. S .,1..„ ---,. 1 F F Q-46 Q-47 Q-48 Q-49 Q-50 ... . .. , . . ' ' ' .o'i o• ‘\ 0.\ .7' 0 z - .o .)`o () 07 'N . 'N:*".....",...A,.i n l ..... ,.. / 0....................0,,,,,,,c .-- „..0......,........,0.„.,,,cy..-,. 0 „,,,,,,7 .„, „ 0 \ " / 0. cy • v . 0 N .._ f O N / N .7 .7 o o . 7 o 0 ) \ ---- s oz 0 oo ,” * . / \ zo ZN / y VN / Cc ---1° s %.„. "N s ---- N., . with *0 o II with *o O ° ",..0„...„,,,,....,,S 1, "0„...„,,,,,Si, ,.. N... / ."'",. / ,7 NV\ / z o \ () 0 () 0 " ' N' ' N ) CI C i CI 3 , 0 .. )CI 5. Compounds of general formula (I) according to any one of claims 1 to 4 and / or their salt, characterized in that R 1 represents hydrogen, fluorine, R 2 represents fluorine, chlorine, bromine, cyano, nitro, R 3 and R 4 independently of one another represent hydrogen, fluorine, chlorine, bromine, methyl, ethyl, R 5 stands for hydrogen, R 6 stands for methyl, ethyl, R 7represents hydrogen, G represents methylene, (methyl)methylene, (ethyl)methylene, (prop-1-yl)methylene, (prop-2-yl)methylene, (but-1-yl)methylene, (pent-1-yl)methylene, (dimethyl)methylene, (diethyl)methylene, ethylene, n-propylene, (1-methyl)ethyl-1-ene, (2-methyl)ethyl-1-ene, n-butylene, 1-methylpropyl-1-ene, 2-methylpropyl-1-ene, 3-methylpropyl-1-ene, 1,1-dimethylethyl-1-ene, 2,2-dimethylethyl-1-ene, 1-ethylethyl-1-ene, 2-ethylethyl-1-ene, n-pentylene, X represents methyl or amino, preferably methyl, and Q represents one of the groups Q-1 to Q-1 specifically mentioned in claim 4. Q-500.

6. Compounds of general formula (I) according to any one of claims 1 to 5 and / or a salt thereof, characterized in that R 1 represents hydrogen, fluorine, R 2 stands for fluorine, chlorine, bromine, cyano, nitro, R 3 and R 4 independently represent hydrogen, R 5 stands for hydrogen, R 6 stands for methyl, ethyl, R 7represents hydrogen, G represents methylene, (methyl)methylene, (ethyl)methylene, (dimethyl)methylene, ethylene, n-propylene, (1-methyl)ethyl-1-ene, (2-methyl)ethyl-1-ene, n-butylene, X represents methyl or amino, preferably methyl, and Q represents one of the groups Q-1 to Q-500 specifically mentioned in claim 4.

7. Compounds of the general formula (I) according to any one of claims 1 to 6 and / or a salt thereof, characterized in that R 1 represents hydrogen, fluorine, R 2 stands for chlorine, bromine, cyano, nitro, R 3 and R 4 stand for hydrogen, R 5 stands for hydrogen, R 6 stands for methyl, ethyl, R 7 stands for hydrogen, G stands for methylene, X stands for methyl and Q represents one of the groups Q-1 to Q-500 specifically mentioned in claim 4.

8. Compounds of the general formula (I) according to any one of claims 1 to 7 and / or a salt thereof, characterized in that R 1stands for fluorine, R 2 stands for chlorine, R 3 and R 4 stand for hydrogen, R 5 stands for hydrogen, R 6 stands for methyl, R 7 represents hydrogen, G represents methylene, X represents methyl, and Q represents one of the groups Q-371, Q-442, Q-471, or Q-481 mentioned in claim 4.

9. Use of one or more compounds of the general formula (I) as defined in any one of claims 1 to 8 and / or salts thereof, as a herbicide and / or plant growth regulator, preferably in crops of useful and / or ornamental plants.

10. A herbicidal and / or plant growth regulating agent, characterized in that the agent contains one or more compounds of the general formula (I) as defined in any one of claims 1 to 8 and / or salts thereof, and furthermore one or more substances selected from groups (i) and / or (ii), with (i) one or more further agrochemically active substances, preferably selected from the group consisting of insecticides, acaricides, nematicides, other herbicides, fungicides, safeners, fertilizers, and / or other growth regulators, (ii) one or more formulation auxiliaries customary in plant protection.

11. A method for controlling weeds or for regulating plant growth, characterized in that an effective amount of - one or more compounds of the general formula (I) as defined in any one of claims 1 to 8 and / or salts thereof, or - an agent according to claim 10 is applied to the plants, plant seeds, the soil in or on which the plants grow, or the cultivated area.

Images